{
  "usdmVersion": "4.0",
  "generatedAt": "2026-01-23T02:31:27.201804",
  "generator": "Protocol2USDM v6.5.0",
  "study": {
    "id": "8ffcef34-67d4-410e-ad55-3d0c8b19e8c6",
    "instanceType": "Study",
    "versions": [
      {
        "id": "98d9884b-3683-4491-8bc3-a26dbf78c58b",
        "instanceType": "StudyVersion",
        "versionIdentifier": "1.0",
        "studyDesigns": [
          {
            "id": "d46035ae-8230-4bd2-8371-0aa7d3eae661",
            "name": "Study Design",
            "rationale": "Protocol-defined study design for investigating efficacy and safety",
            "instanceType": "InterventionalStudyDesign",
            "blindingSchema": {
              "id": "98c3af6c-67f9-4b8a-8c92-c9b4fc404e90",
              "standardCode": {
                "id": "ec6bd720-95e4-4c08-b69a-b00c4bad193a",
                "code": "Double Blind",
                "codeSystem": "http://www.cdisc.org",
                "codeSystemVersion": "2024-09-27",
                "decode": "Double Blind",
                "instanceType": "Code"
              },
              "instanceType": "AliasCode"
            },
            "randomizationType": {
              "code": "Randomized"
            },
            "arms": [
              {
                "id": "19eda89d-394e-42d5-a474-5c8112fd7697",
                "name": "PDR001 + Dabrafenib + Trametinib",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "PDR001 in combination with dabrafenib and trametinib",
                "type": {
                  "id": "C174266",
                  "code": "C174266",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Investigational Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "5e8c04a1-60b8-469c-8c05-d8d986c0f0ea",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              },
              {
                "id": "463c9798-2037-4934-9c04-baf1c38d3e26",
                "name": "Placebo + Dabrafenib + Trametinib",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Placebo in combination with dabrafenib and trametinib",
                "type": {
                  "id": "C174268",
                  "code": "C174268",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.12e",
                  "decode": "Placebo Control Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "377eb5a8-782d-438a-bf8b-2ecd731eeb78",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              }
            ],
            "studyCohorts": [
              {
                "id": "774ea9e8-d8a2-4e0c-959f-e8686952bb1d",
                "name": "Part 1: Safety run-in",
                "instanceType": "StudyCohort",
                "characteristic": "Subjects enrolled to determine dose-limiting toxicities and recommended regimen"
              },
              {
                "id": "dc627cc6-a503-4489-b1e2-6c126cce6345",
                "name": "Part 2: Biomarker cohort",
                "instanceType": "StudyCohort",
                "characteristic": "Subjects enrolled for pharmacodynamic and biomarker characterization"
              },
              {
                "id": "d7abe4ed-1858-4087-b549-d16bdceedaf0",
                "name": "Part 3: Randomized part",
                "instanceType": "StudyCohort",
                "characteristic": "Treatment-naive patients with BRAF V600 mutant melanoma randomized to double-blind treatment"
              }
            ],
            "studyCells": [
              {
                "id": "ddcc1a62-a461-493e-bfdf-aa1b15329502",
                "armId": "19eda89d-394e-42d5-a474-5c8112fd7697",
                "epochId": "c8beb933-cf47-4316-815a-e216abe6da62",
                "elementIds": [
                  "9e6a7043-fa61-49e7-aa67-066f791dd3c7"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "788d3adb-2ad5-4639-8632-7cd0e69c17aa",
                "armId": "19eda89d-394e-42d5-a474-5c8112fd7697",
                "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23",
                "elementIds": [
                  "7bbe580a-4cee-480d-baea-d36eeb09e338"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "033289a6-a0a9-45a6-80d7-5e44fbfbb1d4",
                "armId": "19eda89d-394e-42d5-a474-5c8112fd7697",
                "epochId": "f82007d7-8606-4120-b073-7056f0173f13",
                "elementIds": [
                  "9a28c0f5-e7d2-4745-8a6a-6e194e4fa456"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "91f1121d-b10f-4d4b-8479-231abd7d0e26",
                "armId": "19eda89d-394e-42d5-a474-5c8112fd7697",
                "epochId": "45174ff6-dc88-4aac-9542-6284a3f097d6",
                "elementIds": [
                  "f8c25e65-3e85-4021-8498-31982410948f"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "7a6e2c27-6b2c-42ac-84f0-73b8ba17aeec",
                "armId": "463c9798-2037-4934-9c04-baf1c38d3e26",
                "epochId": "c8beb933-cf47-4316-815a-e216abe6da62",
                "elementIds": [
                  "0a1878d9-4a7f-4e08-a2cf-7f905ad428cf"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "be4e81c2-d068-4b2f-ba01-f9efd17b39d7",
                "armId": "463c9798-2037-4934-9c04-baf1c38d3e26",
                "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23",
                "elementIds": [
                  "358088af-9260-4e8f-9e13-546f06d34340"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "6ae40a1d-e3ab-4152-993e-bff4d58070db",
                "armId": "463c9798-2037-4934-9c04-baf1c38d3e26",
                "epochId": "f82007d7-8606-4120-b073-7056f0173f13",
                "elementIds": [
                  "4bfc74a4-977e-41d7-b5b8-21657c7ef4b0"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "59b0eaf2-660b-4748-b0a3-b5587cea254b",
                "armId": "463c9798-2037-4934-9c04-baf1c38d3e26",
                "epochId": "45174ff6-dc88-4aac-9542-6284a3f097d6",
                "elementIds": [
                  "3c7e43a4-b365-48cc-9598-76272d2d3ed8"
                ],
                "instanceType": "StudyCell"
              }
            ],
            "studyElements": [
              {
                "id": "9e6a7043-fa61-49e7-aa67-066f791dd3c7",
                "name": "PDR001 + Dabrafenib + Trametinib - Screening",
                "instanceType": "StudyElement",
                "description": "Treatment period for PDR001 + Dabrafenib + Trametinib during Screening"
              },
              {
                "id": "7bbe580a-4cee-480d-baea-d36eeb09e338",
                "name": "PDR001 + Dabrafenib + Trametinib - Treatment Phase",
                "instanceType": "StudyElement",
                "description": "Treatment period for PDR001 + Dabrafenib + Trametinib during Treatment Phase"
              },
              {
                "id": "9a28c0f5-e7d2-4745-8a6a-6e194e4fa456",
                "name": "PDR001 + Dabrafenib + Trametinib - Safety Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for PDR001 + Dabrafenib + Trametinib during Safety Follow-up"
              },
              {
                "id": "f8c25e65-3e85-4021-8498-31982410948f",
                "name": "PDR001 + Dabrafenib + Trametinib - Survival Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for PDR001 + Dabrafenib + Trametinib during Survival Follow-up"
              },
              {
                "id": "0a1878d9-4a7f-4e08-a2cf-7f905ad428cf",
                "name": "Placebo + Dabrafenib + Trametinib - Screening",
                "instanceType": "StudyElement",
                "description": "Treatment period for Placebo + Dabrafenib + Trametinib during Screening"
              },
              {
                "id": "358088af-9260-4e8f-9e13-546f06d34340",
                "name": "Placebo + Dabrafenib + Trametinib - Treatment Phase",
                "instanceType": "StudyElement",
                "description": "Treatment period for Placebo + Dabrafenib + Trametinib during Treatment Phase"
              },
              {
                "id": "4bfc74a4-977e-41d7-b5b8-21657c7ef4b0",
                "name": "Placebo + Dabrafenib + Trametinib - Safety Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for Placebo + Dabrafenib + Trametinib during Safety Follow-up"
              },
              {
                "id": "3c7e43a4-b365-48cc-9598-76272d2d3ed8",
                "name": "Placebo + Dabrafenib + Trametinib - Survival Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for Placebo + Dabrafenib + Trametinib during Survival Follow-up"
              }
            ],
            "maskingRoles": [
              {
                "id": "bac68211-c9d9-471c-85d5-ddd1bc3323d8",
                "text": "Subject is masked in this Double Blind study",
                "isMasked": true,
                "instanceType": "Masking"
              },
              {
                "id": "7b4b856a-3dfe-4915-9233-d418cdd64d2d",
                "text": "Investigator is masked in this Double Blind study",
                "isMasked": true,
                "instanceType": "Masking"
              }
            ],
            "eligibilityCriteria": [
              {
                "id": "9d52b518-b3f0-48b3-8955-d76dfe5d23b5",
                "identifier": "5.2.1",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "fa83c306-7f64-4cd0-baed-d1e6c8e7d993",
                "instanceType": "EligibilityCriterion",
                "name": "Safety run-in specific inclusion",
                "nextId": "5fa9f3da-4d55-4e16-b872-29b0eb5df746"
              },
              {
                "id": "5fa9f3da-4d55-4e16-b872-29b0eb5df746",
                "identifier": "5.2.2",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "08bd095b-8a15-4631-8d5d-0cb5a0163889",
                "instanceType": "EligibilityCriterion",
                "name": "Biomarker cohort specific inclusion",
                "previousId": "9d52b518-b3f0-48b3-8955-d76dfe5d23b5",
                "nextId": "c02ac7f8-225e-4509-84b1-64c2c0fc536d"
              },
              {
                "id": "c02ac7f8-225e-4509-84b1-64c2c0fc536d",
                "identifier": "5.2.3",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "a849bab3-be18-4c02-b99e-3d71c92b219c",
                "instanceType": "EligibilityCriterion",
                "name": "Randomized part specific inclusion",
                "previousId": "5fa9f3da-4d55-4e16-b872-29b0eb5df746",
                "nextId": "3fdf17b3-c968-4e0a-9323-b62446375a3f"
              },
              {
                "id": "3fdf17b3-c968-4e0a-9323-b62446375a3f",
                "identifier": "5.2.4",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "343020d4-34ca-4c14-96c6-2976279493c9",
                "instanceType": "EligibilityCriterion",
                "name": "General inclusion criteria",
                "previousId": "c02ac7f8-225e-4509-84b1-64c2c0fc536d"
              },
              {
                "id": "27730e5c-359a-476d-a3d5-abf644d9aca0",
                "identifier": "5.3.1",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "5e95ff4e-f92c-4139-9c95-d5534a2a5f1e",
                "instanceType": "EligibilityCriterion",
                "name": "Safety run-in specific exclusion",
                "nextId": "17da9aae-1077-4d4c-a260-32fac01e78e8"
              },
              {
                "id": "17da9aae-1077-4d4c-a260-32fac01e78e8",
                "identifier": "5.3.2",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "4e9fa6d1-de4a-4d77-9825-183397b8c6d4",
                "instanceType": "EligibilityCriterion",
                "name": "Biomarker and Randomized part specific exclusion",
                "previousId": "27730e5c-359a-476d-a3d5-abf644d9aca0",
                "nextId": "1f4bc2e1-29ab-4807-bc59-e739a42ad30f"
              },
              {
                "id": "1f4bc2e1-29ab-4807-bc59-e739a42ad30f",
                "identifier": "5.3.3",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "0471e5e7-45e8-4569-a43b-f1c8e44b68d6",
                "instanceType": "EligibilityCriterion",
                "name": "General exclusion criteria",
                "previousId": "17da9aae-1077-4d4c-a260-32fac01e78e8"
              }
            ],
            "population": {
              "id": "c1131d0c-6a39-4175-aa16-49dc9ee5ebac",
              "name": "Study Population",
              "includesHealthySubjects": false,
              "criterionIds": [
                "9d52b518-b3f0-48b3-8955-d76dfe5d23b5",
                "5fa9f3da-4d55-4e16-b872-29b0eb5df746",
                "c02ac7f8-225e-4509-84b1-64c2c0fc536d",
                "3fdf17b3-c968-4e0a-9323-b62446375a3f",
                "27730e5c-359a-476d-a3d5-abf644d9aca0",
                "17da9aae-1077-4d4c-a260-32fac01e78e8",
                "1f4bc2e1-29ab-4807-bc59-e739a42ad30f"
              ],
              "instanceType": "StudyDesignPopulation",
              "description": "Target population defined by eligibility criteria"
            },
            "objectives": [
              {
                "id": "5977f1ba-ec29-4bd2-80fc-bffaa2c80b3a",
                "name": "Primary Efficacy Objective",
                "text": "To evaluate the efficacy of Drug X compared to placebo",
                "level": {
                  "id": "C85826",
                  "code": "C85826",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Primary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "dc0559b9-ca06-4972-8171-a85ab7c2f6d3"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "a08cb318-dbc0-4d0c-a442-378e88b93078",
                "name": "Key Secondary Objective",
                "text": "To characterize the overall survival benefit",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "84a9e868-e12b-4620-9e65-67110a92c81b"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "3c37de4e-0289-4833-a2ff-06303e37a31c",
                "name": "Safety Objective",
                "text": "To evaluate safety and tolerability of PDR001 in combination with dabrafenib and trametinib",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "29489cc6-b607-449b-8d2a-c17eefb0621c"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "8d14ec33-3e21-41fd-a7cb-fe4f8c0b592e",
                "name": "Biomarker Objective",
                "text": "To identify and characterize potential resistance mechanism",
                "level": {
                  "id": "C163559",
                  "code": "C163559",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Exploratory Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "7118ce18-bdea-4821-bf37-665cd7287a99"
                ],
                "instanceType": "Objective"
              }
            ],
            "endpoints": [
              {
                "id": "dc0559b9-ca06-4972-8171-a85ab7c2f6d3",
                "name": "Primary Efficacy Endpoint",
                "text": "investigator-assessed PFS",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "84a9e868-e12b-4620-9e65-67110a92c81b",
                "name": "Key Secondary Endpoint",
                "text": "Overall Survival (OS)",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "29489cc6-b607-449b-8d2a-c17eefb0621c",
                "name": "Safety Endpoint",
                "text": "Incidence and severity of adverse events (AEs) and treatment related AEs (TRAEs)",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Safety"
              },
              {
                "id": "7118ce18-bdea-4821-bf37-665cd7287a99",
                "name": "Exploratory Biomarker Endpoint",
                "text": "Mandatory blood and optional tissue sample collection at the time of progression",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Biomarker"
              }
            ],
            "estimands": [
              {
                "id": "5e741976-bb5e-4b8e-8130-277498e0ceef",
                "name": "Primary Efficacy Estimand - PFS",
                "populationSummary": "Adult patients with untreated BRAF V600 mutant melanoma (Full Analysis Set/ITT) Summary measure: Hazard Ratio (HR) from a stratified Cox proportional hazards model.",
                "analysisPopulationId": "1c2ac062-c1a4-41c3-ae53-f30517455ec3",
                "variableOfInterestId": "dc0559b9-ca06-4972-8171-a85ab7c2f6d3",
                "interventionIds": [
                  "950e58aa-cf5c-4e1e-8b7d-a511b3d4d04e"
                ],
                "intercurrentEvents": [
                  {
                    "id": "8a2f3d7d-c2ed-4da4-af06-fc0a05572a22",
                    "name": "Treatment discontinuation",
                    "text": "Discontinuation of study treatment for any reason other than disease progression or death",
                    "strategy": "Treatment Policy",
                    "instanceType": "IntercurrentEvent"
                  },
                  {
                    "id": "003fe985-3349-4d5c-8a71-e6ac92fc49e2",
                    "name": "Death",
                    "text": "Death due to any cause",
                    "strategy": "Composite",
                    "instanceType": "IntercurrentEvent"
                  },
                  {
                    "id": "4f9aceea-9467-48f2-9fc6-cb04628fe06e",
                    "name": "COVID-19 related disruption",
                    "text": "Delays in treatment or virtual visits due to the COVID-19 pandemic",
                    "strategy": "Treatment Policy",
                    "instanceType": "IntercurrentEvent"
                  }
                ],
                "instanceType": "Estimand",
                "treatment": "PDR001 in combination with dabrafenib and trametinib vs Placebo in combination with dabrafenib and trametinib",
                "analysisPopulation": "Adult patients with untreated BRAF V600 mutant melanoma (Full Analysis Set/ITT)",
                "variableOfInterest": "Progression-Free Survival (PFS) based on investigator assessment per RECIST 1.1",
                "summaryMeasure": "Hazard Ratio (HR) from a stratified Cox proportional hazards model"
              },
              {
                "id": "a5470fec-c726-4f89-8f09-c14a7e6ac16c",
                "name": "Key Secondary Estimand - OS",
                "populationSummary": "Adult patients with untreated BRAF V600 mutant melanoma (Full Analysis Set/ITT) Summary measure: Hazard Ratio (HR).",
                "analysisPopulationId": "055be5f2-8f79-4bd6-a432-987ccea917e3",
                "variableOfInterestId": "84a9e868-e12b-4620-9e65-67110a92c81b",
                "interventionIds": [
                  "c84c0ef2-d9c6-4e33-a558-37cb13d4c028"
                ],
                "intercurrentEvents": [
                  {
                    "id": "fcc4f4d2-d850-4436-93b6-f84790359463",
                    "name": "Treatment switching/Unblinding",
                    "text": "Mandatory unblinding and discontinuation of placebo following final PFS analysis",
                    "strategy": "Treatment Policy",
                    "instanceType": "IntercurrentEvent"
                  }
                ],
                "instanceType": "Estimand",
                "treatment": "PDR001 in combination with dabrafenib and trametinib vs Placebo in combination with dabrafenib and trametinib",
                "analysisPopulation": "Adult patients with untreated BRAF V600 mutant melanoma (Full Analysis Set/ITT)",
                "variableOfInterest": "Overall Survival (OS)",
                "summaryMeasure": "Hazard Ratio (HR)"
              },
              {
                "id": "858572fa-dd36-4b14-ba14-deb1dee28414",
                "name": "Safety Estimand",
                "populationSummary": "All patients who received at least one dose of study treatment (Safety Set) Summary measure: Risk difference or frequency proportions.",
                "analysisPopulationId": "24e1aa25-9ef9-4376-89ad-1ca760d75293",
                "variableOfInterestId": "29489cc6-b607-449b-8d2a-c17eefb0621c",
                "interventionIds": [
                  "6ac45217-36b1-4520-89b3-ffa96dbbb8ad"
                ],
                "intercurrentEvents": [
                  {
                    "id": "6e9b2eb7-8c89-460e-8d28-61dc8d18bd72",
                    "name": "Treatment discontinuation",
                    "text": "Discontinuation of any or all three drugs due to AEs",
                    "strategy": "While on Treatment",
                    "instanceType": "IntercurrentEvent"
                  }
                ],
                "instanceType": "Estimand",
                "treatment": "PDR001 in combination with dabrafenib and trametinib vs Placebo in combination with dabrafenib and trametinib",
                "analysisPopulation": "All patients who received at least one dose of study treatment (Safety Set)",
                "variableOfInterest": "Incidence and severity of adverse events (AEs) and treatment related AEs (TRAEs)",
                "summaryMeasure": "Risk difference or frequency proportions"
              }
            ],
            "scheduleTimelines": [
              {
                "id": "af7f0ca5-5f7f-4985-a7a4-3d51a15f8658",
                "name": "Main Schedule Timeline",
                "mainTimeline": true,
                "instanceType": "ScheduleTimeline",
                "entryCondition": "Subject enrolled in study",
                "entryId": "af29b2f1-c12f-42bb-95ec-8a2a3b4bccb2",
                "instances": [
                  {
                    "id": "af29b2f1-c12f-42bb-95ec-8a2a3b4bccb2",
                    "activityIds": [
                      "a6a3ad74-a23e-4c63-96f2-8625abb982ea"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_1",
                    "encounterId": "233680c1-370b-44fb-a5e8-74bd0d8e8797",
                    "epochId": "c8beb933-cf47-4316-815a-e216abe6da62"
                  },
                  {
                    "id": "7bfee31c-656d-4d94-9e1c-8542ac3f795a",
                    "activityIds": [
                      "26e1ab38-15d3-492e-bf2d-cfff6d02a07e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@enc_1",
                    "encounterId": "233680c1-370b-44fb-a5e8-74bd0d8e8797",
                    "epochId": "c8beb933-cf47-4316-815a-e216abe6da62"
                  },
                  {
                    "id": "75bd6170-3ee8-44d6-bc85-02401acca9e4",
                    "activityIds": [
                      "883f288b-3ab8-4819-9751-402dfafb5733"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_1",
                    "encounterId": "233680c1-370b-44fb-a5e8-74bd0d8e8797",
                    "epochId": "c8beb933-cf47-4316-815a-e216abe6da62"
                  },
                  {
                    "id": "e22ed1ba-7150-4dad-bd02-cf44a96e36a4",
                    "activityIds": [
                      "b53dd21a-14ce-422d-ab3b-056ad4761c84"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_1",
                    "encounterId": "233680c1-370b-44fb-a5e8-74bd0d8e8797",
                    "epochId": "c8beb933-cf47-4316-815a-e216abe6da62"
                  },
                  {
                    "id": "7b6be9bf-74fd-42ec-9b5e-9af987c93a5a",
                    "activityIds": [
                      "4f50e206-c67f-461f-9f6e-cdf8e05e7cd9"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_1",
                    "encounterId": "233680c1-370b-44fb-a5e8-74bd0d8e8797",
                    "epochId": "c8beb933-cf47-4316-815a-e216abe6da62"
                  },
                  {
                    "id": "83c0ea0f-d9ae-4c77-b2d8-10b83d531bdb",
                    "activityIds": [
                      "5051d041-f995-4db5-aef1-2ea47b9767d7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_6@enc_1",
                    "encounterId": "233680c1-370b-44fb-a5e8-74bd0d8e8797",
                    "epochId": "c8beb933-cf47-4316-815a-e216abe6da62"
                  },
                  {
                    "id": "244684e4-b1bd-4ee9-9607-5f624d0b80f3",
                    "activityIds": [
                      "74858707-e0da-4baa-988f-3d002f421daf"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@enc_1",
                    "encounterId": "233680c1-370b-44fb-a5e8-74bd0d8e8797",
                    "epochId": "c8beb933-cf47-4316-815a-e216abe6da62"
                  },
                  {
                    "id": "06fded52-e6e1-485b-934d-296fd1229550",
                    "activityIds": [
                      "96204503-e3ea-4d1c-aa32-b0946d94a797"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@enc_1",
                    "encounterId": "233680c1-370b-44fb-a5e8-74bd0d8e8797",
                    "epochId": "c8beb933-cf47-4316-815a-e216abe6da62"
                  },
                  {
                    "id": "335a26e1-151a-4186-8310-8f110a2989b3",
                    "activityIds": [
                      "5a5b2221-2342-41b8-b160-01cbd553444b"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_9@enc_1",
                    "encounterId": "233680c1-370b-44fb-a5e8-74bd0d8e8797",
                    "epochId": "c8beb933-cf47-4316-815a-e216abe6da62"
                  },
                  {
                    "id": "6aa62500-6a89-41c6-ab46-6b22c64d5e6b",
                    "activityIds": [
                      "05e514d8-27f8-41de-9c83-4c4ec7504867"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_10@enc_1",
                    "encounterId": "233680c1-370b-44fb-a5e8-74bd0d8e8797",
                    "epochId": "c8beb933-cf47-4316-815a-e216abe6da62"
                  },
                  {
                    "id": "0025f8a3-a50a-4c05-a190-651f19645975",
                    "activityIds": [
                      "07eae9fd-c41c-44cd-97c3-6da437a55a36"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_11@enc_1",
                    "encounterId": "233680c1-370b-44fb-a5e8-74bd0d8e8797",
                    "epochId": "c8beb933-cf47-4316-815a-e216abe6da62"
                  },
                  {
                    "id": "f2672008-5f2e-4a1c-9563-06f7336b30f3",
                    "activityIds": [
                      "517a28f3-fc96-4d1d-97d0-728b5bf65bca"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_12@enc_1",
                    "encounterId": "233680c1-370b-44fb-a5e8-74bd0d8e8797",
                    "epochId": "c8beb933-cf47-4316-815a-e216abe6da62"
                  },
                  {
                    "id": "a7a99ae9-0b75-417a-83e5-02e1b02911d9",
                    "activityIds": [
                      "c95b7c00-7f03-4d7f-80ee-a65c9657f90c"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_13@enc_12",
                    "encounterId": "7b8beecd-d8ed-454e-a353-9a2ca8a18c5d",
                    "epochId": "f82007d7-8606-4120-b073-7056f0173f13"
                  },
                  {
                    "id": "b37c93a9-9655-47a3-87ea-f2b2bb352985",
                    "activityIds": [
                      "c95b7c00-7f03-4d7f-80ee-a65c9657f90c"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_13@enc_13",
                    "encounterId": "93d04d45-49fb-42ec-8f65-7859e3bc0483",
                    "epochId": "f82007d7-8606-4120-b073-7056f0173f13"
                  },
                  {
                    "id": "9caf9b00-6fd9-4f1d-8ab7-97e4bcea4536",
                    "activityIds": [
                      "c95b7c00-7f03-4d7f-80ee-a65c9657f90c"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_13@enc_14",
                    "encounterId": "767f3fdf-7511-4a3a-a531-b80885ece3a4",
                    "epochId": "f82007d7-8606-4120-b073-7056f0173f13"
                  },
                  {
                    "id": "7e358c01-9a15-4ff4-b3cd-048149f81d4f",
                    "activityIds": [
                      "c95b7c00-7f03-4d7f-80ee-a65c9657f90c"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_13@enc_15",
                    "encounterId": "445a0fea-bfbf-4b46-919a-d58d27ccc81a",
                    "epochId": "f82007d7-8606-4120-b073-7056f0173f13"
                  },
                  {
                    "id": "076e41f9-dde1-4657-a6a5-1482aeb13bdc",
                    "activityIds": [
                      "c95b7c00-7f03-4d7f-80ee-a65c9657f90c"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_13@enc_16",
                    "encounterId": "76d9b2d2-99aa-4d10-9cf4-37eab9945a92",
                    "epochId": "f82007d7-8606-4120-b073-7056f0173f13"
                  },
                  {
                    "id": "f08edd99-cd21-4ee1-8dbc-92330fc1c19f",
                    "activityIds": [
                      "c95b7c00-7f03-4d7f-80ee-a65c9657f90c"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_13@enc_17",
                    "encounterId": "d695260e-71d8-44af-aaaa-656b6aaef0af",
                    "epochId": "f82007d7-8606-4120-b073-7056f0173f13"
                  },
                  {
                    "id": "9505aded-f197-4cea-98eb-66374570c27a",
                    "activityIds": [
                      "c95b7c00-7f03-4d7f-80ee-a65c9657f90c"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_13@enc_18",
                    "encounterId": "86e942a9-ed50-4bb8-b863-4cad07a33b0a",
                    "epochId": "f82007d7-8606-4120-b073-7056f0173f13"
                  },
                  {
                    "id": "6eb0da91-59a5-4f26-836d-9e58c02a3a18",
                    "activityIds": [
                      "e2130c2d-da8b-45b4-9df5-5d6a2b5e008d"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_14@enc_2",
                    "encounterId": "d8011093-0f47-45ef-b9b7-7525de5f221e",
                    "timingId": "99864543-85e0-4911-9d58-6c0b785e40ff",
                    "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23"
                  },
                  {
                    "id": "7108e3f7-b5de-49f9-a2f6-5c4e7684547d",
                    "activityIds": [
                      "e2130c2d-da8b-45b4-9df5-5d6a2b5e008d"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_14@enc_5",
                    "encounterId": "fe95fe18-c4d4-4902-b4ed-9fa6cab34631",
                    "timingId": "99864543-85e0-4911-9d58-6c0b785e40ff",
                    "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23"
                  },
                  {
                    "id": "92da74e4-70ae-48ff-9bf4-7522aa580d51",
                    "activityIds": [
                      "e2130c2d-da8b-45b4-9df5-5d6a2b5e008d"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_14@enc_8",
                    "encounterId": "bb077b8f-52e1-4678-bda4-c71687b8c749",
                    "timingId": "99864543-85e0-4911-9d58-6c0b785e40ff",
                    "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23"
                  },
                  {
                    "id": "4dbd0451-b9eb-4e1a-b130-349a64355fea",
                    "activityIds": [
                      "e2130c2d-da8b-45b4-9df5-5d6a2b5e008d"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_14@enc_10",
                    "encounterId": "0cb82d63-fd32-4488-a817-37efc335ef04",
                    "timingId": "99864543-85e0-4911-9d58-6c0b785e40ff",
                    "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23"
                  },
                  {
                    "id": "8d0534e9-c234-4225-95cc-6760908e97e8",
                    "activityIds": [
                      "b4c26fa7-6172-464c-88ad-03a56caa742e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_15@enc_11",
                    "encounterId": "05d414aa-4601-4f32-adb6-e06fdef4da5a",
                    "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23"
                  },
                  {
                    "id": "1e733722-a3f0-4f43-8f30-fb649f59d54e",
                    "activityIds": [
                      "b4c26fa7-6172-464c-88ad-03a56caa742e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_15@enc_17",
                    "encounterId": "d695260e-71d8-44af-aaaa-656b6aaef0af",
                    "epochId": "f82007d7-8606-4120-b073-7056f0173f13"
                  },
                  {
                    "id": "11dbe0e5-a021-469c-ab25-65a86ba7610e",
                    "activityIds": [
                      "b4c26fa7-6172-464c-88ad-03a56caa742e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_15@enc_18",
                    "encounterId": "86e942a9-ed50-4bb8-b863-4cad07a33b0a",
                    "epochId": "f82007d7-8606-4120-b073-7056f0173f13"
                  },
                  {
                    "id": "e060b666-cd9e-4c10-9814-4cf827174b35",
                    "activityIds": [
                      "24b84935-9db2-4fd0-b454-2a618ed8e408"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_16@enc_1",
                    "encounterId": "233680c1-370b-44fb-a5e8-74bd0d8e8797",
                    "epochId": "c8beb933-cf47-4316-815a-e216abe6da62"
                  },
                  {
                    "id": "cda2233e-f7d5-403d-a69a-6c6131525dbc",
                    "activityIds": [
                      "bcef8e1b-af59-4704-8c3f-31e9fae38e10"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_17@enc_1",
                    "encounterId": "233680c1-370b-44fb-a5e8-74bd0d8e8797",
                    "epochId": "c8beb933-cf47-4316-815a-e216abe6da62"
                  },
                  {
                    "id": "3e177eba-1182-40ed-8d81-4fa19aaf17ac",
                    "activityIds": [
                      "bcef8e1b-af59-4704-8c3f-31e9fae38e10"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_17@enc_2",
                    "encounterId": "d8011093-0f47-45ef-b9b7-7525de5f221e",
                    "timingId": "99864543-85e0-4911-9d58-6c0b785e40ff",
                    "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23"
                  },
                  {
                    "id": "4d40b0f5-6426-4075-a843-8e1dd987ae0f",
                    "activityIds": [
                      "bcef8e1b-af59-4704-8c3f-31e9fae38e10"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_17@enc_8",
                    "encounterId": "bb077b8f-52e1-4678-bda4-c71687b8c749",
                    "timingId": "99864543-85e0-4911-9d58-6c0b785e40ff",
                    "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23"
                  },
                  {
                    "id": "e637b481-dbf1-4e2f-b238-2da6167060ed",
                    "activityIds": [
                      "87e5e1ca-2ac1-4a63-b01d-e33175190a43"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_18@enc_1",
                    "encounterId": "233680c1-370b-44fb-a5e8-74bd0d8e8797",
                    "epochId": "c8beb933-cf47-4316-815a-e216abe6da62"
                  },
                  {
                    "id": "5d342d4d-f336-41be-b496-6e28a5f664b3",
                    "activityIds": [
                      "7df28861-2961-4a5a-81bc-0dbe73108d4a"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_19@enc_1",
                    "encounterId": "233680c1-370b-44fb-a5e8-74bd0d8e8797",
                    "epochId": "c8beb933-cf47-4316-815a-e216abe6da62"
                  },
                  {
                    "id": "9704b905-bfdc-4eb5-9162-cc49b30ef553",
                    "activityIds": [
                      "2ca12bf7-9b65-4ed9-9e88-0a518ce57ab8"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_20@enc_1",
                    "encounterId": "233680c1-370b-44fb-a5e8-74bd0d8e8797",
                    "epochId": "c8beb933-cf47-4316-815a-e216abe6da62"
                  },
                  {
                    "id": "f73383d9-a0b5-4d13-8dfa-1a67b7f58800",
                    "activityIds": [
                      "4c6654f0-323e-4c89-9ee8-358f5483f4f0"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_21@enc_1",
                    "encounterId": "233680c1-370b-44fb-a5e8-74bd0d8e8797",
                    "epochId": "c8beb933-cf47-4316-815a-e216abe6da62"
                  },
                  {
                    "id": "5e0d0b14-1700-4508-b5aa-a432b1581cf8",
                    "name": "Anchor: FirstDose",
                    "description": "Time anchor for scheduling: FirstDose",
                    "encounterId": "d8011093-0f47-45ef-b9b7-7525de5f221e",
                    "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23",
                    "activityIds": [],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "e4dfb418-f6a8-45af-af86-3a6c2f9d9b3a",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      }
                    ],
                    "scheduledDay": 1
                  },
                  {
                    "id": "68a77598-ac72-4166-95b6-c248f30a6b1c",
                    "name": "Anchor: CycleStart",
                    "description": "Time anchor for scheduling: CycleStart",
                    "encounterId": "d8011093-0f47-45ef-b9b7-7525de5f221e",
                    "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23",
                    "activityIds": [],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "e4dfb418-f6a8-45af-af86-3a6c2f9d9b3a",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      }
                    ],
                    "scheduledDay": 1
                  },
                  {
                    "id": "75bde574-3a8c-45a5-ac53-5dd523259517",
                    "name": "Anchor: Enrollment",
                    "description": "Time anchor for scheduling: Enrollment",
                    "encounterId": "d8011093-0f47-45ef-b9b7-7525de5f221e",
                    "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23",
                    "activityIds": [],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "e4dfb418-f6a8-45af-af86-3a6c2f9d9b3a",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      }
                    ],
                    "scheduledDay": 1
                  },
                  {
                    "id": "97dae3da-0c48-472a-96b9-5c483f64064e",
                    "name": "Anchor: InformedConsent",
                    "description": "Time anchor for scheduling: InformedConsent",
                    "encounterId": "d8011093-0f47-45ef-b9b7-7525de5f221e",
                    "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23",
                    "activityIds": [],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "e4dfb418-f6a8-45af-af86-3a6c2f9d9b3a",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      }
                    ],
                    "scheduledDay": 1
                  },
                  {
                    "id": "0aacb1ba-943a-4076-868d-46df58e6f2a6",
                    "name": "Anchor: Custom",
                    "description": "Time anchor for scheduling: Custom",
                    "encounterId": "d8011093-0f47-45ef-b9b7-7525de5f221e",
                    "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23",
                    "activityIds": [],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "e4dfb418-f6a8-45af-af86-3a6c2f9d9b3a",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      }
                    ],
                    "scheduledDay": 1
                  },
                  {
                    "id": "c54aee51-0ccb-445e-8751-bf5f940873e7",
                    "name": "Anchor: Screening Window",
                    "activityIds": [],
                    "encounterId": "d8011093-0f47-45ef-b9b7-7525de5f221e",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "5a2fe0cc-6ea6-413d-a9e2-89b914c14da2",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "8ba47d42-be86-4706-baed-81a1bde3d1a6",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23"
                  },
                  {
                    "id": "357fa0b7-a598-4c6f-972b-b675df210dd9",
                    "name": "Anchor: Post-Cycle 1 Visit Window",
                    "activityIds": [],
                    "encounterId": "d8011093-0f47-45ef-b9b7-7525de5f221e",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "771a3a16-e2d3-4dc8-ac91-9ddb9e319260",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "da7d3f97-4322-4703-8a5a-8bd5941a6b3d",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23"
                  },
                  {
                    "id": "d96026a3-f7d2-44c2-9682-819110692e5d",
                    "name": "Anchor: PDR001 Contraception Follow-up",
                    "activityIds": [],
                    "encounterId": "d8011093-0f47-45ef-b9b7-7525de5f221e",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "a186b185-9cbf-4b17-8733-b01a44b97824",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "c1460961-da9a-4132-89a5-4139bb9259b7",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23"
                  },
                  {
                    "id": "060c2f07-dd1f-43fd-bbc5-73b32a95c717",
                    "name": "Anchor: Trametinib Contraception Follow-up",
                    "activityIds": [],
                    "encounterId": "d8011093-0f47-45ef-b9b7-7525de5f221e",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "4b515994-5395-443a-a344-0603aaf8548f",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "cc7d2448-1eec-42ee-b0b2-ed800b9db496",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23"
                  },
                  {
                    "id": "0c93fcbd-9539-424a-9401-838ec7dbc42d",
                    "name": "Anchor: Dabrafenib Contraception Follow-up",
                    "activityIds": [],
                    "encounterId": "d8011093-0f47-45ef-b9b7-7525de5f221e",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "d97849ca-6dc9-4f05-8db1-7d45a2ed21b0",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "a1114c47-9f61-4a5a-8d12-c3d7084314b7",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23"
                  }
                ],
                "timings": [
                  {
                    "id": "af980e36-b8b4-4f21-a668-b69e20092385",
                    "name": "Screening Window",
                    "type": {
                      "id": "69fa2cff-8e37-4c1f-bafe-4669e20a8919",
                      "code": "C71151",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Within",
                      "instanceType": "Code"
                    },
                    "value": "P28D",
                    "valueLabel": "Day 28",
                    "relativeToFrom": {
                      "id": "455aa96a-8517-44f7-94b1-c5e1512a70da",
                      "code": "C71154",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Randomization",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "c54aee51-0ccb-445e-8751-bf5f940873e7",
                    "instanceType": "Timing",
                    "windowLower": "-P28D",
                    "windowUpper": "-P1D"
                  },
                  {
                    "id": "99864543-85e0-4911-9d58-6c0b785e40ff",
                    "name": "Cycle 1 Day 1 Assessment Window",
                    "type": {
                      "id": "05a63823-f294-44e4-8c4b-36ebf1e878ff",
                      "code": "C71151",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Within",
                      "instanceType": "Code"
                    },
                    "value": "P7D",
                    "valueLabel": "Day 7",
                    "relativeToFrom": {
                      "id": "70102327-64ab-41ee-9cf3-10aec56e2324",
                      "code": "C71155",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "First Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "5e0d0b14-1700-4508-b5aa-a432b1581cf8",
                    "instanceType": "Timing",
                    "windowLower": "-P7D",
                    "windowUpper": "P0D"
                  },
                  {
                    "id": "83cd3abe-e07a-4eee-bf24-f555ab9ee0ba",
                    "name": "Post-Cycle 1 Visit Window",
                    "type": {
                      "id": "f3777e1b-386b-4c07-bab6-80560e33d681",
                      "code": "C71148",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Fixed Reference",
                      "instanceType": "Code"
                    },
                    "value": "P0D",
                    "valueLabel": "Day 0",
                    "relativeToFrom": {
                      "id": "633b960e-f284-4e7a-a312-1ea6c47fde73",
                      "code": "C71157",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Previous Visit",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "357fa0b7-a598-4c6f-972b-b675df210dd9",
                    "instanceType": "Timing",
                    "windowLower": "-P7D",
                    "windowUpper": "P7D"
                  },
                  {
                    "id": "90206569-f88a-45ab-8398-41696c0a8989",
                    "name": "Tumor Assessment Frequency (Early)",
                    "type": {
                      "id": "b417a585-79b2-4107-ade7-1df9491a1c92",
                      "code": "C71148",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Fixed Reference",
                      "instanceType": "Code"
                    },
                    "value": "P8W",
                    "valueLabel": "8 weeks",
                    "relativeToFrom": {
                      "id": "d2fdf910-b718-40ba-9229-be938e11b2d6",
                      "code": "C71155",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "First Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "3aa1ab41-d727-4ffa-9556-6f2e3818f154",
                    "instanceType": "Timing",
                    "windowLower": "-P7W",
                    "windowUpper": "P7W"
                  },
                  {
                    "id": "90b32e28-ea30-4a27-9c20-a70d084aa766",
                    "name": "Tumor Assessment Frequency (Late)",
                    "type": {
                      "id": "4e90f8eb-68ff-4429-abcf-72c2af1d229d",
                      "code": "C71148",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Fixed Reference",
                      "instanceType": "Code"
                    },
                    "value": "P12W",
                    "valueLabel": "12 weeks",
                    "relativeToFrom": {
                      "id": "ae770f2e-7b83-4559-9352-a66c7241192b",
                      "code": "C71153",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Study Start",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "e9715912-c065-4aa9-979f-48127b80ca32",
                    "instanceType": "Timing",
                    "windowLower": "-P7W",
                    "windowUpper": "P7W"
                  },
                  {
                    "id": "3c918d39-2e55-4def-a4f6-d564f05554f1",
                    "name": "Confirmatory Tumor Assessment",
                    "type": {
                      "id": "77ff4e5c-9aca-4eb6-b031-3b68e38737ec",
                      "code": "C71150",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "After",
                      "instanceType": "Code"
                    },
                    "value": "P4W",
                    "valueLabel": "4 weeks",
                    "relativeToFrom": {
                      "id": "f526593c-ae2b-4fb8-8e75-a11c775e71f9",
                      "code": "C71157",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Previous Visit",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "fb16b0fb-bb67-411b-8b16-71dae4834a25",
                    "instanceType": "Timing",
                    "windowLower": "P4W",
                    "windowUpper": "P0D"
                  },
                  {
                    "id": "8fb3549c-be98-4d5e-86a9-2b98ad21b8b8",
                    "name": "PDR001 Contraception Follow-up",
                    "type": {
                      "id": "f27f3323-e928-45bb-9470-984ea52f7c23",
                      "code": "C71150",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "After",
                      "instanceType": "Code"
                    },
                    "value": "P150D",
                    "valueLabel": "Day 150",
                    "relativeToFrom": {
                      "id": "3a9ef18b-a7d2-4689-b78c-68b2e39113fd",
                      "code": "C71156",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Last Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "d96026a3-f7d2-44c2-9682-819110692e5d",
                    "instanceType": "Timing",
                    "windowLower": "P150D",
                    "windowUpper": "P0D"
                  },
                  {
                    "id": "b25dae2d-4de2-4a0d-a3f7-7f0401c32e0a",
                    "name": "Trametinib Contraception Follow-up",
                    "type": {
                      "id": "c37159fa-213a-4362-894a-1cb8c447ab6b",
                      "code": "C71150",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "After",
                      "instanceType": "Code"
                    },
                    "value": "P120D",
                    "valueLabel": "Day 120",
                    "relativeToFrom": {
                      "id": "05501d80-4b55-4d8e-9036-6fb3bd86f6a3",
                      "code": "C71156",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Last Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "060c2f07-dd1f-43fd-bbc5-73b32a95c717",
                    "instanceType": "Timing",
                    "windowLower": "P120D",
                    "windowUpper": "P0D"
                  },
                  {
                    "id": "8db8a62d-e467-4dd6-b5f3-81f4c8636828",
                    "name": "Dabrafenib Contraception Follow-up",
                    "type": {
                      "id": "1cb46495-919c-40ad-95c9-d2aabe713d0e",
                      "code": "C71150",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "After",
                      "instanceType": "Code"
                    },
                    "value": "P30D",
                    "valueLabel": "Day 30",
                    "relativeToFrom": {
                      "id": "997c0cfb-7868-416f-a6b9-a6666fe27bce",
                      "code": "C71156",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Last Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "0c93fcbd-9539-424a-9401-838ec7dbc42d",
                    "instanceType": "Timing",
                    "windowLower": "P30D",
                    "windowUpper": "P0D"
                  }
                ],
                "exits": [
                  {
                    "id": "46c5183f-5f2d-4696-ba74-1a689b57d75b",
                    "name": "Unblinding Exit",
                    "exitType": "Early Termination",
                    "instanceType": "ScheduleTimelineExit",
                    "description": "Subject must be discontinued from study treatment if unblinded (prior to Amendment 6)"
                  },
                  {
                    "id": "ed3edb93-d225-4c06-bd19-d36528895f47",
                    "name": "Study Completion",
                    "exitType": "Completion",
                    "instanceType": "ScheduleTimelineExit",
                    "description": "Completion of 5-year overall survival follow-up"
                  },
                  {
                    "id": "45e858ec-61c7-43f2-81f2-e43e718106e8",
                    "name": "Withdrawal of Consent",
                    "exitType": "Early Termination",
                    "instanceType": "ScheduleTimelineExit",
                    "description": "Subject does not want to participate and disallows further data collection"
                  }
                ]
              }
            ],
            "encounters": [
              {
                "id": "d8011093-0f47-45ef-b9b7-7525de5f221e",
                "name": "Cycle 1 Day 1",
                "instanceType": "Encounter",
                "type": {
                  "id": "54ce75f6-a81f-4e8a-a6b1-59f99d23c254",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23",
                "extensionAttributes": [
                  {
                    "id": "ff60b476-836c-43d0-9ec5-aee35c3896ba",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "e55c2763-90a0-4a00-8c2b-365a2ba18763",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "ee1f0f95-e8c7-4cca-a84f-2913984b9cec",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 1
                  }
                ]
              },
              {
                "id": "fe95fe18-c4d4-4902-b4ed-9fa6cab34631",
                "name": "Cycle 2 Day 1",
                "instanceType": "Encounter",
                "type": {
                  "id": "036294e9-129a-445a-b14a-558b30d508fa",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23",
                "extensionAttributes": [
                  {
                    "id": "db604c54-e542-4663-a896-a7d9c3b1eeef",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "bade97e0-3d54-4e1c-9d81-6cd69371a4c6",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "5b6fa317-9770-4fe7-8264-46d0e6d20449",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 1
                  }
                ]
              },
              {
                "id": "bb077b8f-52e1-4678-bda4-c71687b8c749",
                "name": "Cycle 3 Day 1",
                "instanceType": "Encounter",
                "type": {
                  "id": "aef2e5ea-8155-45b0-ac16-b05dc1fad1ab",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23",
                "extensionAttributes": [
                  {
                    "id": "7173bf51-30c2-472b-b4aa-90324b4e1c8e",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "9aa0c407-a7a3-4df2-bebf-6ca68f4bb79f",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "eb11b6ab-a610-499e-bf34-c3b0301b11fc",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 1
                  }
                ]
              },
              {
                "id": "0cb82d63-fd32-4488-a817-37efc335ef04",
                "name": "Subsequent Cycles Day 1",
                "instanceType": "Encounter",
                "type": {
                  "id": "21cdfc9b-abee-4a5b-b4ed-9e122038710e",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23",
                "extensionAttributes": [
                  {
                    "id": "6e32ace2-073e-474b-beb5-dbd22bb153bf",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "ad164f6c-ee72-4a43-95a5-a97119d06542",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "1aab34c6-3a0e-442d-8e13-5c3e7c7ea8fb",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 1
                  }
                ]
              },
              {
                "id": "b9959f8e-3246-4dd6-9c9d-8502aeabb907",
                "name": "Cycle 1 Day 8",
                "instanceType": "Encounter",
                "type": {
                  "id": "c4239e2e-39b7-4ad4-93a9-520d56a4d5b3",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23",
                "extensionAttributes": [
                  {
                    "id": "dc72684f-8439-4cf2-bd8b-2bcc517b00ed",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "a49ae7dd-7523-4aca-8ce6-d09d3f467d67",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "0be43d72-3a5b-4060-b151-d987bbcc1d21",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 8
                  }
                ]
              },
              {
                "id": "500ebb45-0b00-4bd2-b993-a1b145ee4c3b",
                "name": "Cycle 2 Day 8",
                "instanceType": "Encounter",
                "type": {
                  "id": "ad78ead0-82dd-4194-9c5b-38b87c008442",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23",
                "extensionAttributes": [
                  {
                    "id": "94c0b632-e946-4b60-9043-8d5e9e65065b",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "fc2f9427-48c3-4b67-a4fe-2bdf01c7a78f",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "01cd11fe-367f-47ce-ad37-74334f41ab95",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 8
                  }
                ]
              },
              {
                "id": "d49cd1dc-3bb8-4bda-b642-256db9088c8d",
                "name": "Cycle 1 Day 15",
                "instanceType": "Encounter",
                "type": {
                  "id": "5b7e8eb4-39cf-4cad-a04b-11b2b553ef54",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23",
                "extensionAttributes": [
                  {
                    "id": "f3ca2095-8ca9-4023-b341-a8825c2d6b5c",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "0b47afe8-9143-4135-8458-3a0d497033b8",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "715a30ed-22c2-4035-b261-71247f41f919",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 15
                  }
                ]
              },
              {
                "id": "41d477ba-b7d1-4d8e-b931-0891871dfd25",
                "name": "Cycle 2 Day 15",
                "instanceType": "Encounter",
                "type": {
                  "id": "f1fb3a4b-a760-44e8-beae-2261f1a16fe2",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23",
                "extensionAttributes": [
                  {
                    "id": "3fec3d2d-d423-4324-b06d-d768a32d685a",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "7e0f7734-6b2f-4f1e-8fdb-7777432ed6a2",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "9034eaca-21ee-4611-bdb5-1695f64c978d",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 15
                  }
                ]
              },
              {
                "id": "21b94e4c-b610-4135-9e81-46cb787fde7b",
                "name": "Cycle 3 Day 15",
                "instanceType": "Encounter",
                "type": {
                  "id": "e34ac92a-4c1c-4cee-ad10-7799ced39163",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23",
                "extensionAttributes": [
                  {
                    "id": "c22cbc45-64ad-427a-bcfa-452acd5e4815",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "b7b6b69d-187e-4bbc-ae04-bd3068e5180b",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "f60e7d95-1e87-4080-8571-e1eba1b0c1cc",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 15
                  }
                ]
              },
              {
                "id": "445a0fea-bfbf-4b46-919a-d58d27ccc81a",
                "name": "120-Day Safety Follow Up",
                "instanceType": "Encounter",
                "type": {
                  "id": "66bf0f94-2977-4c13-be6c-6515c5ef6f1d",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Early Termination Visit",
                  "instanceType": "Code"
                },
                "epochId": "f82007d7-8606-4120-b073-7056f0173f13",
                "extensionAttributes": [
                  {
                    "id": "e9ff099d-5a89-4b32-a6e6-91c394ebf48f",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "20bab4fc-0748-400a-a77f-b167824ba446",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "76d9b2d2-99aa-4d10-9cf4-37eab9945a92",
                "name": "150-Day Safety Follow Up",
                "instanceType": "Encounter",
                "type": {
                  "id": "ce23dca5-209a-4186-8504-a91b3ba9f9d6",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Early Termination Visit",
                  "instanceType": "Code"
                },
                "epochId": "f82007d7-8606-4120-b073-7056f0173f13",
                "extensionAttributes": [
                  {
                    "id": "051ad103-0643-4932-b251-6bdab88c1066",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "b159a40a-92ca-4967-a6db-76a3a833c7fa",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "7b8beecd-d8ed-454e-a353-9a2ca8a18c5d",
                "name": "30-Day Safety Follow Up",
                "instanceType": "Encounter",
                "type": {
                  "id": "d0ee4bf5-d762-4335-a227-20c95a24add0",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Early Termination Visit",
                  "instanceType": "Code"
                },
                "epochId": "f82007d7-8606-4120-b073-7056f0173f13",
                "extensionAttributes": [
                  {
                    "id": "76aab131-98b2-4bd7-9fe2-6f0a62685ad9",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "c0dc38e2-baef-4b9c-9fd0-de87b71cb5c6",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "93d04d45-49fb-42ec-8f65-7859e3bc0483",
                "name": "60-Day Safety Follow Up",
                "instanceType": "Encounter",
                "type": {
                  "id": "d210e976-2262-47db-9141-4fe110e0abc3",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Early Termination Visit",
                  "instanceType": "Code"
                },
                "epochId": "f82007d7-8606-4120-b073-7056f0173f13",
                "extensionAttributes": [
                  {
                    "id": "426dd5e1-16e8-40e2-8e23-8c24ca4f2e6d",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "82452fb9-617d-4f2b-947e-70e256115d51",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "767f3fdf-7511-4a3a-a531-b80885ece3a4",
                "name": "90-Day Safety Follow Up",
                "instanceType": "Encounter",
                "type": {
                  "id": "86d60dfa-5dd8-4e5b-a400-eae5082b0cbb",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Early Termination Visit",
                  "instanceType": "Code"
                },
                "epochId": "f82007d7-8606-4120-b073-7056f0173f13",
                "extensionAttributes": [
                  {
                    "id": "0dfb59f9-780a-46d0-84c7-16b62d8f8cdd",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "d167cd75-7532-45d2-a832-f978130d8014",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "d695260e-71d8-44af-aaaa-656b6aaef0af",
                "name": "End of Post Treatment Follow Up",
                "instanceType": "Encounter",
                "type": {
                  "id": "93147fb1-2024-457c-bc47-a8e2ac17a766",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Visit",
                  "instanceType": "Code"
                },
                "epochId": "f82007d7-8606-4120-b073-7056f0173f13",
                "extensionAttributes": [
                  {
                    "id": "fc98b9b0-b24a-40e9-b426-eccfd2a18c4c",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "8cd9974d-92f0-411b-82ee-ba47bf51782b",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "05d414aa-4601-4f32-adb6-e06fdef4da5a",
                "name": "End of Study Treatment (EoT)",
                "instanceType": "Encounter",
                "type": {
                  "id": "d346b12d-f269-416d-aa83-cb750eb3d150",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Visit",
                  "instanceType": "Code"
                },
                "epochId": "54e7585a-70b5-48dd-9fb7-327f24fd9e23",
                "extensionAttributes": [
                  {
                    "id": "f0a96391-c9a4-4a1d-80c4-97d2e456dcb0",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "c27c229a-b4e7-4554-94d9-eec03c563329",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "233680c1-370b-44fb-a5e8-74bd0d8e8797",
                "name": "Screening (-28 to -1)",
                "instanceType": "Encounter",
                "type": {
                  "id": "fdbd94d3-34ac-4291-868d-3d4b6aec80f3",
                  "code": "C98779",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Screening Visit",
                  "instanceType": "Code"
                },
                "epochId": "c8beb933-cf47-4316-815a-e216abe6da62",
                "extensionAttributes": [
                  {
                    "id": "cb39f41a-5f65-4c96-b9e0-e83c59b7a8a0",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "6ef90d18-b7a4-49ef-b4bf-9f6a9095aa12",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "86e942a9-ed50-4bb8-b863-4cad07a33b0a",
                "name": "Survival Follow Up",
                "instanceType": "Encounter",
                "type": {
                  "id": "2153a117-cb86-4828-891c-b9e585a1be0f",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "f82007d7-8606-4120-b073-7056f0173f13",
                "extensionAttributes": [
                  {
                    "id": "867938c3-d834-4597-94e7-e210eb3b3b37",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "59bbbf35-2410-468a-8c46-efa5a9057039",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              }
            ],
            "activities": [
              {
                "id": "5a5b2221-2342-41b8-b160-01cbd553444b",
                "name": "Alcohol History",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "c14569ad-a3f0-4350-b720-6126a8f795f0",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "f65c4537-3d8c-45bf-a163-d6fc407cb4a8",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "6ce91034-867d-46a8-b409-902e0980fa85",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "c95b7c00-7f03-4d7f-80ee-a65c9657f90c",
                "name": "Antineoplastic therapies since discontinuation of study treatment",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "c344db86-3798-4772-bb17-e22c831558d8",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "793cbe61-bc1b-4701-b9e6-d4a6b297d3ce",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "82ca7d18-108d-496c-bb8d-2ac78f5a35c5",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "036b4fc1-ad14-40c7-9936-5b8fc83fbbc6",
                "name": "Blood Draw",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "036b4fc1-ad14-40c7-9936-5b8fc83fbbc6",
                    "name": "Blood Draw",
                    "procedureType": "Biospecimen Collection",
                    "code": {
                      "id": "7cebfc4e-3f2a-4c3e-ab68-60cd025d1005",
                      "code": "36415",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "Collection of venous blood by venipuncture",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Blood (serum) collection",
                    "description": "Collection of blood samples for PDR001 PK and IG analysis"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "3120ad5c-c2c6-489d-958c-2c6fa8c81878",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "8d022138-9fa8-4227-8092-e1baecdf981b",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "4aaad0b1-8943-4a70-886d-29e184422882",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "56d1da04-0d44-4564-8900-9abc54245746",
                "name": "Computed Tomography",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "56d1da04-0d44-4564-8900-9abc54245746",
                    "name": "Computed Tomography",
                    "procedureType": "Imaging Technique",
                    "code": {
                      "id": "96ed073a-a93a-4c4d-97df-48bdaf4a9518",
                      "code": "74177",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "Computed tomography, abdomen and pelvis; with contrast material(s)",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "CT",
                    "description": "Imaging assessment for tumor response per RECIST 1.1"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "b14d72bf-90f3-4364-b782-84cd2d9bced9",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "006d5ea0-2bbd-452d-9c34-ba7c3c98fcaa",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "2bdd707b-d1f5-44e2-8a5c-6012ce2dbe6d",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "4f50e206-c67f-461f-9f6e-cdf8e05e7cd9",
                "name": "Demography",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "0f1864cf-669c-47a7-bb83-95fef3ce4c7a",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "1145fe73-fd6a-44e2-83cf-ad189124a07d",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "c39360b6-db09-4b63-b1dd-189fc2af2279",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "96204503-e3ea-4d1c-aa32-b0946d94a797",
                "name": "Diagnosis and extent of cancer",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "1535e8a9-e1d2-4121-89b3-484cb91e48da",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "0f201948-1830-4b2c-aed8-edeb6f32bb4b",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "2a87c209-01aa-4ea5-9467-de886e4afa7d",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "b4c26fa7-6172-464c-88ad-03a56caa742e",
                "name": "Disposition Assessment (at the end of each study phase)",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "56d35928-ffdf-45d5-b7cc-eb0a30a0a395",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "4ba5c6db-9511-43c1-8814-425b09c7574e",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "44d505c6-88c6-40e9-b76c-bb7c01c4686d",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "e2130c2d-da8b-45b4-9df5-5d6a2b5e008d",
                "name": "Drug Supply (IRT)",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "e50133b1-00f2-4cb0-b7d1-bcdf11d4175a",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "004be586-9f1d-4d6a-a867-796514b6750a",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "e4379a1c-27ef-41f5-bab3-7a2a4b310349",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "7df28861-2961-4a5a-81bc-0dbe73108d4a",
                "name": "EORTC QLQ-C30",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "4eadfd9e-ffe0-4f4c-b69e-bf574a935cee",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "24db0f3b-d2ef-40b6-ba5e-9c75a8a78077",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "3e808d1b-2fbe-47f7-940a-36b47827d36e",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "2ca12bf7-9b65-4ed9-9e88-0a518ce57ab8",
                "name": "EQ-5D-5L",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "03ca120e-e87d-44fe-9b21-5a003e9f81d0",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "7ffbc93e-ee36-4e44-b19f-b659dece8a10",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "dd817267-ba3a-4a74-b98c-bcb60519f215",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "9ec5a58e-6897-4e61-8afe-7a5055228347",
                "name": "Echocardiogram",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "9ec5a58e-6897-4e61-8afe-7a5055228347",
                    "name": "Echocardiogram",
                    "procedureType": "Imaging Technique",
                    "code": {
                      "id": "844ce504-0f15-44ab-892b-a8493b1c6d66",
                      "code": "93306",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "Echocardiography, transthoracic, real-time with image documentation",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "ECHO",
                    "description": "Ultrasound imaging of the heart to assess LVEF"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "3606cc16-8abe-4476-ae65-cf08f777acee",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "68b02f14-5ec4-44d4-8e1e-f307e39b3e9d",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "9ba33bf0-f221-4a16-9163-7c48308fd6a7",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "b2ec919d-614f-4702-8b38-4ca9bb21b3f3",
                "name": "Electrocardiogram",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "b2ec919d-614f-4702-8b38-4ca9bb21b3f3",
                    "name": "Electrocardiogram",
                    "procedureType": "Diagnostic Procedure",
                    "code": {
                      "id": "a03c3403-69d3-46ae-a980-4252aa47636c",
                      "code": "93000",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "Electrocardiogram, routine ECG with at least 12 leads",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "ECG",
                    "description": "Standard 12-lead electrocardiogram collection"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "09554e39-3892-417c-888d-8529b795bcf6",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "76d693d0-a482-4d0b-80cb-f360a6d72d7c",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "4adc5351-6390-4a06-9ca6-9963bcac7b5f",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "4c6654f0-323e-4c89-9ee8-358f5483f4f0",
                "name": "FACT-M subscale (16 questions)",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "2caef61c-f3bf-4568-b70f-7063f80b4439",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "9223f59f-0a00-4794-9345-fac62415fa80",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "assessment"
                  },
                  {
                    "id": "a1f233ea-3768-46ee-9710-16b2be5a1412",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "07eae9fd-c41c-44cd-97c3-6da437a55a36",
                "name": "HIV History",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "17d531b9-76df-45a5-93d8-5273ab162af8",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "bd4ad565-ffca-4237-8b13-ed0bd1751f67",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "72fab1a7-7c27-437f-b142-925052ea6a81",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "883f288b-3ab8-4819-9751-402dfafb5733",
                "name": "IRT Registration-Enrollment",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "6c6753fa-d461-4af6-a947-e0dd0b161403",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "90dbb116-0b1f-4ab6-bb0b-417015084e00",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "documentation"
                  },
                  {
                    "id": "47a50a27-ebe9-4e37-b5e6-5eb5869d92f3",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "5051d041-f995-4db5-aef1-2ea47b9767d7",
                "name": "Inclusion/exclusion",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "e4c56927-70bd-4056-9645-c3431a86a71c",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "b49aaf08-023d-4c79-b95d-cd5ed8a8dd23",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "ba079c82-9e90-4ede-9247-a06416e98355",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "2a3770f2-0428-4317-b3b8-f3887a145616",
                "name": "Intravenous Infusion",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "2a3770f2-0428-4317-b3b8-f3887a145616",
                    "name": "Intravenous Infusion",
                    "procedureType": "Therapeutic Procedure",
                    "code": {
                      "id": "54fb2c6c-e810-4968-93c4-b00b4334c7d1",
                      "code": "96365",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "Intravenous infusion, for therapy, prophylaxis, or diagnosis",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "i.v. infusion",
                    "description": "Administration of PDR001 or placebo"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "fb2328c9-58e0-4c4a-a671-6bf7c475700a",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "a3987559-9c58-457d-99aa-4feb744a59cc",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "0d6eff6e-2f5f-4ed7-a312-2f0297eaa844",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "9d62d40e-4b94-4e85-8a6f-631aec067d40",
                "name": "Magnetic Resonance Imaging",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "9d62d40e-4b94-4e85-8a6f-631aec067d40",
                    "name": "Magnetic Resonance Imaging",
                    "procedureType": "Imaging Technique",
                    "code": {
                      "id": "02be03c4-9722-4df1-a1df-b3734c2989ed",
                      "code": "70551",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "Magnetic resonance (eg, proton) imaging, brain",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "MRI",
                    "description": "Brain imaging assessment at screening"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "731b6eef-28a6-48a9-af20-d5df2f50db23",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "9f07c912-96de-41a9-9684-1ab519413a8f",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "1265523d-a3b5-472e-b737-7643e8406ab7",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "bcef8e1b-af59-4704-8c3f-31e9fae38e10",
                "name": "Newly acquired tumor tissue for central BRAF V600 mutation testing",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "da9b7e9f-e2fa-4035-9bab-3f7eff2c93ad",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "5a3fb13a-02a0-4649-b923-01d39b0e619d",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "679159fa-2a30-43a2-979f-d8dca0c5ec24",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "8337ba30-667c-47c0-9841-16add23c593a",
                "name": "Ophthalmologic Examination",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "8337ba30-667c-47c0-9841-16add23c593a",
                    "name": "Ophthalmologic Examination",
                    "procedureType": "Diagnostic Procedure",
                    "code": {
                      "id": "df390e5c-9f95-416a-838c-71633ad4fdff",
                      "code": "92004",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "Ophthalmological services: medical examination and evaluation",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Eye Exam",
                    "description": "Examination including visual acuity and optical coherence tomography"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "9592dcf8-86de-42c0-b32e-0e104e20baf8",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "178df418-bef8-43fb-8ad1-69dee2200545",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "aa3b9313-d6cb-4ff5-a73a-15d461657d52",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "74858707-e0da-4baa-988f-3d002f421daf",
                "name": "Past and current medical conditions including cardiovascular medical history and risk factors",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "c8e11b36-4d36-4d27-aa0f-ae9fcb51c43a",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "a379bf56-9d9e-4608-a532-0db9463a5413",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "e7841da2-6538-48b0-ace9-9bbcb7b2bbea",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "26e1ab38-15d3-492e-bf2d-cfff6d02a07e",
                "name": "Pharmacogenetic ICF",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "9cf8e717-1325-48d7-8181-c6e956684303",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "4b78abbf-b0b9-41c0-a530-97731e2a41f6",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "dc461b81-0263-4572-9d01-0cb2f6ab83d9",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "66990db9-c6e7-4973-8cdf-0d8e423fd199",
                "name": "Physical Examination",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "3857fadb-c743-4db2-9a1c-d699935ca785",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "da9b5e8b-8322-4789-a249-6a04354620fc",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "bf212b52-830f-4497-8bd6-b6730b5da588",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "24b84935-9db2-4fd0-b454-2a618ed8e408",
                "name": "Physical Examination (complete)",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "c1b08ce7-cbbd-4817-8bd4-5473f42ef77d",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "58409d88-12f9-4e44-ac8c-5cb9ce22a56c",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "298e184f-0bf7-4356-99a9-cb3f7c7e8c19",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "517a28f3-fc96-4d1d-97d0-728b5bf65bca",
                "name": "Prior antineoplastic therapies (meds, surgery, radiation)",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "bf40d05c-ee0a-48c6-b48b-eab93d0f9a90",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "b37254d1-6fc5-4efe-be3b-261a5ec065d0",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "9e3e8d6d-4652-4e43-8614-e062b65c2ca9",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "05e514d8-27f8-41de-9c83-4c4ec7504867",
                "name": "Smoking History",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "6d6143fd-b608-4479-a2af-b63db467a32e",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "4c2b7fd9-f909-4882-bb2f-8481758a7c7c",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "c3d19ee7-c3cf-4428-888e-ab4c97b037a7",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "a6a3ad74-a23e-4c63-96f2-8625abb982ea",
                "name": "Study ICF",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "a64f4574-5223-4147-bb7c-ca69736a8bd5",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "3164b473-8845-4c9f-88e2-5e32a9558117",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "aff2924e-22ed-467f-b74a-153a67bdac0b",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "b53dd21a-14ce-422d-ab3b-056ad4761c84",
                "name": "Treatment beyond progression ICF",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "63095eef-486e-4229-b5f1-77602a7203c8",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "564c3c56-5c97-4e03-9621-3c93d899a700",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "5f35932b-00f4-493b-8a66-3a2aa7e986ab",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "4ecd5a76-3c41-46b4-a339-d162a5e85d97",
                "name": "Tumor Biopsy",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "4ecd5a76-3c41-46b4-a339-d162a5e85d97",
                    "name": "Tumor Biopsy",
                    "procedureType": "Biospecimen Collection",
                    "code": {
                      "id": "725c7e69-7a06-41b1-a00d-34f4bbf8b9e4",
                      "code": "20206",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "Biopsy, muscle, percutaneous needle",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Biopsy",
                    "description": "Collection of archival or new tumor tissue samples"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "40e7cedd-8d21-46d8-9251-540bf83d8cd2",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "bbdda8c0-cdf4-405d-b3a2-e9e5d7a1a771",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "5e4b64af-e887-4f5a-ba10-24e5b2e551ff",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "87e5e1ca-2ac1-4a63-b01d-e33175190a43",
                "name": "Tumor tissue (archival or new) for central BRAF V600 mutation testing",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "46a7666f-e90c-4d10-a5f4-fdda72f289b0",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "aa787a0b-a240-4cd6-a4f0-c0a566f8bfbb",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "bd59bfd9-6e79-4725-a2a8-81aa0c4e96b7",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "e1933515-f8a1-4da3-8e6a-5c7ce6d3bb1d",
                "name": "Urinalysis",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "e1933515-f8a1-4da3-8e6a-5c7ce6d3bb1d",
                    "name": "Urinalysis",
                    "procedureType": "Biospecimen Collection",
                    "code": {
                      "id": "99c821f0-9f8b-4710-ac29-69b2ea1deaf8",
                      "code": "81001",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "Urinalysis, by dip stick or tablet reagent; automated, with microscopy",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Urine collection",
                    "description": "Microscopy and macroscopic assessment of urine"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "c2f187d5-8722-4e5e-882a-baa73e02c92c",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "ff6e2619-eab8-46c0-a737-4237f1c9138a",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "d8231b01-b9de-413f-a29a-6161f03c9bc9",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              }
            ],
            "epochs": [
              {
                "id": "c8beb933-cf47-4316-815a-e216abe6da62",
                "name": "Screening/Baseline",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "e3ba306f-5c42-46a5-a9a5-db9d506d1d17",
                  "code": "C98779",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Screening Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "a553baf0-038a-4372-9b75-57f7bef79ed7",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "3334c44a-95e5-4882-8a86-60191e4da357",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "48dabdbe-11bf-4160-9567-f11b810d8a53",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "1"
                  }
                ]
              },
              {
                "id": "54e7585a-70b5-48dd-9fb7-327f24fd9e23",
                "name": "Treatment (Cycle = 28 days)",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "3a1bd20c-02bf-452b-b058-c045a77b323c",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "4a896441-f230-4b27-ae2a-c1daaceed20c",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "f7c2e1e8-ecba-4919-bc3c-ae99b4173ca8",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "sub"
                  }
                ]
              },
              {
                "id": "f82007d7-8606-4120-b073-7056f0173f13",
                "name": "Follow-Up Period",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "f0bed4d8-c0a5-4507-a72b-8f7d13930ce7",
                  "code": "C98781",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Follow-up Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "da545676-8309-4f12-8b91-129c18156f0b",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "0fb72772-569d-4337-9235-8beb054c5a9f",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "2db32525-9df9-4957-b324-15f57790a316",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "2"
                  }
                ]
              }
            ],
            "activityGroups": [
              {
                "id": "5e874b8a-c661-4868-8b88-73a504a1c7db",
                "name": "Obtain Informed Consent",
                "description": null,
                "childIds": [
                  "a6a3ad74-a23e-4c63-96f2-8625abb982ea",
                  "26e1ab38-15d3-492e-bf2d-cfff6d02a07e",
                  "883f288b-3ab8-4819-9751-402dfafb5733",
                  "b53dd21a-14ce-422d-ab3b-056ad4761c84"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Study ICF",
                  "Pharmacogenetic ICF",
                  "IRT Registration-Enrollment",
                  "Treatment beyond progression ICF"
                ]
              },
              {
                "id": "68c4f0af-d66b-4b18-9dd8-f8862aa40a62",
                "name": "Patient History",
                "description": null,
                "childIds": [
                  "4f50e206-c67f-461f-9f6e-cdf8e05e7cd9",
                  "5051d041-f995-4db5-aef1-2ea47b9767d7",
                  "74858707-e0da-4baa-988f-3d002f421daf",
                  "96204503-e3ea-4d1c-aa32-b0946d94a797",
                  "5a5b2221-2342-41b8-b160-01cbd553444b",
                  "05e514d8-27f8-41de-9c83-4c4ec7504867",
                  "07eae9fd-c41c-44cd-97c3-6da437a55a36",
                  "517a28f3-fc96-4d1d-97d0-728b5bf65bca",
                  "c95b7c00-7f03-4d7f-80ee-a65c9657f90c"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Demography",
                  "Inclusion/exclusion",
                  "Past and current medical conditions including cardiovascular medical history and risk factors",
                  "Diagnosis and extent of cancer",
                  "Alcohol History",
                  "Smoking History",
                  "HIV History",
                  "Prior antineoplastic therapies (meds, surgery, radiation)",
                  "Prior/concomitant medications",
                  "Antineoplastic therapies since discontinuation of study treatment"
                ]
              },
              {
                "id": "0fdd337d-09ec-46a5-80bc-2cd3e6ecd2a4",
                "name": "Enrollment",
                "description": null,
                "childIds": [
                  "e2130c2d-da8b-45b4-9df5-5d6a2b5e008d",
                  "b4c26fa7-6172-464c-88ad-03a56caa742e"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Drug Supply (IRT)",
                  "Disposition Assessment (at the end of each study phase)"
                ]
              },
              {
                "id": "ea2383dc-10e5-4b1d-8c2d-9d21cae037cb",
                "name": "Physical Examination",
                "description": null,
                "childIds": [
                  "24b84935-9db2-4fd0-b454-2a618ed8e408"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Physical Examination (complete)"
                ]
              },
              {
                "id": "141b1d99-4d6e-410c-b4dd-88a024e806cd",
                "name": "Safety",
                "description": null,
                "childIds": [],
                "instanceType": "Activity",
                "activityNames": [
                  "Adverse events",
                  "Serious adverse events"
                ]
              },
              {
                "id": "1b913529-a113-4ea6-b48f-aaed35dfe37d",
                "name": "Biomarkers",
                "description": null,
                "childIds": [
                  "bcef8e1b-af59-4704-8c3f-31e9fae38e10",
                  "87e5e1ca-2ac1-4a63-b01d-e33175190a43"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Newly acquired tumor tissue for central BRAF V600 mutation testing",
                  "Tumor tissue (archival or new) for central BRAF V600 mutation testing"
                ]
              },
              {
                "id": "78b0d002-50f9-44c3-91f0-69eacc09b41c",
                "name": "Patient Reported Outcomes",
                "description": null,
                "childIds": [
                  "7df28861-2961-4a5a-81bc-0dbe73108d4a",
                  "2ca12bf7-9b65-4ed9-9e88-0a518ce57ab8",
                  "4c6654f0-323e-4c89-9ee8-358f5483f4f0"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "EORTC QLQ-C30",
                  "EQ-5D-5L",
                  "FACT-M subscale (16 questions)"
                ]
              }
            ],
            "notes": [
              {
                "id": "3d7acf44-d089-4023-b244-ec43870c1030",
                "text": "For Cycle 1, all assessments have a  3 day window unless otherwise indicated.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "1cefc373-65c5-49e7-ad40-17aa3bff51f2",
                "text": "After Cycle 1, all assessments have a  7 day window, unless otherwise indicated.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "af9bdc59-ec8a-455a-ba47-14c28e165b15",
                "text": "If study drug is being held due to toxicity, then the scheduled visits and assessments should still be performed per protocol.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "61a74b54-322b-4d75-a924-063fa26ed236",
                "text": "Suspected AEs up to Day 150; non-suspected AEs up to Day 150 or start of new post treatment anti-neoplastic medication, whichever is sooner.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "aadefcd0-99ea-4ab0-92f9-a69c7df7e7bf",
                "text": "Following final PFS analysis; colour digital photography assessments are no longer required.",
                "instanceType": "CommentAnnotation"
              }
            ],
            "model": {
              "id": "cc82bdb8-c326-4e36-8fe9-cba881f9e8e7",
              "code": "C49649",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Crossover Study",
              "instanceType": "Code"
            },
            "indications": [
              {
                "id": "cae4cdef-d110-47af-a66c-a4f6ae0c2625",
                "name": "Melanoma",
                "isRareDisease": false,
                "instanceType": "Indication",
                "description": "BRAF V600 mutation-positive unresectable or metastatic melanoma"
              }
            ],
            "procedures": [
              {
                "id": "036b4fc1-ad14-40c7-9936-5b8fc83fbbc6",
                "name": "Blood Draw",
                "procedureType": "Biospecimen Collection",
                "code": {
                  "id": "7cebfc4e-3f2a-4c3e-ab68-60cd025d1005",
                  "code": "36415",
                  "codeSystem": "CPT",
                  "codeSystemVersion": "",
                  "decode": "Collection of venous blood by venipuncture",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Blood (serum) collection",
                "description": "Collection of blood samples for PDR001 PK and IG analysis"
              },
              {
                "id": "b2ec919d-614f-4702-8b38-4ca9bb21b3f3",
                "name": "Electrocardiogram",
                "procedureType": "Diagnostic Procedure",
                "code": {
                  "id": "a03c3403-69d3-46ae-a980-4252aa47636c",
                  "code": "93000",
                  "codeSystem": "CPT",
                  "codeSystemVersion": "",
                  "decode": "Electrocardiogram, routine ECG with at least 12 leads",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "ECG",
                "description": "Standard 12-lead electrocardiogram collection"
              },
              {
                "id": "9ec5a58e-6897-4e61-8afe-7a5055228347",
                "name": "Echocardiogram",
                "procedureType": "Imaging Technique",
                "code": {
                  "id": "844ce504-0f15-44ab-892b-a8493b1c6d66",
                  "code": "93306",
                  "codeSystem": "CPT",
                  "codeSystemVersion": "",
                  "decode": "Echocardiography, transthoracic, real-time with image documentation",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "ECHO",
                "description": "Ultrasound imaging of the heart to assess LVEF"
              },
              {
                "id": "9d62d40e-4b94-4e85-8a6f-631aec067d40",
                "name": "Magnetic Resonance Imaging",
                "procedureType": "Imaging Technique",
                "code": {
                  "id": "02be03c4-9722-4df1-a1df-b3734c2989ed",
                  "code": "70551",
                  "codeSystem": "CPT",
                  "codeSystemVersion": "",
                  "decode": "Magnetic resonance (eg, proton) imaging, brain",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "MRI",
                "description": "Brain imaging assessment at screening"
              },
              {
                "id": "56d1da04-0d44-4564-8900-9abc54245746",
                "name": "Computed Tomography",
                "procedureType": "Imaging Technique",
                "code": {
                  "id": "96ed073a-a93a-4c4d-97df-48bdaf4a9518",
                  "code": "74177",
                  "codeSystem": "CPT",
                  "codeSystemVersion": "",
                  "decode": "Computed tomography, abdomen and pelvis; with contrast material(s)",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "CT",
                "description": "Imaging assessment for tumor response per RECIST 1.1"
              },
              {
                "id": "4ecd5a76-3c41-46b4-a339-d162a5e85d97",
                "name": "Tumor Biopsy",
                "procedureType": "Biospecimen Collection",
                "code": {
                  "id": "725c7e69-7a06-41b1-a00d-34f4bbf8b9e4",
                  "code": "20206",
                  "codeSystem": "CPT",
                  "codeSystemVersion": "",
                  "decode": "Biopsy, muscle, percutaneous needle",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Biopsy",
                "description": "Collection of archival or new tumor tissue samples"
              },
              {
                "id": "8337ba30-667c-47c0-9841-16add23c593a",
                "name": "Ophthalmologic Examination",
                "procedureType": "Diagnostic Procedure",
                "code": {
                  "id": "df390e5c-9f95-416a-838c-71633ad4fdff",
                  "code": "92004",
                  "codeSystem": "CPT",
                  "codeSystemVersion": "",
                  "decode": "Ophthalmological services: medical examination and evaluation",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Eye Exam",
                "description": "Examination including visual acuity and optical coherence tomography"
              },
              {
                "id": "2a3770f2-0428-4317-b3b8-f3887a145616",
                "name": "Intravenous Infusion",
                "procedureType": "Therapeutic Procedure",
                "code": {
                  "id": "54fb2c6c-e810-4968-93c4-b00b4334c7d1",
                  "code": "96365",
                  "codeSystem": "CPT",
                  "codeSystemVersion": "",
                  "decode": "Intravenous infusion, for therapy, prophylaxis, or diagnosis",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "i.v. infusion",
                "description": "Administration of PDR001 or placebo"
              },
              {
                "id": "e1933515-f8a1-4da3-8e6a-5c7ce6d3bb1d",
                "name": "Urinalysis",
                "procedureType": "Biospecimen Collection",
                "code": {
                  "id": "99c821f0-9f8b-4710-ac29-69b2ea1deaf8",
                  "code": "81001",
                  "codeSystem": "CPT",
                  "codeSystemVersion": "",
                  "decode": "Urinalysis, by dip stick or tablet reagent; automated, with microscopy",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Urine collection",
                "description": "Microscopy and macroscopic assessment of urine"
              }
            ],
            "analysisPopulations": [
              {
                "id": "c1131d0c-6a39-4175-aa16-49dc9ee5ebac",
                "name": "Full Analysis Set",
                "text": "Unless otherwise stated, all definitions and analysis methods are the same as given in the SAP used for the primary analysis of the study. Please refer to the final PFS analysis SAP for Part 3 (CPDR001F2301 Statistical Analysis Plan (SAP) for Part 3_Amendment3_Final) and Part 1 and 2 (CPDR001F2301 Statistical Analysis Plan (SAP) for Part 1 and 2_Amendment3_Final).",
                "populationType": "Efficacy",
                "instanceType": "AnalysisPopulation",
                "label": "FAS",
                "populationDescription": "Unless otherwise stated, all definitions and analysis methods are the same as given in the SAP used for the primary analysis of the study. Please refer to the final PFS analysis SAP for Part 3 (CPDR001F2301 Statistical Analysis Plan (SAP) for Part 3_Amendment3_Final) and Part 1 and 2 (CPDR001F2301 Statistical Analysis Plan (SAP) for Part 1 and 2_Amendment3_Final).",
                "criteria": "Refer to primary analysis SAP (PFS analysis SAP) for Part 1, 2, and 3"
              },
              {
                "id": "d0511077-9fc6-4e17-be07-530f55847bd5",
                "name": "Safety Analysis Set",
                "text": "Unless otherwise stated, all definitions and analysis methods are the same as given in the SAP used for the primary analysis of the study. Please refer to the final PFS analysis SAP for Part 3 (CPDR001F2301 Statistical Analysis Plan (SAP) for Part 3_Amendment3_Final) and Part 1 and 2 (CPDR001F2301 Statistical Analysis Plan (SAP) for Part 1 and 2_Amendment3_Final).",
                "populationType": "Safety",
                "instanceType": "AnalysisPopulation",
                "label": "SAF",
                "populationDescription": "Unless otherwise stated, all definitions and analysis methods are the same as given in the SAP used for the primary analysis of the study. Please refer to the final PFS analysis SAP for Part 3 (CPDR001F2301 Statistical Analysis Plan (SAP) for Part 3_Amendment3_Final) and Part 1 and 2 (CPDR001F2301 Statistical Analysis Plan (SAP) for Part 1 and 2_Amendment3_Final).",
                "criteria": "Refer to primary analysis SAP (PFS analysis SAP) for Part 1, 2, and 3"
              },
              {
                "id": "0a8039dc-2b94-4efb-a2f7-1b99ac9e7252",
                "name": "Per-Protocol Set",
                "text": "Unless otherwise stated, all definitions and analysis methods are the same as given in the SAP used for the primary analysis of the study. Please refer to the final PFS analysis SAP for Part 3 (CPDR001F2301 Statistical Analysis Plan (SAP) for Part 3_Amendment3_Final).",
                "populationType": "Efficacy",
                "instanceType": "AnalysisPopulation",
                "label": "PPS",
                "populationDescription": "Unless otherwise stated, all definitions and analysis methods are the same as given in the SAP used for the primary analysis of the study. Please refer to the final PFS analysis SAP for Part 3 (CPDR001F2301 Statistical Analysis Plan (SAP) for Part 3_Amendment3_Final).",
                "criteria": "Refer to primary analysis SAP (PFS analysis SAP) for Part 3"
              }
            ],
            "characteristics": [
              {
                "id": "28b6c57e-2392-4b1a-85df-a836f745bfb2",
                "code": "OVERALL_SURVIVAL",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Overall Survival",
                "instanceType": "Code"
              },
              {
                "id": "7ce0428a-c6b1-4e97-9a08-58d33f94fb77",
                "code": "ADVERSE_EVENTS",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Adverse Events",
                "instanceType": "Code"
              },
              {
                "id": "bdbe7fa7-84a1-40d9-80e7-1e0e30790e79",
                "code": "PD-L1_EXPRESSION_STA",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "PD-L1 expression status",
                "instanceType": "Code"
              },
              {
                "id": "81ef0b89-5ee2-4d23-a964-b7aa3a3408c9",
                "code": "TUMOR_MUTATIONAL_BUR",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Tumor Mutational Burden",
                "instanceType": "Code"
              }
            ],
            "extensionAttributes": [
              {
                "id": "ext_conceptual_0e2c1bc8-f82b-46b6-a8da-77d5a1bf53ed",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-conceptualAnchors",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"3aa1ab41-d727-4ffa-9556-6f2e3818f154\", \"name\": \"Tumor Assessment Frequency (Early)\", \"classification\": \"Conceptual\", \"note\": \"Pure timing reference - no visit or activity instance\"}, {\"id\": \"e9715912-c065-4aa9-979f-48127b80ca32\", \"name\": \"Tumor Assessment Frequency (Late)\", \"classification\": \"Conceptual\", \"note\": \"Pure timing reference - no visit or activity instance\"}, {\"id\": \"fb16b0fb-bb67-411b-8b16-71dae4834a25\", \"name\": \"Confirmatory Tumor Assessment\", \"classification\": \"Conceptual\", \"note\": \"Pure timing reference - no visit or activity instance\"}]"
              },
              {
                "id": "daa838d3-0d8d-4376-ab8c-2354bec5881a",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-promotionIssues",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: c54aee51-0ccb-445e-8751-bf5f940873e7 (encounter: enc_2)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"warning\", \"category\": \"timing_reference_remapped\", \"message\": \"Timing 'Cycle 1 Day 1 Assessment Window' reference remapped: f2cf5855-e1bb-4e26-b1c3-62901122d021 \\u2192 anchor_inst_anchor_1\", \"affectedPath\": \"$.timings[?(@.id=='timing_2')]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: 357fa0b7-a598-4c6f-972b-b675df210dd9 (encounter: enc_2)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"conceptual_anchor_stored\", \"message\": \"CONCEPTUAL anchor 'Tumor Assessment Frequency (Early)' stored as timing reference (no visit)\", \"affectedPath\": \"$.extensionAttributes[?(@.url contains 'conceptualAnchors')]\"}, {\"severity\": \"info\", \"category\": \"conceptual_anchor_stored\", \"message\": \"CONCEPTUAL anchor 'Tumor Assessment Frequency (Late)' stored as timing reference (no visit)\", \"affectedPath\": \"$.extensionAttributes[?(@.url contains 'conceptualAnchors')]\"}, {\"severity\": \"info\", \"category\": \"conceptual_anchor_stored\", \"message\": \"CONCEPTUAL anchor 'Confirmatory Tumor Assessment' stored as timing reference (no visit)\", \"affectedPath\": \"$.extensionAttributes[?(@.url contains 'conceptualAnchors')]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: d96026a3-f7d2-44c2-9682-819110692e5d (encounter: enc_2)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: 060c2f07-dd1f-43fd-bbc5-73b32a95c717 (encounter: enc_2)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: 0c93fcbd-9539-424a-9401-838ec7dbc42d (encounter: enc_2)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}]"
              },
              {
                "id": "23bce897-b687-4643-b867-3c9f1a4abf48",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-timeAnchors",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"7e684f44-6ede-4818-bb12-140ea94388c4\", \"definition\": \"First administration of investigational product\", \"anchorType\": \"FirstDose\", \"classification\": \"Event\", \"timelineId\": null, \"dayValue\": 1, \"sourceText\": \"first dose \\nof study treatment\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"058aefd4-f5d2-4d96-8690-60fa10783dce\", \"definition\": \"Day 1 of Cycle 1\", \"anchorType\": \"CycleStart\", \"classification\": \"Conceptual\", \"timelineId\": null, \"dayValue\": 1, \"sourceText\": \"Cycle 1 Day 1\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"0234f37b-1e09-4547-9f20-68169f06f85b\", \"definition\": \"Point/time of patient entry into the study; the point at which informed consent must be obtained (i.e. prior to starting any of the procedures described in the protocol)\", \"anchorType\": \"Enrollment\", \"classification\": \"Event\", \"timelineId\": null, \"dayValue\": 1, \"sourceText\": \"Enrollment: Point/time of patient entry into the study; the point at which informed consent must be obtained (i.e. prior to starting any of the procedures described in the protocol)\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"3db3a560-ff6c-44bf-a1d8-573bd280690b\", \"definition\": \"Informed consent obtained\", \"anchorType\": \"InformedConsent\", \"classification\": \"Event\", \"timelineId\": null, \"dayValue\": 1, \"sourceText\": \"informed consent\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"0e9e0b61-623a-4721-8a67-19af429379b0\", \"definition\": \"procedure\", \"anchorType\": \"Custom\", \"classification\": \"Conceptual\", \"timelineId\": null, \"dayValue\": 1, \"sourceText\": \"procedure\", \"encounterId\": null, \"activityId\": null}]"
              },
              {
                "id": "d46ffb84-b75a-4adb-8450-ad5ad545813a",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-repetitions",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"2684f047-4497-4e29-81fe-dd665931196e\", \"type\": \"Daily\", \"interval\": \"P1D\", \"sourceText\": \"od\"}, {\"id\": \"17524d27-cb66-4ff8-9c40-6dde270c3578\", \"type\": \"Daily\", \"interval\": \"P1D\", \"sourceText\": \"QD\"}, {\"id\": \"6e1b23d4-82df-4d8d-80b3-172b5020ed4c\", \"type\": \"Interval\", \"sourceText\": \"BID\"}, {\"id\": \"764cf134-50b3-4307-a71c-0689af95c0c2\", \"type\": \"Cycle\", \"sourceText\": \"Cycle 1 Day 8\"}, {\"id\": \"f3d54016-8a50-4118-9e53-315b09f4c5a5\", \"type\": \"Cycle\", \"sourceText\": \"Cycle 1 Day 15\"}, {\"id\": \"23eeb1c0-5893-4233-9814-317ba9134dc3\", \"type\": \"Cycle\", \"sourceText\": \"Cycle \\n4 Day 1\"}, {\"id\": \"bd5a0758-0ae0-45de-a996-9bc618ee7b64\", \"type\": \"Cycle\", \"sourceText\": \"Cycle 22 Day 1\"}, {\"id\": \"f12258e9-ea5d-486c-93ac-138ef4684c08\", \"type\": \"Cycle\", \"sourceText\": \"C1D1\"}, {\"id\": \"9c9e04cd-4c83-496f-bc04-03b5430e512e\", \"type\": \"Continuous\", \"sourceText\": \"Treatment period\"}, {\"id\": \"1661656a-677f-4097-9fbd-c72b2b99744c\", \"type\": \"Continuous\", \"sourceText\": \"treatment \\nperiod\"}, {\"id\": \"fcbc4a81-eb23-4c0d-919c-e8b1832766b6\", \"type\": \"Continuous\", \"sourceText\": \"follow-up period\"}, {\"id\": \"4c030fc5-b959-4722-ab56-80c6209d7765\", \"type\": \"Continuous\", \"sourceText\": \"follow up period\"}, {\"id\": \"9ffd86ee-e5fc-409a-90b7-a5ab2d7e5c24\", \"type\": \"Continuous\", \"sourceText\": \"observation period\"}, {\"id\": \"4d9f3f16-6259-4b36-a916-c8720d364e6f\", \"type\": \"Continuous\", \"sourceText\": \"30 days after\"}, {\"id\": \"2e5de034-2eb9-4559-94ac-69ffa3aa3f47\", \"type\": \"Continuous\", \"sourceText\": \"120 \\ndays after\"}, {\"id\": \"e3abbf60-b05b-429e-a2c7-9eaf9d3b2b6e\", \"type\": \"Continuous\", \"sourceText\": \"150 days after\"}, {\"id\": \"84ba6a99-6355-4492-b466-3e1b66bdc94c\", \"type\": \"Cycle\", \"startOffset\": \"P0D\", \"interval\": \"P21D\", \"exitCondition\": \"final PFS analysis\", \"sourceText\": \"Visit evaluation schedule: Safety run-In part (Part 1) \\u2013 visit schedule updated and applicable following final PFS analysis\"}, {\"id\": \"2dea0b8b-a7cf-4537-b9ce-3ad61fdb2a1c\", \"type\": \"Cycle\", \"startOffset\": \"P0D\", \"interval\": \"P21D\", \"exitCondition\": \"final PFS analysis\", \"sourceText\": \"Visit evaluation schedule: Biomarker cohort (Part 2) \\u2013 visit schedule updated and applicable following final PFS analysis\"}, {\"id\": \"be7e8938-935c-48c2-a634-dde293e8a12a\", \"type\": \"Cycle\", \"startOffset\": \"P0D\", \"interval\": \"P21D\", \"exitCondition\": \"final PFS analysis\", \"sourceText\": \"Visit evaluation schedule: Double-blind, randomized, placebo-controlled part (Part 3) \\u2013 visit schedule updated and is applicable following final PFS analysis\"}]"
              },
              {
                "id": "30041136-b2a2-4f66-85df-7b2b15bb121c",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-crossoverDesign",
                "instanceType": "ExtensionAttribute",
                "valueString": "{\"id\": \"b8bee455-226c-418d-9c7a-9664f860db9b\", \"isCrossover\": true, \"numPeriods\": 2, \"numSequences\": 2, \"periods\": [\"Period 1\", \"Period 2\"], \"sequences\": [\"AB\", \"BA\"], \"washoutRequired\": false, \"sourceText\": \"crossover\"}"
              },
              {
                "id": "38a6d7af-82ef-42e8-a3f2-298cc35619e3",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-entityMappings",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"abstractConcept\": \"SCREENING\", \"entityType\": \"epoch\", \"resolvedId\": \"c8beb933-cf47-4316-815a-e216abe6da62\", \"resolvedName\": \"Screening/Baseline\", \"confidence\": 1.0, \"reasoning\": \"The epoch name 'Screening/Baseline' directly corresponds to the concept of screening for eligibility.\"}, {\"abstractConcept\": \"SAFETY_FOLLOW_UP\", \"entityType\": \"epoch\", \"resolvedId\": \"f82007d7-8606-4120-b073-7056f0173f13\", \"resolvedName\": \"Follow-Up Period\", \"confidence\": 1.0, \"reasoning\": \"Safety assessments are a primary objective of the post-treatment 'Follow-Up Period'.\"}, {\"abstractConcept\": \"TREATMENT_PHASE\", \"entityType\": \"epoch\", \"resolvedId\": \"54e7585a-70b5-48dd-9fb7-327f24fd9e23\", \"resolvedName\": \"Treatment (Cycle = 28 days)\", \"confidence\": 1.0, \"reasoning\": \"The epoch name 'Treatment' directly corresponds to the concept of a treatment phase where the intervention is administered.\"}, {\"abstractConcept\": \"EFFICACY_FOLLOW_UP\", \"entityType\": \"epoch\", \"resolvedId\": \"f82007d7-8606-4120-b073-7056f0173f13\", \"resolvedName\": \"Follow-Up Period\", \"confidence\": 1.0, \"reasoning\": \"Efficacy assessments (e.g., disease progression) are a primary objective of the post-treatment 'Follow-Up Period'.\"}, {\"abstractConcept\": \"SURVIVAL_FOLLOW_UP\", \"entityType\": \"epoch\", \"resolvedId\": \"f82007d7-8606-4120-b073-7056f0173f13\", \"resolvedName\": \"Follow-Up Period\", \"confidence\": 1.0, \"reasoning\": \"Long-term survival tracking is a primary objective of the post-treatment 'Follow-Up Period'.\"}]"
              },
              {
                "id": "630b291a-0995-4c08-8031-c6e81b87f8ee",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-traversalConstraints",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"945d6928-eb04-4835-8bed-a06ae508fd26\", \"requiredSequence\": [\"epoch_1\", \"period_1\", \"period_2\", \"epoch_end_of_study\"], \"allowEarlyExit\": true, \"exitEpochIds\": [], \"mandatoryVisits\": [\"enc_1\", \"enc_2\", \"enc_11\"], \"sourceText\": \"crossover\"}, {\"id\": \"5db7647e-873e-4673-8dc7-003d4862e79b\", \"requiredSequence\": [\"epoch_1\", \"epoch_2\", \"epoch_3\", \"epoch_3\", \"epoch_3\"], \"allowEarlyExit\": true, \"exitEpochIds\": [], \"mandatoryVisits\": [\"enc_1\", \"enc_1\", \"enc_2\", \"enc_11\", \"enc_11\", \"enc_12\"], \"sourceText\": \"[{'condition': 'Subject experiences toxicity or Adverse Event', 'path': ['TREATMENT_DISCONTINUATION', 'FOLLOW_UP_FOR_TOXICITIES', 'SAFETY_FOLLOW_UP']}, {'condition': 'Subject discontinues treatment for reasons other than disease progression', 'path': ['EFFICACY_FOLLOW_UP', 'SURVIVAL_FOLLOW_UP']}, {'condition': 'Subject withdraws consent', 'path': ['WITHDRAWAL_OF_STUDY_CONSENT', 'LOST_TO_FOLLOW_UP']}]\"}]"
              },
              {
                "id": "ab4b70db-a59e-4fb7-a1e0-a8c5ceb82a7a",
                "url": "https://protocol2usdm.io/extensions/x-footnoteConditions",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"9e0c7707-05a1-438e-b5c7-a34d247463c1\", \"conditionType\": \"procedure_conditional\", \"text\": \"For Cycle 1, all assessments have a \\u00b1 3 day window unless otherwise indicated.\", \"footnoteId\": \"541f9258-b090-4ff5-91fa-ba9a06481f3b\", \"structuredCondition\": \"cycle == 1 ? window(P3D) : null\", \"appliesToActivityIds\": [\"b4c26fa7-6172-464c-88ad-03a56caa742e\"], \"sourceText\": \"For Cycle 1, all assessments have a \\u00b1 3 day window unless otherwise indicated.\"}, {\"id\": \"2c5ee186-7139-4124-bb83-637acabdb942\", \"conditionType\": \"timing_after\", \"text\": \"After Cycle 1, all assessments have a \\u00b1 7 day window, unless otherwise indicated.\", \"footnoteId\": \"59dbe2a8-c7e4-462f-a8f3-b18e41519872\", \"structuredCondition\": \"cycle > 1 ? window(P7D) : null\", \"appliesToActivityIds\": [\"b4c26fa7-6172-464c-88ad-03a56caa742e\"], \"sourceText\": \"After Cycle 1, all assessments have a \\u00b1 7 day window, unless otherwise indicated.\"}, {\"id\": \"a777c308-642c-4d9b-8f99-2bca2dcd3dcf\", \"conditionType\": \"sequence\", \"text\": \"If study drug is being held due to toxicity, then the scheduled visits and assessments should still be performed per protocol.\", \"footnoteId\": \"dd088c1e-d153-4b33-8e05-1cfc22683a8a\", \"structuredCondition\": \"if(drug_hold == true) { perform_assessments = true }\", \"appliesToActivityIds\": [\"b4c26fa7-6172-464c-88ad-03a56caa742e\", \"e2130c2d-da8b-45b4-9df5-5d6a2b5e008d\", \"a6a3ad74-a23e-4c63-96f2-8625abb982ea\"], \"sourceText\": \"If study drug is being held due to toxicity, then the scheduled visits and assessments should still \"}, {\"id\": \"c134449d-6f4a-451d-a243-451d33ce4b6b\", \"conditionType\": \"general\", \"text\": \"Suspected AEs up to Day 150; non-suspected AEs up to Day 150 or start of new post treatment anti-neoplastic medication, whichever is sooner.\", \"footnoteId\": \"c9c5d206-f4d9-4ee4-81b7-7a1fd461a915\", \"structuredCondition\": \"min(day_150, start_of_new_anti_neoplastic_medication)\", \"appliesToActivityIds\": [\"b53dd21a-14ce-422d-ab3b-056ad4761c84\"], \"sourceText\": \"Suspected AEs up to Day 150; non-suspected AEs up to Day 150 or start of new post treatment anti-neo\"}, {\"id\": \"42af301b-303c-4e5c-8341-25ac3e68baa0\", \"conditionType\": \"timing_after\", \"text\": \"Following final PFS analysis; colour digital photography assessments are no longer required.\", \"footnoteId\": \"bc97fd71-c658-46b9-be10-35288e3c7cc8\", \"structuredCondition\": \"if(final_pfs_analysis == complete) { required = false }\", \"appliesToActivityIds\": [\"b4c26fa7-6172-464c-88ad-03a56caa742e\"], \"sourceText\": \"Following final PFS analysis; colour digital photography assessments are no longer required.\"}]"
              },
              {
                "id": "87a59fb5-5a5c-49ad-98d3-b7a33311fdef",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-endpointAlgorithms",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"dc0559b9-ca06-4972-8171-a85ab7c2f6d3\", \"name\": \"Primary: Progression-Free Survival (PFS)\", \"endpointType\": \"Primary\", \"inputs\": [\"Date of randomization\", \"Date of first documented progression\", \"Date of death\", \"Investigator assessment (RECIST)\"], \"timeWindow\": {\"reference\": \"Randomization\", \"duration\": \"Until progression or death\"}, \"algorithm\": \"Time from randomization to the first documented progression or death due to any cause\", \"successCriteria\": \"Statistically significant improvement in PFS (P < 0.025 one-sided, though protocol reported P = 0.042 as not meeting primary endpoint)\", \"sourceText\": \"The final Progression-Free Survival (PFS) analysis occurred using a data cut-off date of 01-Jul-2020. The primary objective of this amendment is to enable continuation of the study following the final\"}, {\"id\": \"84a9e868-e12b-4620-9e65-67110a92c81b\", \"name\": \"Key Secondary: Overall Survival (OS)\", \"endpointType\": \"Secondary\", \"inputs\": [\"Date of randomization\", \"Date of death\"], \"timeWindow\": {\"reference\": \"Randomization\", \"duration\": \"Until death\"}, \"algorithm\": \"Time from randomization to the date of death from any cause\", \"successCriteria\": \"Statistically significant improvement in OS (not formally tested if primary endpoint not met)\", \"sourceText\": \"Since the primary endpoint was not met the key secondary endpoint OS was not formally statistically tested.\"}, {\"id\": \"29489cc6-b607-449b-8d2a-c17eefb0621c\", \"name\": \"Safety: Treatment Related Adverse Events (TRAEs)\", \"endpointType\": \"Secondary\", \"inputs\": [\"Adverse Event (AE) occurrence\", \"AE Grade (NCI CTCAE)\", \"Relationship to study drug\"], \"timeWindow\": {\"reference\": \"First dose of study treatment\", \"duration\": \"Throughout study duration\"}, \"algorithm\": \"(Number of patients with at least one TRAE / Total patients in safety set) * 100\", \"successCriteria\": \"Manageable safety profile with dose interruptions and reductions\", \"sourceText\": \"The safety data demonstrated that the treatment related AEs (TRAEs) all grades occurred in 98.5% vs. 87.5% of patients, and \\u2265 grade 3 in 54.7% vs. 33.3% of patients\"}]"
              },
              {
                "id": "3e33dc32-aa68-4095-adc5-7438b2cc3efc",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-derivedVariables",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"7430ed80-2c2b-432a-8a2e-e53037a381e2\", \"name\": \"Progression-Free Survival (PFS)\", \"variableType\": \"TimeToEvent\", \"sourceVariables\": [\"Date of randomization\", \"Date of first documented progression\", \"Date of death\"], \"derivationRule\": \"The time from the date of randomization to the date of the first documented progression or death due to any cause. Progression is determined per RECIST 1.1.\", \"baselineDefinition\": \"Date of randomization\", \"baselineVisit\": \"Day 1\", \"analysisWindow\": \"Defined schedule per RECIST 1.1 (prior to 01-Jul-2020 DCO)\", \"imputationRule\": \"Censoring rules applied for missing assessments or start of new anti-cancer therapy\", \"unit\": \"Months\"}, {\"id\": \"ad5bfcf7-e956-47ae-a4f5-0e9984f69531\", \"name\": \"Tumor Response\", \"variableType\": \"Categorical\", \"sourceVariables\": [\"Target lesions\", \"Non-target lesions\", \"New lesions\"], \"derivationRule\": \"Categorized as CR, PR, SD, or PD based on RECIST 1.1 criteria\", \"baselineDefinition\": \"Last assessment prior to randomization\", \"baselineVisit\": \"Screening\", \"analysisWindow\": \"Per defined schedule in Table 7-1/7-2 (discontinued after final PFS analysis)\", \"imputationRule\": \"Missing or unevaluable assessments treated as Unknown/Missing\"}]"
              },
              {
                "id": "9485cfe2-12f9-473a-85f0-f55dc9722c25",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-stateMachine",
                "instanceType": "ExtensionAttribute",
                "valueString": "{\"id\": \"b47ac281-a036-477f-aada-a82f1e1b63b6\", \"initialState\": \"Molecular Pre Screening\", \"terminalStates\": [\"Early Termination\", \"Completed\"], \"states\": [\"Molecular Pre Screening\", \"Screening\", \"Treatment Phase\", \"End Of Treatment\", \"Safety Follow Up\", \"Efficacy Follow Up\", \"Survival Follow Up\", \"Early Termination\"], \"transitions\": [{\"fromState\": \"Molecular Pre Screening\", \"toState\": \"Screening\", \"trigger\": \"Progress to Screening\"}, {\"fromState\": \"Screening\", \"toState\": \"Treatment Phase\", \"trigger\": \"Progress to Treatment Phase\"}, {\"fromState\": \"Treatment Phase\", \"toState\": \"End Of Treatment\", \"trigger\": \"Progress to End Of Treatment\"}, {\"fromState\": \"End Of Treatment\", \"toState\": \"Safety Follow Up\", \"trigger\": \"Progress to Safety Follow Up\"}, {\"fromState\": \"Safety Follow Up\", \"toState\": \"Efficacy Follow Up\", \"trigger\": \"Progress to Efficacy Follow Up\"}, {\"fromState\": \"Efficacy Follow Up\", \"toState\": \"Survival Follow Up\", \"trigger\": \"Progress to Survival Follow Up\"}, {\"fromState\": \"Treatment Phase\", \"toState\": \"Early Termination\", \"trigger\": \"Subject exits to Early Termination\"}, {\"fromState\": \"End Of Treatment\", \"toState\": \"Early Termination\", \"trigger\": \"Subject exits to Early Termination\"}], \"epochIds\": {\"Molecular Pre Screening\": \"MOLECULAR_PRE_SCREENING\", \"Screening\": \"SCREENING\", \"Treatment Phase\": \"TREATMENT_PHASE\", \"End Of Treatment\": \"END_OF_TREATMENT\", \"Safety Follow Up\": \"SAFETY_FOLLOW_UP\", \"Efficacy Follow Up\": \"EFFICACY_FOLLOW_UP\", \"Survival Follow Up\": \"SURVIVAL_FOLLOW_UP\", \"Early Termination\": \"EARLY_TERMINATION\"}}"
              },
              {
                "id": "b1ced3b0-dfbf-4893-b871-b0fab8b99e13",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-dosingRegimens",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"f4e37474-ebb0-499c-b44c-bce5bcdc76a0\", \"treatmentName\": \"PDR001 (spartalizumab)\", \"frequency\": \"Q4W\", \"route\": \"IV\", \"startDay\": 1, \"durationDescription\": \"Until disease progression or unacceptable toxicity\", \"doseModifications\": [\"Dose modifications and management guidelines for infusion reactions\", \"General dose modification instructions for PDR001 or placebo\"]}, {\"id\": \"e3667b8c-ab8f-4f14-899e-1af560445cef\", \"treatmentName\": \"Dabrafenib\", \"frequency\": \"BID\", \"route\": \"Oral\", \"startDay\": 1, \"durationDescription\": \"Until disease progression or unacceptable toxicity\", \"doseModifications\": [\"Dose modifications and management guidelines for adverse events common to PDR001, dabrafenib and trametinib\"]}, {\"id\": \"0f7ba106-2b84-45bc-8bf9-38a079d6e22c\", \"treatmentName\": \"Trametinib\", \"frequency\": \"QD\", \"route\": \"Oral\", \"startDay\": 1, \"durationDescription\": \"Until disease progression or unacceptable toxicity\", \"doseModifications\": [\"Dose modifications and management guidelines for adverse events common to PDR001, dabrafenib and trametinib\"]}, {\"id\": \"c8a141d9-baf0-4d58-b2b9-110615d922c5\", \"treatmentName\": \"Placebo\", \"frequency\": \"Q4W\", \"route\": \"IV\", \"startDay\": 1, \"durationDescription\": \"Until disease progression or unacceptable toxicity\", \"doseModifications\": [\"General dose modification instructions for PDR001 or placebo\"]}]"
              },
              {
                "id": "b04886d1-b627-4e3a-be98-663e35a290e3",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-visitWindows",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"111e1856-b48d-4881-918d-c5e9a6e0c233\", \"visitName\": \"Screening\", \"targetDay\": -14, \"windowBefore\": 7, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 1, \"epoch\": \"Screening phase\", \"sourceText\": \"Screening phase.....................................................................................74 4.1.2 Treatment phase............................................................................\"}, {\"id\": \"ff66f40e-888f-4f67-bccb-b519b7beadb7\", \"visitName\": \"Early Termination\", \"targetDay\": null, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 2, \"sourceText\": \"Overview of dabrafenib and trametinib.................................................53 2 Rationale ...................................................................................................\"}, {\"id\": \"aceff40d-c750-4ca4-8981-9e460d7f1501\", \"visitName\": \"End of treatment\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 3, \"epoch\": \"End of treatment\", \"sourceText\": \"End of treatment ....................................................................................75 4.1.4 Safety follow-up..........................................................................\"}, {\"id\": \"2f1c521c-1fb4-4e64-92e4-e716dc451d01\", \"visitName\": \"baseline\", \"targetDay\": 0, \"windowBefore\": 1, \"windowAfter\": 1, \"isRequired\": true, \"visitNumber\": 4, \"sourceText\": \"Post baseline imaging assessments (Section 7.2.1.2) updated to reflect requirements following final PFS analysis \\u2022\"}, {\"id\": \"a15e4235-4022-4b29-a262-ca070f0a1a0c\", \"visitName\": \"Visit 600\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 5, \"sourceText\": \"combination with dabrafenib and trametinib in patients with untreated BRAF V600 mutant melanoma. Results from KEYNOTE-022 Part 3 (Ascierto et al., 2018b) suggest a 5 months delayed treatment effect fo\"}, {\"id\": \"18e80abe-60cf-4e2f-b177-84b2c42881c4\", \"visitName\": \"end of study\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 7, \"isRequired\": true, \"visitNumber\": 6, \"sourceText\": \"Clarified definition of end of study (Section 4.3) in the case that statistically significant interim (at the time of the primary PFS analysis) or final OS results are demonstrated. \\u2022\"}, {\"id\": \"40f0b18f-bf82-44c5-b081-f81875e16320\", \"visitName\": \"Visit 1\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 7, \"sourceText\": \"primary endpoint was PFS based on investigator assessed response by RECIST v1.1. The final PFS analysis showed that the study did not meet its primary endpoint of investigator- assessed PFS. The combi\"}, {\"id\": \"dce59703-9cb8-44b8-8e5c-dd5bc57c945d\", \"visitName\": \"Treatment Period Visits\", \"targetDay\": null, \"windowBefore\": null, \"windowAfter\": null, \"isRequired\": true, \"visitNumber\": 4, \"epoch\": \"Treatment phase\"}, {\"id\": \"dbc3bff7-32a9-4485-a5b4-877185cb19eb\", \"visitName\": \"Efficacy follow-up\", \"targetDay\": null, \"windowBefore\": null, \"windowAfter\": null, \"isRequired\": true, \"visitNumber\": 7, \"epoch\": \"Efficacy follow-up\"}, {\"id\": \"1162224f-f1a9-4290-92e9-dcbb0c7e422d\", \"visitName\": \"Survival follow-up\", \"targetDay\": null, \"windowBefore\": null, \"windowAfter\": null, \"isRequired\": true, \"visitNumber\": 8, \"epoch\": \"Survival follow-up\"}, {\"id\": \"188ac2ef-af8b-494c-9b95-5a3c47e37c1e\", \"visitName\": \"randomization\", \"targetDay\": 1, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 13, \"epoch\": \"Treatment phase\", \"sourceText\": \"Subject numbering, treatment assignment or randomization...............................129 6.5.1 Subject numbering...............................................................................129\"}, {\"id\": \"d047ac40-7259-411a-92eb-bad64f46c965\", \"visitName\": \"Day 8\", \"targetDay\": 8, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 14, \"sourceText\": \"at Cycle 1 Day 8 for Part 2 (Table 7-10). \\u2022 Added language to allow request for additional archival tumor tissue in case the sample\"}, {\"id\": \"a841d651-9812-4639-8cde-fe72517f2f00\", \"visitName\": \"Day 15\", \"targetDay\": 15, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": false, \"visitNumber\": 15, \"sourceText\": \"Added an additional optional tumor biopsy collection at Cycle 1 Day 15 for part 3 to expand biomarker analyses with samples collected in part 3 (Tables 7-3; Table 7-16); (Section 7.2.4.1)\"}, {\"id\": \"cb1d653f-8f14-4b65-8ca3-ce712cfa64cc\", \"visitName\": \"Day 18\", \"targetDay\": 18, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 16, \"sourceText\": \"induction of its own metabolism. Mean accumulation AUC Day 18/Day 1 ratios was 0.73. Dabrafenib binds to human plasma protein and is 99.7% bound. The metabolism of dabrafenib is primarily mediated by \"}, {\"id\": \"1dd0c444-1602-47ed-bb34-e5bc3f20b278\", \"visitName\": \"Day 29\", \"targetDay\": 29, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 17, \"sourceText\": \"The start day of PDR001 for part 1 DL-1b was revised from \\u2018from Day 29\\u2019 to \\u2018starting at C2D1 (Day 29)\\u2019 in Table 6-2 to align with Table 6-5. \\u2022\"}, {\"id\": \"f3ddbddc-58e2-4a9c-b74a-91312998dffa\", \"visitName\": \"Day 31\", \"targetDay\": 31, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 18, \"sourceText\": \"medication\\u2019 and the beginning of the \\u2018post treatment\\u2019 was changed to \\u2018at day 31 after last dose of study medication\\u2019. Inserted a paragraph stating that summaries for deaths, all AEs, and all SAEs coll\"}, {\"id\": \"cec02aee-a431-49d5-bae4-930d76636d72\", \"visitName\": \"Follow-up\", \"targetDay\": 365, \"windowBefore\": 7, \"windowAfter\": 7, \"isRequired\": true, \"visitNumber\": 19, \"sourceText\": \"Safety follow-up....................................................................................75 4.1.5 Efficacy follow-up.........................................................................\"}]"
              },
              {
                "id": "a658eb60-683e-4a50-8ced-ea3de3a92de7",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-randomizationScheme",
                "instanceType": "ExtensionAttribute",
                "valueString": "{\"id\": \"3b509d12-7739-44d2-ac89-86bfa60b99b1\", \"ratio\": \"1:1:1\", \"method\": \"Stratified block randomization\", \"centralRandomization\": true, \"blockSize\": \"Not specified in provided text\", \"stratificationFactors\": [{\"id\": \"5f7ac42a-80ef-4a10-8d9f-73087369b27a\", \"name\": \"BRAF mutation status\", \"categories\": [\"BRAF V600-mutant\", \"BRAF wild-type\"], \"isBlocking\": false}, {\"id\": \"e6cf2844-4e92-4cfa-94ff-b9839c8474b0\", \"name\": \"Prior anti-PD-1/PD-L1 therapy for unresectable or metastatic melanoma\", \"categories\": [\"Yes\", \"No\"], \"isBlocking\": false}, {\"id\": \"e15cda4d-49b3-49a0-9c6a-de982dbcf30b\", \"name\": \"LDH level\", \"categories\": [\"\\u2264 ULN\", \"> ULN\"], \"isBlocking\": false}], \"sourceText\": \"Novartis\\nConfidential\\nPage 4 of 289\\nAmended Protocol Version 07 (Clean)\\nProtocol No. CPDR001F2301\\n6.3.6\\nFollow-up for toxicities.......................................................................1\"}"
              },
              {
                "id": "ext_execution_model_c9f27512-3755-4009-814b-232dc55ddcbc",
                "url": "https://protocol2usdm.io/extensions/x-executionModel",
                "instanceType": "ExtensionAttribute",
                "valueObject": {
                  "schemaVersion": "1.0.0",
                  "extractionTimestamp": "2026-01-23T02:32:05.047088",
                  "executionModel": {
                    "timeAnchors": [
                      {
                        "id": "7e684f44-6ede-4818-bb12-140ea94388c4",
                        "definition": "First administration of investigational product",
                        "anchorType": "FirstDose",
                        "classification": "Event",
                        "timelineId": null,
                        "dayValue": 1,
                        "sourceText": "first dose \nof study treatment",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "058aefd4-f5d2-4d96-8690-60fa10783dce",
                        "definition": "Day 1 of Cycle 1",
                        "anchorType": "CycleStart",
                        "classification": "Conceptual",
                        "timelineId": null,
                        "dayValue": 1,
                        "sourceText": "Cycle 1 Day 1",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "0234f37b-1e09-4547-9f20-68169f06f85b",
                        "definition": "Point/time of patient entry into the study; the point at which informed consent must be obtained (i.e. prior to starting any of the procedures described in the protocol)",
                        "anchorType": "Enrollment",
                        "classification": "Event",
                        "timelineId": null,
                        "dayValue": 1,
                        "sourceText": "Enrollment: Point/time of patient entry into the study; the point at which informed consent must be obtained (i.e. prior to starting any of the procedures described in the protocol)",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "3db3a560-ff6c-44bf-a1d8-573bd280690b",
                        "definition": "Informed consent obtained",
                        "anchorType": "InformedConsent",
                        "classification": "Event",
                        "timelineId": null,
                        "dayValue": 1,
                        "sourceText": "informed consent",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "0e9e0b61-623a-4721-8a67-19af429379b0",
                        "definition": "procedure",
                        "anchorType": "Custom",
                        "classification": "Conceptual",
                        "timelineId": null,
                        "dayValue": 1,
                        "sourceText": "procedure",
                        "encounterId": null,
                        "activityId": null
                      }
                    ],
                    "repetitions": [
                      {
                        "id": "2684f047-4497-4e29-81fe-dd665931196e",
                        "type": "Daily",
                        "interval": "P1D",
                        "sourceText": "od"
                      },
                      {
                        "id": "17524d27-cb66-4ff8-9c40-6dde270c3578",
                        "type": "Daily",
                        "interval": "P1D",
                        "sourceText": "QD"
                      },
                      {
                        "id": "6e1b23d4-82df-4d8d-80b3-172b5020ed4c",
                        "type": "Interval",
                        "sourceText": "BID"
                      },
                      {
                        "id": "764cf134-50b3-4307-a71c-0689af95c0c2",
                        "type": "Cycle",
                        "sourceText": "Cycle 1 Day 8"
                      },
                      {
                        "id": "f3d54016-8a50-4118-9e53-315b09f4c5a5",
                        "type": "Cycle",
                        "sourceText": "Cycle 1 Day 15"
                      },
                      {
                        "id": "23eeb1c0-5893-4233-9814-317ba9134dc3",
                        "type": "Cycle",
                        "sourceText": "Cycle \n4 Day 1"
                      },
                      {
                        "id": "bd5a0758-0ae0-45de-a996-9bc618ee7b64",
                        "type": "Cycle",
                        "sourceText": "Cycle 22 Day 1"
                      },
                      {
                        "id": "f12258e9-ea5d-486c-93ac-138ef4684c08",
                        "type": "Cycle",
                        "sourceText": "C1D1"
                      },
                      {
                        "id": "9c9e04cd-4c83-496f-bc04-03b5430e512e",
                        "type": "Continuous",
                        "sourceText": "Treatment period"
                      },
                      {
                        "id": "1661656a-677f-4097-9fbd-c72b2b99744c",
                        "type": "Continuous",
                        "sourceText": "treatment \nperiod"
                      },
                      {
                        "id": "fcbc4a81-eb23-4c0d-919c-e8b1832766b6",
                        "type": "Continuous",
                        "sourceText": "follow-up period"
                      },
                      {
                        "id": "4c030fc5-b959-4722-ab56-80c6209d7765",
                        "type": "Continuous",
                        "sourceText": "follow up period"
                      },
                      {
                        "id": "9ffd86ee-e5fc-409a-90b7-a5ab2d7e5c24",
                        "type": "Continuous",
                        "sourceText": "observation period"
                      },
                      {
                        "id": "4d9f3f16-6259-4b36-a916-c8720d364e6f",
                        "type": "Continuous",
                        "sourceText": "30 days after"
                      },
                      {
                        "id": "2e5de034-2eb9-4559-94ac-69ffa3aa3f47",
                        "type": "Continuous",
                        "sourceText": "120 \ndays after"
                      },
                      {
                        "id": "e3abbf60-b05b-429e-a2c7-9eaf9d3b2b6e",
                        "type": "Continuous",
                        "sourceText": "150 days after"
                      },
                      {
                        "id": "84ba6a99-6355-4492-b466-3e1b66bdc94c",
                        "type": "Cycle",
                        "startOffset": "P0D",
                        "interval": "P21D",
                        "exitCondition": "final PFS analysis",
                        "sourceText": "Visit evaluation schedule: Safety run-In part (Part 1)  visit schedule updated and applicable following final PFS analysis"
                      },
                      {
                        "id": "2dea0b8b-a7cf-4537-b9ce-3ad61fdb2a1c",
                        "type": "Cycle",
                        "startOffset": "P0D",
                        "interval": "P21D",
                        "exitCondition": "final PFS analysis",
                        "sourceText": "Visit evaluation schedule: Biomarker cohort (Part 2)  visit schedule updated and applicable following final PFS analysis"
                      },
                      {
                        "id": "be7e8938-935c-48c2-a634-dde293e8a12a",
                        "type": "Cycle",
                        "startOffset": "P0D",
                        "interval": "P21D",
                        "exitCondition": "final PFS analysis",
                        "sourceText": "Visit evaluation schedule: Double-blind, randomized, placebo-controlled part (Part 3)  visit schedule updated and is applicable following final PFS analysis"
                      }
                    ],
                    "samplingConstraints": [],
                    "traversalConstraints": [
                      {
                        "id": "945d6928-eb04-4835-8bed-a06ae508fd26",
                        "requiredSequence": [
                          "SCREENING",
                          "PERIOD_1",
                          "PERIOD_2",
                          "END_OF_STUDY"
                        ],
                        "allowEarlyExit": true,
                        "exitEpochIds": [
                          "86ab1089-4bc8-445b-b28f-ab7d8e393054"
                        ],
                        "mandatoryVisits": [
                          "Screening",
                          "Day 1",
                          "End of Study"
                        ],
                        "sourceText": "crossover"
                      },
                      {
                        "id": "5db7647e-873e-4673-8dc7-003d4862e79b",
                        "requiredSequence": [
                          "MOLECULAR_PRE_SCREENING",
                          "SCREENING",
                          "TREATMENT_PHASE",
                          "END_OF_TREATMENT",
                          "SAFETY_FOLLOW_UP",
                          "EFFICACY_FOLLOW_UP",
                          "SURVIVAL_FOLLOW_UP"
                        ],
                        "allowEarlyExit": true,
                        "exitEpochIds": [
                          "86ab1089-4bc8-445b-b28f-ab7d8e393054"
                        ],
                        "mandatoryVisits": [
                          "Molecular Pre-screening",
                          "Screening",
                          "Cycle 1 Day 1",
                          "End of Study",
                          "End of Treatment Visit",
                          "30-Day Safety Follow-up"
                        ],
                        "sourceText": "[{'condition': 'Subject experiences toxicity or Adverse Event', 'path': ['TREATMENT_DISCONTINUATION', 'FOLLOW_UP_FOR_TOXICITIES', 'SAFETY_FOLLOW_UP']}, {'condition': 'Subject discontinues treatment for reasons other than disease progression', 'path': ['EFFICACY_FOLLOW_UP', 'SURVIVAL_FOLLOW_UP']}, {'condition': 'Subject withdraws consent', 'path': ['WITHDRAWAL_OF_STUDY_CONSENT', 'LOST_TO_FOLLOW_UP']}]"
                      }
                    ],
                    "executionTypes": [
                      {
                        "activityId": "Ecg",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Pe",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Adverse Events",
                        "executionType": "Episode",
                        "rationale": "EPISODE signals: 11"
                      },
                      {
                        "activityId": "Concomitant Medications",
                        "executionType": "Episode",
                        "rationale": "EPISODE signals: 2"
                      },
                      {
                        "activityId": "Laboratory Test",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Pharmacokinetic",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Dosing",
                        "executionType": "Episode",
                        "rationale": "EPISODE signals: 2"
                      },
                      {
                        "activityId": "Imaging",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 1"
                      },
                      {
                        "activityId": "Tissue Sample",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Questionnaire",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Screening Phase Assessment",
                        "executionType": "Single",
                        "rationale": "The screening phase is described as a distinct initial period to determine eligibility before entering the treatment phase."
                      },
                      {
                        "activityId": "bc5a23d0-b6ec-495f-9fae-780388a7814b",
                        "executionType": "Single",
                        "rationale": "Safety run-ins involve conditional dose-escalation or safety monitoring workflows to determine the recommended dose for subsequent parts."
                      },
                      {
                        "activityId": "Treatment Phase Monitoring",
                        "executionType": "Single",
                        "rationale": "The treatment phase involves scheduled administration and assessments repeated at defined study visits."
                      },
                      {
                        "activityId": "d1933cd3-179c-4f77-8f3b-bd31a2b0469b",
                        "executionType": "Single",
                        "rationale": "Follow-up assessments are typically scheduled at specific intervals after the end of treatment."
                      },
                      {
                        "activityId": "74fc72bd-c44b-43fb-9759-99dd56b21203",
                        "executionType": "Single",
                        "rationale": "Efficacy follow-up involves repeated assessments over time to monitor long-term outcomes like survival or progression."
                      }
                    ],
                    "crossoverDesign": {
                      "id": "b8bee455-226c-418d-9c7a-9664f860db9b",
                      "isCrossover": true,
                      "numPeriods": 2,
                      "numSequences": 2,
                      "periods": [
                        "Period 1",
                        "Period 2"
                      ],
                      "sequences": [
                        "AB",
                        "BA"
                      ],
                      "washoutRequired": false,
                      "sourceText": "crossover"
                    },
                    "footnoteConditions": [
                      {
                        "id": "9e0c7707-05a1-438e-b5c7-a34d247463c1",
                        "conditionType": "procedure_conditional",
                        "text": "For Cycle 1, all assessments have a  3 day window unless otherwise indicated.",
                        "footnoteId": "541f9258-b090-4ff5-91fa-ba9a06481f3b",
                        "structuredCondition": "cycle == 1 ? window(P3D) : null",
                        "appliesToActivityIds": [
                          "All assessments"
                        ],
                        "sourceText": "For Cycle 1, all assessments have a  3 day window unless otherwise indicated."
                      },
                      {
                        "id": "2c5ee186-7139-4124-bb83-637acabdb942",
                        "conditionType": "timing_after",
                        "text": "After Cycle 1, all assessments have a  7 day window, unless otherwise indicated.",
                        "footnoteId": "59dbe2a8-c7e4-462f-a8f3-b18e41519872",
                        "structuredCondition": "cycle > 1 ? window(P7D) : null",
                        "appliesToActivityIds": [
                          "All assessments"
                        ],
                        "sourceText": "After Cycle 1, all assessments have a  7 day window, unless otherwise indicated."
                      },
                      {
                        "id": "a777c308-642c-4d9b-8f99-2bca2dcd3dcf",
                        "conditionType": "sequence",
                        "text": "If study drug is being held due to toxicity, then the scheduled visits and assessments should still be performed per protocol.",
                        "footnoteId": "dd088c1e-d153-4b33-8e05-1cfc22683a8a",
                        "structuredCondition": "if(drug_hold == true) { perform_assessments = true }",
                        "appliesToActivityIds": [
                          "Scheduled visits",
                          "Assessments"
                        ],
                        "sourceText": "If study drug is being held due to toxicity, then the scheduled visits and assessments should still "
                      },
                      {
                        "id": "c134449d-6f4a-451d-a243-451d33ce4b6b",
                        "conditionType": "general",
                        "text": "Suspected AEs up to Day 150; non-suspected AEs up to Day 150 or start of new post treatment anti-neoplastic medication, whichever is sooner.",
                        "footnoteId": "c9c5d206-f4d9-4ee4-81b7-7a1fd461a915",
                        "structuredCondition": "min(day_150, start_of_new_anti_neoplastic_medication)",
                        "appliesToActivityIds": [
                          "AE reporting"
                        ],
                        "sourceText": "Suspected AEs up to Day 150; non-suspected AEs up to Day 150 or start of new post treatment anti-neo"
                      },
                      {
                        "id": "42af301b-303c-4e5c-8341-25ac3e68baa0",
                        "conditionType": "timing_after",
                        "text": "Following final PFS analysis; colour digital photography assessments are no longer required.",
                        "footnoteId": "bc97fd71-c658-46b9-be10-35288e3c7cc8",
                        "structuredCondition": "if(final_pfs_analysis == complete) { required = false }",
                        "appliesToActivityIds": [
                          "Colour digital photography assessments"
                        ],
                        "sourceText": "Following final PFS analysis; colour digital photography assessments are no longer required."
                      }
                    ],
                    "endpointAlgorithms": [
                      {
                        "id": "dc0559b9-ca06-4972-8171-a85ab7c2f6d3",
                        "name": "Primary: Progression-Free Survival (PFS)",
                        "endpointType": "Primary",
                        "inputs": [
                          "Date of randomization",
                          "Date of first documented progression",
                          "Date of death",
                          "Investigator assessment (RECIST)"
                        ],
                        "timeWindow": {
                          "reference": "Randomization",
                          "duration": "Until progression or death"
                        },
                        "algorithm": "Time from randomization to the first documented progression or death due to any cause",
                        "successCriteria": "Statistically significant improvement in PFS (P < 0.025 one-sided, though protocol reported P = 0.042 as not meeting primary endpoint)",
                        "sourceText": "The final Progression-Free Survival (PFS) analysis occurred using a data cut-off date of 01-Jul-2020. The primary objective of this amendment is to enable continuation of the study following the final"
                      },
                      {
                        "id": "84a9e868-e12b-4620-9e65-67110a92c81b",
                        "name": "Key Secondary: Overall Survival (OS)",
                        "endpointType": "Secondary",
                        "inputs": [
                          "Date of randomization",
                          "Date of death"
                        ],
                        "timeWindow": {
                          "reference": "Randomization",
                          "duration": "Until death"
                        },
                        "algorithm": "Time from randomization to the date of death from any cause",
                        "successCriteria": "Statistically significant improvement in OS (not formally tested if primary endpoint not met)",
                        "sourceText": "Since the primary endpoint was not met the key secondary endpoint OS was not formally statistically tested."
                      },
                      {
                        "id": "29489cc6-b607-449b-8d2a-c17eefb0621c",
                        "name": "Safety: Treatment Related Adverse Events (TRAEs)",
                        "endpointType": "Secondary",
                        "inputs": [
                          "Adverse Event (AE) occurrence",
                          "AE Grade (NCI CTCAE)",
                          "Relationship to study drug"
                        ],
                        "timeWindow": {
                          "reference": "First dose of study treatment",
                          "duration": "Throughout study duration"
                        },
                        "algorithm": "(Number of patients with at least one TRAE / Total patients in safety set) * 100",
                        "successCriteria": "Manageable safety profile with dose interruptions and reductions",
                        "sourceText": "The safety data demonstrated that the treatment related AEs (TRAEs) all grades occurred in 98.5% vs. 87.5% of patients, and  grade 3 in 54.7% vs. 33.3% of patients"
                      }
                    ],
                    "derivedVariables": [
                      {
                        "id": "7430ed80-2c2b-432a-8a2e-e53037a381e2",
                        "name": "Progression-Free Survival (PFS)",
                        "variableType": "TimeToEvent",
                        "sourceVariables": [
                          "Date of randomization",
                          "Date of first documented progression",
                          "Date of death"
                        ],
                        "derivationRule": "The time from the date of randomization to the date of the first documented progression or death due to any cause. Progression is determined per RECIST 1.1.",
                        "baselineDefinition": "Date of randomization",
                        "baselineVisit": "Day 1",
                        "analysisWindow": "Defined schedule per RECIST 1.1 (prior to 01-Jul-2020 DCO)",
                        "imputationRule": "Censoring rules applied for missing assessments or start of new anti-cancer therapy",
                        "unit": "Months"
                      },
                      {
                        "id": "ad5bfcf7-e956-47ae-a4f5-0e9984f69531",
                        "name": "Tumor Response",
                        "variableType": "Categorical",
                        "sourceVariables": [
                          "Target lesions",
                          "Non-target lesions",
                          "New lesions"
                        ],
                        "derivationRule": "Categorized as CR, PR, SD, or PD based on RECIST 1.1 criteria",
                        "baselineDefinition": "Last assessment prior to randomization",
                        "baselineVisit": "Screening",
                        "analysisWindow": "Per defined schedule in Table 7-1/7-2 (discontinued after final PFS analysis)",
                        "imputationRule": "Missing or unevaluable assessments treated as Unknown/Missing"
                      }
                    ],
                    "stateMachine": {
                      "id": "b47ac281-a036-477f-aada-a82f1e1b63b6",
                      "initialState": "Molecular Pre Screening",
                      "terminalStates": [
                        "Early Termination",
                        "Completed"
                      ],
                      "states": [
                        "Molecular Pre Screening",
                        "Screening",
                        "Treatment Phase",
                        "End Of Treatment",
                        "Safety Follow Up",
                        "Efficacy Follow Up",
                        "Survival Follow Up",
                        "Early Termination"
                      ],
                      "transitions": [
                        {
                          "fromState": "Molecular Pre Screening",
                          "toState": "Screening",
                          "trigger": "Progress to Screening"
                        },
                        {
                          "fromState": "Screening",
                          "toState": "Treatment Phase",
                          "trigger": "Progress to Treatment Phase"
                        },
                        {
                          "fromState": "Treatment Phase",
                          "toState": "End Of Treatment",
                          "trigger": "Progress to End Of Treatment"
                        },
                        {
                          "fromState": "End Of Treatment",
                          "toState": "Safety Follow Up",
                          "trigger": "Progress to Safety Follow Up"
                        },
                        {
                          "fromState": "Safety Follow Up",
                          "toState": "Efficacy Follow Up",
                          "trigger": "Progress to Efficacy Follow Up"
                        },
                        {
                          "fromState": "Efficacy Follow Up",
                          "toState": "Survival Follow Up",
                          "trigger": "Progress to Survival Follow Up"
                        },
                        {
                          "fromState": "Treatment Phase",
                          "toState": "Early Termination",
                          "trigger": "Subject exits to Early Termination"
                        },
                        {
                          "fromState": "End Of Treatment",
                          "toState": "Early Termination",
                          "trigger": "Subject exits to Early Termination"
                        }
                      ],
                      "epochIds": {
                        "Molecular Pre Screening": "MOLECULAR_PRE_SCREENING",
                        "Screening": "SCREENING",
                        "Treatment Phase": "TREATMENT_PHASE",
                        "End Of Treatment": "END_OF_TREATMENT",
                        "Safety Follow Up": "SAFETY_FOLLOW_UP",
                        "Efficacy Follow Up": "EFFICACY_FOLLOW_UP",
                        "Survival Follow Up": "SURVIVAL_FOLLOW_UP",
                        "Early Termination": "EARLY_TERMINATION"
                      }
                    },
                    "dosingRegimens": [
                      {
                        "id": "f4e37474-ebb0-499c-b44c-bce5bcdc76a0",
                        "treatmentName": "PDR001 (spartalizumab)",
                        "frequency": "Q4W",
                        "route": "IV",
                        "startDay": 1,
                        "durationDescription": "Until disease progression or unacceptable toxicity",
                        "doseModifications": [
                          "Dose modifications and management guidelines for infusion reactions",
                          "General dose modification instructions for PDR001 or placebo"
                        ]
                      },
                      {
                        "id": "e3667b8c-ab8f-4f14-899e-1af560445cef",
                        "treatmentName": "Dabrafenib",
                        "frequency": "BID",
                        "route": "Oral",
                        "startDay": 1,
                        "durationDescription": "Until disease progression or unacceptable toxicity",
                        "doseModifications": [
                          "Dose modifications and management guidelines for adverse events common to PDR001, dabrafenib and trametinib"
                        ]
                      },
                      {
                        "id": "0f7ba106-2b84-45bc-8bf9-38a079d6e22c",
                        "treatmentName": "Trametinib",
                        "frequency": "QD",
                        "route": "Oral",
                        "startDay": 1,
                        "durationDescription": "Until disease progression or unacceptable toxicity",
                        "doseModifications": [
                          "Dose modifications and management guidelines for adverse events common to PDR001, dabrafenib and trametinib"
                        ]
                      },
                      {
                        "id": "c8a141d9-baf0-4d58-b2b9-110615d922c5",
                        "treatmentName": "Placebo",
                        "frequency": "Q4W",
                        "route": "IV",
                        "startDay": 1,
                        "durationDescription": "Until disease progression or unacceptable toxicity",
                        "doseModifications": [
                          "General dose modification instructions for PDR001 or placebo"
                        ]
                      }
                    ],
                    "visitWindows": [
                      {
                        "id": "111e1856-b48d-4881-918d-c5e9a6e0c233",
                        "visitName": "Screening",
                        "targetDay": -14,
                        "windowBefore": 7,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 1,
                        "epoch": "Screening phase",
                        "sourceText": "Screening phase.....................................................................................74 4.1.2 Treatment phase............................................................................"
                      },
                      {
                        "id": "ff66f40e-888f-4f67-bccb-b519b7beadb7",
                        "visitName": "Early Termination",
                        "targetDay": null,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 2,
                        "sourceText": "Overview of dabrafenib and trametinib.................................................53 2 Rationale ..................................................................................................."
                      },
                      {
                        "id": "aceff40d-c750-4ca4-8981-9e460d7f1501",
                        "visitName": "End of treatment",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 3,
                        "epoch": "End of treatment",
                        "sourceText": "End of treatment ....................................................................................75 4.1.4 Safety follow-up.........................................................................."
                      },
                      {
                        "id": "2f1c521c-1fb4-4e64-92e4-e716dc451d01",
                        "visitName": "baseline",
                        "targetDay": 0,
                        "windowBefore": 1,
                        "windowAfter": 1,
                        "isRequired": true,
                        "visitNumber": 4,
                        "sourceText": "Post baseline imaging assessments (Section 7.2.1.2) updated to reflect requirements following final PFS analysis "
                      },
                      {
                        "id": "a15e4235-4022-4b29-a262-ca070f0a1a0c",
                        "visitName": "Visit 600",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 5,
                        "sourceText": "combination with dabrafenib and trametinib in patients with untreated BRAF V600 mutant melanoma. Results from KEYNOTE-022 Part 3 (Ascierto et al., 2018b) suggest a 5 months delayed treatment effect fo"
                      },
                      {
                        "id": "18e80abe-60cf-4e2f-b177-84b2c42881c4",
                        "visitName": "end of study",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 7,
                        "isRequired": true,
                        "visitNumber": 6,
                        "sourceText": "Clarified definition of end of study (Section 4.3) in the case that statistically significant interim (at the time of the primary PFS analysis) or final OS results are demonstrated. "
                      },
                      {
                        "id": "40f0b18f-bf82-44c5-b081-f81875e16320",
                        "visitName": "Visit 1",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 7,
                        "sourceText": "primary endpoint was PFS based on investigator assessed response by RECIST v1.1. The final PFS analysis showed that the study did not meet its primary endpoint of investigator- assessed PFS. The combi"
                      },
                      {
                        "id": "fe80a411-0966-49d7-824d-6d1af393efcd",
                        "visitName": "Molecular pre-screening",
                        "targetDay": null,
                        "windowBefore": null,
                        "windowAfter": null,
                        "isRequired": true,
                        "visitNumber": 1,
                        "epoch": "Pre-screening"
                      },
                      {
                        "id": "dce59703-9cb8-44b8-8e5c-dd5bc57c945d",
                        "visitName": "Treatment Period Visits",
                        "targetDay": null,
                        "windowBefore": null,
                        "windowAfter": null,
                        "isRequired": true,
                        "visitNumber": 4,
                        "epoch": "Treatment phase"
                      },
                      {
                        "id": "b6b93a4e-1698-4723-9721-12292ff724a0",
                        "visitName": "Safety follow-up",
                        "targetDay": null,
                        "windowBefore": null,
                        "windowAfter": null,
                        "isRequired": true,
                        "visitNumber": 6,
                        "epoch": "Safety follow-up"
                      },
                      {
                        "id": "dbc3bff7-32a9-4485-a5b4-877185cb19eb",
                        "visitName": "Efficacy follow-up",
                        "targetDay": null,
                        "windowBefore": null,
                        "windowAfter": null,
                        "isRequired": true,
                        "visitNumber": 7,
                        "epoch": "Efficacy follow-up"
                      },
                      {
                        "id": "1162224f-f1a9-4290-92e9-dcbb0c7e422d",
                        "visitName": "Survival follow-up",
                        "targetDay": null,
                        "windowBefore": null,
                        "windowAfter": null,
                        "isRequired": true,
                        "visitNumber": 8,
                        "epoch": "Survival follow-up"
                      },
                      {
                        "id": "188ac2ef-af8b-494c-9b95-5a3c47e37c1e",
                        "visitName": "randomization",
                        "targetDay": 1,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 13,
                        "epoch": "Treatment phase",
                        "sourceText": "Subject numbering, treatment assignment or randomization...............................129 6.5.1 Subject numbering...............................................................................129"
                      },
                      {
                        "id": "d047ac40-7259-411a-92eb-bad64f46c965",
                        "visitName": "Day 8",
                        "targetDay": 8,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 14,
                        "sourceText": "at Cycle 1 Day 8 for Part 2 (Table 7-10).  Added language to allow request for additional archival tumor tissue in case the sample"
                      },
                      {
                        "id": "a841d651-9812-4639-8cde-fe72517f2f00",
                        "visitName": "Day 15",
                        "targetDay": 15,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": false,
                        "visitNumber": 15,
                        "sourceText": "Added an additional optional tumor biopsy collection at Cycle 1 Day 15 for part 3 to expand biomarker analyses with samples collected in part 3 (Tables 7-3; Table 7-16); (Section 7.2.4.1)"
                      },
                      {
                        "id": "cb1d653f-8f14-4b65-8ca3-ce712cfa64cc",
                        "visitName": "Day 18",
                        "targetDay": 18,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 16,
                        "sourceText": "induction of its own metabolism. Mean accumulation AUC Day 18/Day 1 ratios was 0.73. Dabrafenib binds to human plasma protein and is 99.7% bound. The metabolism of dabrafenib is primarily mediated by "
                      },
                      {
                        "id": "1dd0c444-1602-47ed-bb34-e5bc3f20b278",
                        "visitName": "Day 29",
                        "targetDay": 29,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 17,
                        "sourceText": "The start day of PDR001 for part 1 DL-1b was revised from from Day 29 to starting at C2D1 (Day 29) in Table 6-2 to align with Table 6-5. "
                      },
                      {
                        "id": "f3ddbddc-58e2-4a9c-b74a-91312998dffa",
                        "visitName": "Day 31",
                        "targetDay": 31,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 18,
                        "sourceText": "medication and the beginning of the post treatment was changed to at day 31 after last dose of study medication. Inserted a paragraph stating that summaries for deaths, all AEs, and all SAEs coll"
                      },
                      {
                        "id": "cec02aee-a431-49d5-bae4-930d76636d72",
                        "visitName": "Follow-up",
                        "targetDay": 365,
                        "windowBefore": 7,
                        "windowAfter": 7,
                        "isRequired": true,
                        "visitNumber": 19,
                        "sourceText": "Safety follow-up....................................................................................75 4.1.5 Efficacy follow-up........................................................................."
                      }
                    ],
                    "randomizationScheme": {
                      "id": "3b509d12-7739-44d2-ac89-86bfa60b99b1",
                      "ratio": "1:1:1",
                      "method": "Stratified block randomization",
                      "centralRandomization": true,
                      "blockSize": "Not specified in provided text",
                      "stratificationFactors": [
                        {
                          "id": "5f7ac42a-80ef-4a10-8d9f-73087369b27a",
                          "name": "BRAF mutation status",
                          "categories": [
                            "BRAF V600-mutant",
                            "BRAF wild-type"
                          ],
                          "isBlocking": false
                        },
                        {
                          "id": "e6cf2844-4e92-4cfa-94ff-b9839c8474b0",
                          "name": "Prior anti-PD-1/PD-L1 therapy for unresectable or metastatic melanoma",
                          "categories": [
                            "Yes",
                            "No"
                          ],
                          "isBlocking": false
                        },
                        {
                          "id": "e15cda4d-49b3-49a0-9c6a-de982dbcf30b",
                          "name": "LDH level",
                          "categories": [
                            " ULN",
                            "> ULN"
                          ],
                          "isBlocking": false
                        }
                      ],
                      "sourceText": "Novartis\nConfidential\nPage 4 of 289\nAmended Protocol Version 07 (Clean)\nProtocol No. CPDR001F2301\n6.3.6\nFollow-up for toxicities.......................................................................1"
                    }
                  }
                }
              },
              {
                "id": "06d88747-3c95-4741-953b-441c7bce6c7e",
                "url": "https://protocol2usdm.io/extensions/x-soaFootnotes",
                "valueString": "[\"For Cycle 1, all assessments have a \\u00b1 3 day window unless otherwise indicated.\", \"After Cycle 1, all assessments have a \\u00b1 7 day window, unless otherwise indicated.\", \"If study drug is being held due to toxicity, then the scheduled visits and assessments should still be performed per protocol.\", \"Suspected AEs up to Day 150; non-suspected AEs up to Day 150 or start of new post treatment anti-neoplastic medication, whichever is sooner.\", \"Following final PFS analysis; colour digital photography assessments are no longer required.\"]",
                "instanceType": "ExtensionAttribute"
              }
            ],
            "administrations": [
              {
                "id": "9036460c-f5d9-45ad-9923-4b7200c91a6d",
                "name": "PDR001 (spartalizumab) Administration",
                "instanceType": "Administration",
                "doseFrequency": "Q4W",
                "route": {
                  "id": "5e573704-75b3-4fb1-951a-d4e998d5803a",
                  "code": "IV",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "IV",
                  "instanceType": "Code"
                },
                "duration": "Until disease progression or unacceptable toxicity"
              },
              {
                "id": "8ba6ed68-ba10-47a4-9d57-c8954fd62a37",
                "name": "Dabrafenib Administration",
                "instanceType": "Administration",
                "doseFrequency": "BID",
                "route": {
                  "id": "95a748fa-f2b6-444a-ab06-0c571bb60b15",
                  "code": "Oral",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Oral",
                  "instanceType": "Code"
                },
                "duration": "Until disease progression or unacceptable toxicity"
              },
              {
                "id": "53b3a2cd-7733-4f2f-ac56-50c3d0d7b81b",
                "name": "Trametinib Administration",
                "instanceType": "Administration",
                "doseFrequency": "QD",
                "route": {
                  "id": "da4d3009-9f39-42e2-92d8-f10bd45e2b06",
                  "code": "Oral",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Oral",
                  "instanceType": "Code"
                },
                "duration": "Until disease progression or unacceptable toxicity"
              },
              {
                "id": "52fd9828-4556-4057-ac15-9652ecc221b7",
                "name": "Placebo Administration",
                "instanceType": "Administration",
                "doseFrequency": "Q4W",
                "route": {
                  "id": "809fd8f7-19de-4dfb-988b-bb2313426d30",
                  "code": "IV",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "IV",
                  "instanceType": "Code"
                },
                "duration": "Until disease progression or unacceptable toxicity"
              }
            ]
          }
        ],
        "titles": [
          {
            "id": "76affcef-92f8-4b73-805c-5ab5c442c3f9",
            "text": "A Phase III, randomized, double-blind, placebo-controlled study of PDR001 in combination with dabrafenib and trametinib in patients with BRAF V600 mutation-positive unresectable or metastatic melanoma",
            "type": {
              "id": "3dccc6d0-dce2-4a1f-ab88-3215d95a1ad7",
              "code": "Official Study Title",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Official Study Title",
              "instanceType": "Code"
            },
            "instanceType": "StudyTitle"
          }
        ],
        "studyIdentifiers": [
          {
            "id": "81074b87-d58a-45e9-bb75-aa19cf77e96f",
            "text": "CPDR001F2301",
            "instanceType": "StudyIdentifier",
            "scopeId": "3b99560b-0f37-4db8-9f61-7709294caed9",
            "type": {
              "code": "C132351",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Sponsor Protocol Identifier",
              "instanceType": "Code"
            }
          }
        ],
        "organizations": [
          {
            "id": "3b99560b-0f37-4db8-9f61-7709294caed9",
            "name": "Novartis",
            "type": {
              "id": "1ff156d5-6935-4730-9766-8240cef81980",
              "code": "C54086",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Pharmaceutical Company",
              "instanceType": "Code"
            },
            "identifier": "Novartis",
            "identifierScheme": "DUNS",
            "instanceType": "Organization"
          },
          {
            "id": "3b99560b-0f37-4db8-9f61-7709294caed9",
            "name": "California Cancer Associates for Research and Excellence",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "1",
            "type": {
              "id": "4ebc5474-1cf7-4d09-91ce-5a219d001656",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b97f6825-cc67-4e34-8c7f-330875dfed6c",
            "name": "UC Irvine Medical Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "2",
            "type": {
              "id": "462d6b4d-f998-4c73-bd54-4ba83a561ca9",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "23630f9a-3cce-4e60-990a-fbd041cc29e5",
            "name": "California Pacific Medical Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "3",
            "type": {
              "id": "92203088-e625-4d24-8551-07162eccbe55",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a6de8037-adc6-4504-bff3-a7151e284b6d",
            "name": "Stanford Cancer Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "4",
            "type": {
              "id": "29df05ef-93e9-4deb-988a-312fc91306c2",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a02ac875-2a86-4e34-83c7-7db3bfadc560",
            "name": "University of Kansas Cancer Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "5",
            "type": {
              "id": "88fabc46-b6a5-4aae-8e16-a15479300bf2",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "25f2edf0-18dd-41d6-8f74-342eddbbdd29",
            "name": "Johns Hopkins U",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "6",
            "type": {
              "id": "4e99c8aa-c50f-41d4-a976-7e77dc5ad324",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "768e5440-d33c-44a4-a841-d3d591ade0cc",
            "name": "Nebraska Cancer Specialists",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "7",
            "type": {
              "id": "5960a2cb-5a95-40b2-a585-d934f486f54d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "25320e92-9c56-42b3-82fa-a0bdc62cd57e",
            "name": "NYU Laura and Isaac Perlmutter Cancer Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "8",
            "type": {
              "id": "b8a60564-40e0-4977-bcb5-787ebe60bdfe",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "80e84606-b286-4880-9e11-7fcc34246a1e",
            "name": "University of Pittsburgh Med Center",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "9",
            "type": {
              "id": "89403acd-a92c-466e-a7df-bb45ec7bede2",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7b100b72-0768-4939-86a8-7ec82d70b849",
            "name": "University of Tennessee Medical Ctr",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "10",
            "type": {
              "id": "3b01683e-7822-4021-a05f-07236ea718ad",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "cd9429c1-18cf-4ffd-8f23-78c6c82fb37e",
            "name": "Univ of TX MD Anderson Cancer Cntr",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "11",
            "type": {
              "id": "8574f83d-4068-4794-a8ea-3eb39daaa2ad",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "16fb6987-0676-4bfe-8e1d-17e3a23ab54f",
            "name": "Utah Cancer Specialists",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "12",
            "type": {
              "id": "45b800a1-3107-4e6f-b0fd-4e8bf7171186",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "17eaf46e-b798-4124-b5d5-cf2b82c25eb7",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "13",
            "type": {
              "id": "86bbbe87-7b9d-47c8-a51f-1f8daffc09b1",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4e0f5b06-e1aa-4b22-9e80-ad9b5a944957",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "14",
            "type": {
              "id": "bd4a22fc-f72b-4707-959c-7fc76b7b899d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2cc8a2a3-6b5a-44ab-b404-c549b0ea50d2",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "15",
            "type": {
              "id": "457ed843-bc0b-4bd3-8553-5c0474a4d00a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e92278d5-6a27-414b-a240-e535978f2b72",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "16",
            "type": {
              "id": "e295b7b9-84d6-46f9-aaa1-20920c458f05",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9b62cf8c-4b54-4eed-845e-21bcc4567a89",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "17",
            "type": {
              "id": "a213b8e8-2020-4a58-be8b-351c3bbf5114",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0825f219-2b97-4cf7-8166-a2afccd86d86",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "18",
            "type": {
              "id": "6bd3c674-30f6-4ee2-8f61-d631b015e270",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4aacc3fe-d1c9-4fa9-82ab-b498c115aabb",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "19",
            "type": {
              "id": "678e926a-81ee-4502-9920-ddd035b20933",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2c82fec9-11df-40c4-9e77-52dbe3834643",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "20",
            "type": {
              "id": "59d3b1d5-9110-44db-ad26-29dad6dbb120",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "97a354c6-c4a3-4214-b768-a4dd5459fbc3",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "21",
            "type": {
              "id": "88158190-508a-47ed-a565-c4c5f19e3b10",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3d2166b5-10db-4509-b9ff-68f5fe443017",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "22",
            "type": {
              "id": "91d44517-5165-4ec9-90c4-960bcacdab72",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7405d6ac-1506-4590-9fe3-39cd4b71b81b",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "23",
            "type": {
              "id": "7d3a905e-4f86-4e48-a534-5970d522e485",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "608f5b75-e3dc-47e0-81c1-314bdc2bb14a",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "24",
            "type": {
              "id": "936b500a-19b0-49fb-98c3-aa916555a421",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "711ace5d-86ac-48fb-865b-6f30af276fd9",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "25",
            "type": {
              "id": "8764dbfc-4f21-4cda-afc1-7a6d7f86da7a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c29a9940-a04b-44e9-a79d-e6277efae46c",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "26",
            "type": {
              "id": "2a9ed8fe-64f5-4923-baf5-d58a87866b85",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2ea0e486-f4d3-4dd0-aaaa-e60223a45b9c",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "27",
            "type": {
              "id": "5a671b8e-73cd-471a-94e3-e7e3d9d9d6c9",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d6ac8e4c-2a33-40b1-85ee-b8c961cad14b",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "28",
            "type": {
              "id": "88260c85-cfec-439f-98c2-337711980552",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "58c49b50-095c-4612-ada9-629ed4e559d5",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "29",
            "type": {
              "id": "cef83a44-aa85-4090-80e1-d6b602f5c48e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b4e61522-3345-4d96-9af7-197c306c24f5",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "30",
            "type": {
              "id": "d848c2fd-ceaa-4475-a0fc-a1cc66f65723",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4b5d8244-c828-4a8f-aedf-9f4af8a15b2c",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "31",
            "type": {
              "id": "659e50bb-0f12-4615-aad1-c108a65cf9f3",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d7d560cc-bdcb-4279-b1c9-e114b07d9abb",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "32",
            "type": {
              "id": "363f698f-dd2d-4b0b-bf2a-97f845c49017",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "aed94b6a-9710-4a96-abdd-3513a3c344a7",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "33",
            "type": {
              "id": "fc1c1e04-9ee3-4202-8c61-d3113db1fdbd",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "6d826232-292c-401e-a0ec-dd023557cc12",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "34",
            "type": {
              "id": "831a1ef5-27cf-4cce-a8df-d2b96b36cb08",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3ae750dc-9f00-43c4-a98b-cee09ee6e493",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "35",
            "type": {
              "id": "99d0a9e5-0c73-49b6-94d3-281782b3d40e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a9217b07-150f-4086-9ecc-4e736ec04a10",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "36",
            "type": {
              "id": "e1b787c1-536d-48d7-b087-d8a390faa924",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7041cbca-5506-4a50-8206-ea8caeb90251",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "37",
            "type": {
              "id": "6dc303ed-e004-4971-b9a7-54213787fa6a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "28522dda-e1cc-4a08-b064-4bd522d98a2a",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "38",
            "type": {
              "id": "dc8c26fa-5627-42f6-8727-bb24ad76e2c6",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3f252baf-0c78-4144-9948-45aa4633118d",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "39",
            "type": {
              "id": "228c1c16-50d0-4584-988d-8c19abe90554",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c4b9ae91-2fcb-4819-b7e8-78702376c44e",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "40",
            "type": {
              "id": "406dee9e-0a60-40e0-b344-a60e51a9954f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4dfbccc1-9f35-4fa0-8514-6661449c5dc2",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "41",
            "type": {
              "id": "44cbc838-3888-4b40-820d-504f7fe2cc5c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "aacf85eb-9705-4cee-85c8-ee60389c95d8",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "42",
            "type": {
              "id": "fd9e1bbe-7f39-48ee-8143-a8a5edf62051",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "cae405bc-9efb-442d-af35-62e7e876d3e2",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "43",
            "type": {
              "id": "fae3890b-bcd1-44bc-bf0a-55574b0e6ff6",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "8b9c775f-e2ec-4140-b81f-a638f400c0b3",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "44",
            "type": {
              "id": "a06c9aee-3427-4bd3-9a45-387f610f39f5",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d53c627d-ffa6-4f36-b03f-4d0544b34fef",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "45",
            "type": {
              "id": "87cd3ff1-c462-402e-8667-853fbd31f591",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d8849d44-7626-4cec-8533-7e21e3081f61",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "46",
            "type": {
              "id": "53548dbf-8d8e-42f1-8546-2fb3a9e2099a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "511b9228-950c-4244-9da0-77a1b52c53a1",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "47",
            "type": {
              "id": "7502fc37-8a1d-46f2-9236-46f8cb007690",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7ad1c0c4-8fa5-4f57-b22c-ea228e21a0e8",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "48",
            "type": {
              "id": "e0872617-1645-422d-9eae-96ede1dab0ba",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "8b28c468-9a2d-42de-943d-45b09ff1ba1a",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "49",
            "type": {
              "id": "06c3b05d-a4c4-4a7c-a0cc-03959bf7c3ab",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "8ade3306-2e03-431a-9a2a-457cbda60345",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "50",
            "type": {
              "id": "532e267d-970c-42f0-8b2a-71dac44e886b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1c394bad-2a94-4b4e-954d-87e980da34a4",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "51",
            "type": {
              "id": "0ed1a33f-3fba-45cf-a1e3-b1ee48022a50",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "30398518-1110-4373-a458-856b11d24580",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "52",
            "type": {
              "id": "929a5e15-1566-4327-a859-cabe897ad66c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "8dcbabba-2f5c-4e74-b848-c666ae141bd4",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "53",
            "type": {
              "id": "90884df7-c20d-4d5b-8eb5-0b8dd7cbae49",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "494926a4-8580-4e2a-bca0-75061cace039",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "54",
            "type": {
              "id": "a694299b-974d-404f-986b-88fb4cf74706",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a54b0f0f-6b21-4ea0-aabb-b7fb8f0a29cb",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "55",
            "type": {
              "id": "95a83d12-c48f-4624-8e30-ad5f013671c5",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "acd0db0b-aef5-46f5-9168-5837aef7c029",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "56",
            "type": {
              "id": "de731088-8f58-492e-b536-5a39baeb8cdf",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0619a745-9fba-4859-9551-682860212ae4",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "57",
            "type": {
              "id": "5b32f055-cdbc-4ec5-8084-56d415453124",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "62f1d851-213a-40d1-b807-3003aa7f20a4",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "58",
            "type": {
              "id": "0451fff8-2512-41ca-87cd-cb5b210bc53a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2241d68a-9e74-4a86-8ee8-6fa8ffcc6045",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "59",
            "type": {
              "id": "744a0f6e-72ff-40a9-b1c5-b248c3f1e9f0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0af276e3-8a4a-45a6-b3d5-113d6ed87b86",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "60",
            "type": {
              "id": "06e1ecb6-a355-467b-9eb9-454555d7b4ca",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "6e30d96c-ef1e-4b04-8c85-5c7b8628e380",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "61",
            "type": {
              "id": "38660950-54f7-478a-8cc5-f6df58baf48f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0b3071f1-147d-4ba4-a399-743eebaa7538",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "62",
            "type": {
              "id": "a0a100fc-6090-47bb-9d53-aa5d3f7f9ffa",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c59d5305-7b82-42ae-b15c-903f97a42565",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "63",
            "type": {
              "id": "6b6986a5-b9b4-4419-b366-5205cf7f3dbd",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "16ae2069-4b79-4286-ac6d-c2971ca32f11",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "64",
            "type": {
              "id": "58f61102-9820-4ef3-a4d9-468bc384f04d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "781de71e-524e-46a6-98af-d6efb16fd325",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "65",
            "type": {
              "id": "c11aa366-a9a3-454b-908e-12c270a4d9f4",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "6840bb9a-ceb6-46e0-887f-265148b12840",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "66",
            "type": {
              "id": "0285205b-f68b-49f0-9d60-8e662a6f55be",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "81266d04-ed59-4290-8cf5-66cad844b275",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "67",
            "type": {
              "id": "9da88e13-5c53-4c1a-b907-e8cac421857e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "57cc6d7f-685f-4d9e-98c3-78dd36c7770c",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "68",
            "type": {
              "id": "cfc6e79d-8777-4555-b319-d319723d7a0a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "8f169dd9-262d-42b4-ba8a-673648fa1a74",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "69",
            "type": {
              "id": "45971c26-b21c-4901-a358-9b9f4e17438f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4b46d47e-47e5-41eb-b8d9-0c561a022bd5",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "70",
            "type": {
              "id": "ae423325-ec3e-483a-b634-954a6ea4ae1b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "006432ee-c95c-473b-bc97-bb0022ed9502",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "71",
            "type": {
              "id": "b1854f48-d210-48c2-8281-998bf1e6e3b5",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "13a6545c-2139-4a9b-be60-a9c0a83a1a58",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "72",
            "type": {
              "id": "e974465b-e938-4019-b14f-a4effeb244a0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e5ead6ea-8766-4d55-8300-17b0b3b1d54a",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "73",
            "type": {
              "id": "58b33794-0c96-4510-9496-f99dd45334bf",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ad88e84e-0ab0-449d-afde-89f263d5f400",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "74",
            "type": {
              "id": "1ae91051-f32e-4258-b8a3-6a3e88b67a1c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "612f1bc7-7ccd-4d66-ba95-aba0bab78e6f",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "75",
            "type": {
              "id": "438e4f5c-aa6c-4b06-b564-a39542cd866e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "30cf0dd8-2ddc-4b6f-b455-2076b39b4539",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "76",
            "type": {
              "id": "bc880947-b46c-4695-8a1a-d8dea8a14000",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f18a5c98-780b-482f-93af-424672b92077",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "77",
            "type": {
              "id": "f1a0f5d4-305e-44f8-983f-9151b0aea929",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "995e34e7-8eee-4f4e-b487-0e81cc440d23",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "78",
            "type": {
              "id": "5eec85ce-b130-4412-9a88-52cc04685e3b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "777b8d37-b783-4f6d-96fb-490a348154e5",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "79",
            "type": {
              "id": "5e327158-6e80-4170-9920-1d65082db2ca",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "fab21bb5-a4b1-48f3-b01d-8348912e4698",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "80",
            "type": {
              "id": "d0524d79-3e06-4b1d-b545-e21c1b9fa8c2",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "01bc7776-8ca8-49a7-84d8-c6757ba7f3bc",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "81",
            "type": {
              "id": "1127f1b1-8321-493f-8c34-c6506c8ffe69",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e125d524-8dfd-4304-9e12-752e2100f000",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "82",
            "type": {
              "id": "080a1f34-8743-4186-8d3f-1f8c325d6d92",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "683f9649-9808-4d18-b094-a4fa04c730ba",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "83",
            "type": {
              "id": "7194b027-43b2-4a2f-a8aa-82356e351eb2",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7b326a3a-6307-4f15-b926-5cf0cd562a21",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "84",
            "type": {
              "id": "c1ae8b92-6bef-49b3-abd2-9c43d536275e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9493637f-3224-4706-9619-abb305f09afa",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "85",
            "type": {
              "id": "f5c6362d-65c2-4155-8b88-a49a103ea94a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "10bafece-530a-46bf-a02d-d704f9196fd8",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "86",
            "type": {
              "id": "a6fd60da-8990-47ac-b226-993c28252c51",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "342bab38-f78b-4d8b-8468-4a75337d9380",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "87",
            "type": {
              "id": "24a2bee5-302d-4c0d-8d97-bc081cd3e53e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d5043a90-f1d8-4292-abf1-9742218309ef",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "88",
            "type": {
              "id": "790b5258-e5a3-448b-a4e2-4bbe347fb213",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3788bed7-78d3-4eff-bd52-2e904950f21d",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "89",
            "type": {
              "id": "97eeb738-58ad-489d-928a-26d5f4f8f1fc",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "cd882bed-1dd2-4a8c-b6cd-d354a5dd3879",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "90",
            "type": {
              "id": "07068b97-daac-4a85-bac3-c63f2bfd7a83",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "12641909-457b-4374-8cc9-ff9ff05899d1",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "91",
            "type": {
              "id": "c3f5c281-ee64-4213-953c-826e0eba617d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4a57dcf3-0abc-49bf-9e8e-8c67b5df21e5",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "92",
            "type": {
              "id": "78d73ccc-7857-4cce-9bc0-4dda11116b67",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5013248a-e64d-4412-a1a6-010345bdf823",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "93",
            "type": {
              "id": "ab246ae2-ff90-49f1-b811-3a67647929d7",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "93ca8888-074d-4f04-945a-db399c57f42e",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "94",
            "type": {
              "id": "2b82a974-f5d3-4fcb-af8b-04de1ff93311",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "51eed748-97e3-4a9d-97b3-479b860d4a1e",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "95",
            "type": {
              "id": "ad81852b-6313-4e73-85cd-83a4e9c6ebf0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3780ac8d-c578-4ecd-90a4-9dd2c73f7875",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "96",
            "type": {
              "id": "a225e459-cc16-473c-aa91-a758baa66fdc",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "25a0dad3-9d9e-482c-8ba6-d1e75a169256",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "97",
            "type": {
              "id": "3096a1be-b972-42b7-957a-747b6d28a08a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "06d24fb6-d4a2-49b0-962b-109821c3f426",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "98",
            "type": {
              "id": "0e17031c-6d8b-4c46-87e8-783ccca5fdb3",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9c39ac4d-cbc3-47be-9c45-a28fcf4b4883",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "99",
            "type": {
              "id": "282e1a2c-6078-4323-b8c2-577e1ba6f33f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1e3603a8-f310-4231-8945-15a4f3a0ab3b",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "100",
            "type": {
              "id": "3981a8ad-dea9-4ef0-baec-5aa4b56958ee",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7f4cccff-2cca-4162-9160-2698855a6da5",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "101",
            "type": {
              "id": "9e0c265e-a1c3-4e19-b197-6c6a180547f2",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "50006269-f41d-4d17-b13c-33374d11d9fb",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "102",
            "type": {
              "id": "e55764a2-1382-4792-aa1a-8a8e066ca808",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ef08d6ba-6e65-429a-a400-3bec9af5dbad",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "103",
            "type": {
              "id": "2af73f66-5c48-4648-9c94-68c61dd34dae",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "8066832c-b6fd-47cb-8597-93bbf120d76e",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "104",
            "type": {
              "id": "f95b63c5-1624-4209-8f08-cb176cc2e458",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "8996e625-30b2-42d7-8d60-0f3906d8b752",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "105",
            "type": {
              "id": "130ea9da-4f41-4cc4-83c0-f5c16e51e58f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9bfe2f69-3fd5-4c3c-b190-5ae5287af696",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "106",
            "type": {
              "id": "e0baac2d-0056-445e-ae3e-52bb8d3da5e1",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "887fa372-49e9-4e26-a4b5-517c9a505b7d",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "107",
            "type": {
              "id": "0bf80286-018a-4b67-8c27-8e65100ed8cd",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e95ca027-db59-49c1-b356-9be95fb8bdfe",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "108",
            "type": {
              "id": "e797a66a-36d2-4288-9d58-d12a830155c4",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a8a1cee6-1b22-46fc-b651-e41b23222357",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "109",
            "type": {
              "id": "1817b30b-6099-4b4d-9dbb-5ce3e1c517c6",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "37473a34-f737-4bab-86b8-8230787f87fc",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "110",
            "type": {
              "id": "365f62f5-5ee3-414b-9f96-498085f927f5",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "070ff2ca-ff37-460f-8610-35b46398b29a",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "111",
            "type": {
              "id": "b831da60-1e00-427f-af23-af2ce085ca9a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "fa12b09e-44c1-4cb6-9d59-f5c6e34c3d82",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "112",
            "type": {
              "id": "99a85c2c-3959-4c87-ac60-8b52ab84673f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2db44d6b-3d25-4d9a-a70b-39ec3645dbf3",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "113",
            "type": {
              "id": "a0f8dfcf-96d5-40cc-ac7c-cbd9a26121d5",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7cc8a518-7465-47f8-ad3d-4f942797e3e5",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "114",
            "type": {
              "id": "84455c93-9993-4801-b1be-09c6c44d4a41",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "44fb1573-93e0-4d9c-b319-a55f876e088b",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "115",
            "type": {
              "id": "b67fdb34-b2dc-40e4-a047-cd90690f3441",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4e804634-62a5-4fb4-856b-015033ff0ce8",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "116",
            "type": {
              "id": "c51f4172-6229-4ac3-8593-f39c093662e8",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ddfb3d4f-e8a6-49fa-968e-872534ea27d8",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "117",
            "type": {
              "id": "819f96fc-5786-4853-9784-432b727e1670",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2f6e3b64-37f0-4385-95a6-fc3cfe0bb850",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "118",
            "type": {
              "id": "cc7648c3-c5f9-4d61-ac66-1ebbcbaebdc4",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1e73ffc5-6cee-46fb-81fe-48f8089cedf0",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "119",
            "type": {
              "id": "1045f1da-3105-4ed2-947a-648e4224aef2",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "15e9a182-9660-4996-a0a6-6ff424f17fcf",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "120",
            "type": {
              "id": "f957f2a4-e4be-4c95-bf18-d21d96908b5c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "43f192de-ae33-4373-9e90-5543fa3d2a01",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "121",
            "type": {
              "id": "edf094f9-0a5f-4955-b096-8d6bd0682af9",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0ac8378c-5f61-42e5-a365-31257776b234",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "122",
            "type": {
              "id": "ad0be2fd-ebd4-498e-9458-01c381328557",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1e115e5c-d590-406b-9882-2822a74bcfb1",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "123",
            "type": {
              "id": "39d71edc-d295-4f38-adb6-bcd4b93bbbd3",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "72ddf273-2423-4f1f-ae06-aa312398e2e0",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "124",
            "type": {
              "id": "aa627d08-c57b-4ead-81fe-728ee3a43105",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7f5929c0-b971-4c0f-830d-1efde953da83",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "125",
            "type": {
              "id": "25140b51-87e6-4c5f-977f-00a7751a7fc4",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e70243a2-f25f-416d-9806-09f2007fcbe4",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "126",
            "type": {
              "id": "867a7a8d-d459-442c-b4f4-3688783b772a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "40326a18-8d6d-4cb3-a190-1c8e458d4cbe",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "127",
            "type": {
              "id": "c5217928-dc99-4fd6-9045-19eb22d8f2c8",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9297d242-bf67-4fe2-8d1f-db589eada746",
            "name": "Kyushu University Hospital",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "128",
            "type": {
              "id": "b304ba56-fa36-4d14-b58f-febb60f02470",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9ba039c8-0f87-4f32-8305-9b02d4f338d9",
            "name": "Kyoto University Hospital",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "129",
            "type": {
              "id": "843dd407-e9e8-4ee6-94e8-9f7c4ad2f79d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2b8de7cf-e3eb-4261-b6ae-f24f0036ab43",
            "name": "Osaka International Cancer Institute",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "130",
            "type": {
              "id": "7b1f826e-1542-4979-ba6b-2a181a0abe58",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3fd75078-05e8-40e9-aba6-2eebc1119923",
            "name": "Tokyo Metropolitan Komagome Hospital",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "131",
            "type": {
              "id": "7ce4bc6d-a2fa-4664-8013-f41eca1ab84c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f891caad-ab61-42fa-a970-692d5af3c18d",
            "name": "National Cancer Hospital",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "132",
            "type": {
              "id": "cde3a441-4038-4841-ba8a-a67f20ab107e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "20e0dfc4-c135-4890-b250-d39a76756b28",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "133",
            "type": {
              "id": "9e658599-9afd-461d-be81-622083fcbe74",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "99eabf58-5e5d-42d5-bd1d-351babb4716a",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "134",
            "type": {
              "id": "6cbfe43c-73df-430f-8453-171f865cb349",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "96a5d88a-cd7e-4410-ac93-8ca3fd62dd03",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "135",
            "type": {
              "id": "3148d151-add7-4117-a187-44a395590405",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "fa0dd2d4-8885-488a-afaf-42f666dc4c9d",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "136",
            "type": {
              "id": "cd0e5cd6-d134-4072-86be-3a15d45a503c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "27786173-dd5b-46b3-adc4-e6a8aa533c15",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "137",
            "type": {
              "id": "733b5207-5597-4cb4-9d94-ac67e184dfa8",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "50c7af8b-83f7-46ca-a066-41053b681988",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "138",
            "type": {
              "id": "011cc155-667c-4029-9fb9-47fd09897e12",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "47f96244-0a91-4de7-955c-f7d1287f26cf",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "139",
            "type": {
              "id": "ad773baa-a569-44e8-b458-db8bec080ea7",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7d0bc13d-1858-42f7-9b1e-ea4272987a55",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "140",
            "type": {
              "id": "9b937d43-c7bf-4cac-97b6-e68e5301ddf0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "71df38fc-14c0-4609-ae00-0e1c1cc078e8",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "141",
            "type": {
              "id": "58fae0e6-faa1-400e-b336-718a65b3dccb",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f9feeb80-bca1-4d50-a184-5cef674eb834",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "142",
            "type": {
              "id": "1b8c1405-c861-4d51-86fb-427e3cf5ff01",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9e6db355-cd40-492f-a952-2082f46b2c69",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "143",
            "type": {
              "id": "0e650cc0-6a39-49b8-81c9-d44c93cc2949",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e61478af-f48d-4d24-812c-a79dafb6cd4e",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "144",
            "type": {
              "id": "290c190e-5512-438e-9187-06c531866c1b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "290bbdea-af87-43b2-bcda-94d215fa1573",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "145",
            "type": {
              "id": "7ac88dd7-e22e-4413-a78f-0a04aacaa634",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "69451169-3775-497b-882b-da5f8d33de25",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "146",
            "type": {
              "id": "6de2fada-217a-4e50-9ee0-26a824d12249",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "fbb82125-705b-4d53-9034-8cf94068b964",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "147",
            "type": {
              "id": "a9e2947c-0862-42f4-81b3-460a2f730e93",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a5a0575f-4e76-41d4-98a9-c39a1e59e02e",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "148",
            "type": {
              "id": "bf7112aa-36c2-4ab9-8058-768263ad1c81",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ded28505-690c-499a-adb1-541952e73a17",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "149",
            "type": {
              "id": "de7e0d9d-9123-4f09-b211-9e455d01572e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1b664dbb-4f2f-44d0-9f01-a1777d99cc9e",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "150",
            "type": {
              "id": "5738f773-16a6-458f-b600-e58def472acf",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9effbcdc-b53c-40cf-aeb4-07366370fa30",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "151",
            "type": {
              "id": "16024465-2240-4f57-9c63-544bcc4ea846",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "55de569b-9faa-480f-a082-0d3f1410bb53",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "152",
            "type": {
              "id": "76b5f23f-dbe1-4108-afc8-b78ac6905850",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2f0de98d-b831-443f-8f6b-c2a08cabeadb",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "153",
            "type": {
              "id": "ef4cd447-bbd8-4d79-a321-d2450c6f1de7",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0da5b18c-b7d6-4b73-a4c5-26737ce3eb5a",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "154",
            "type": {
              "id": "1e388e29-fb8a-4634-b0bb-4d6651402fee",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "913e7ed2-81c3-432e-a223-eb6fe1e1ac44",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "155",
            "type": {
              "id": "2bfbb8e7-1677-4f22-bfd5-66e404184a6b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "07f4a072-7199-430b-883a-c53fcf4312b8",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "156",
            "type": {
              "id": "f0f18d42-18cb-44ff-a674-fa0d72aecbd6",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a740eacc-bf19-44c4-a3bf-d7cfb2016c2a",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "157",
            "type": {
              "id": "dd45a06c-f3c8-40a2-94e9-ece5b4d50769",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7ef9612d-4a36-464c-91be-cec22f2e1caa",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "158",
            "type": {
              "id": "16568f55-d2e8-47fb-953f-9555edc78e11",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e6ba6f67-7ff4-410a-b59e-82293a76fab6",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "159",
            "type": {
              "id": "77c33ec1-318e-4de3-b71e-531f809edabc",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "535ec041-a8c7-4abd-8eae-e9d04ec8e152",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "160",
            "type": {
              "id": "178543f9-0cd7-4a7a-8c34-5e4e0981a3f8",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "35033825-e007-46f0-9083-d6b95193be2f",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "161",
            "type": {
              "id": "b7e1f8c3-7ce7-4348-91e1-8daaf4f91e6b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b6d2b7e4-25d2-4927-877e-ed4e2aaf2701",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "162",
            "type": {
              "id": "dade8141-4537-435b-b2ba-1872487b4159",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1fb6542f-9729-434a-a2c2-c00781da12ce",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "163",
            "type": {
              "id": "53c23fe6-acd4-46b4-b04b-ce0f189755b2",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1a216f3d-822b-47bb-a35b-bd831632d3eb",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "164",
            "type": {
              "id": "5a4a1c76-3ded-4230-a737-32b955a0552e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5119a2ed-c9c8-4702-b3e0-b83fb6299138",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "165",
            "type": {
              "id": "320455ae-0181-4e6a-9db2-5e8910cb3001",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ba61ee2f-f5af-48bf-95d8-293342c4bc47",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "166",
            "type": {
              "id": "e273bd0c-8b1c-4532-956b-5ee7edcc99aa",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d2eb85fa-6089-45ea-a1ff-0b57f0725967",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "167",
            "type": {
              "id": "e650ee54-bf45-4ca3-8b5c-a1413098b810",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a58ea1e4-ba41-4a78-984f-6915a60ec323",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "168",
            "type": {
              "id": "a350c683-6acd-4dcc-b41e-4cc64d59f2bc",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c9f96d53-95a3-45a9-a2ab-fe94998e1116",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "169",
            "type": {
              "id": "8ccfe058-f38c-42ce-8e29-fb53d1adc17d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e76517c5-84d2-42a7-a5c7-d0d51ef7becd",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "170",
            "type": {
              "id": "79b86abc-818e-41ee-b559-870fd0be5e6f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e53602d2-6666-428d-a217-2c1d2f907890",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "171",
            "type": {
              "id": "912023e2-d97b-43f5-9a50-abdef2951cac",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7a26b153-ccf3-4480-973a-74e0baa62bb3",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "172",
            "type": {
              "id": "a625969b-dae6-4888-a402-0b740a3f6035",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "89870f34-414d-4796-a874-1bdac1e9541a",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "173",
            "type": {
              "id": "d1e76b96-1a49-4c62-b218-5b43f2e8350d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7e17dc5e-0933-4a4e-84d7-94ffea337edd",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "174",
            "type": {
              "id": "ef70906c-79e6-45a7-b6c0-6da4a84c6726",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3cd1d25e-3260-48ec-81fc-f7c129ad8f5d",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "175",
            "type": {
              "id": "f7ca1334-528d-48ff-984d-4af780eb8544",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a32bb51f-18d8-4f90-94d1-dff9a64b1353",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "176",
            "type": {
              "id": "89b8a7ff-78cd-410f-aec9-49a098951970",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "39c4257e-cf45-4f39-9c28-9640eef85a76",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "177",
            "type": {
              "id": "b0603bdf-6c8c-48a6-9937-acd6f83ed666",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "06378412-5feb-483a-a86f-d8d24bca0a5d",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "178",
            "type": {
              "id": "4c8e6d65-3dd8-42c1-8bca-03688731a1ac",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "489224ab-66a0-4961-9060-59e5183c00b2",
            "name": "Novartis Investigative Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "179",
            "type": {
              "id": "cf9c342a-e942-4097-a16d-941bc2c7ec7b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          }
        ],
        "studyPhase": {
          "id": "add0c578-1cfe-4448-a756-79c0ecc00f35",
          "code": "Phase3",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Phase3",
          "instanceType": "Code"
        },
        "eligibilityCriterionItems": [
          {
            "id": "fa83c306-7f64-4cd0-baed-d1e6c8e7d993",
            "name": "Safety run-in specific inclusion",
            "text": "Specific inclusion criteria for safety run-in (part 1)",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "08bd095b-8a15-4631-8d5d-0cb5a0163889",
            "name": "Biomarker cohort specific inclusion",
            "text": "Specific inclusion criteria for biomarker cohort (part 2)",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "a849bab3-be18-4c02-b99e-3d71c92b219c",
            "name": "Randomized part specific inclusion",
            "text": "Specific inclusion criteria for double-blind, randomized, placebo-controlled part (part 3)",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "343020d4-34ca-4c14-96c6-2976279493c9",
            "name": "General inclusion criteria",
            "text": "Inclusion criteria for all subjects",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "5e95ff4e-f92c-4139-9c95-d5534a2a5f1e",
            "name": "Safety run-in specific exclusion",
            "text": "Specific exclusion criteria for safety run-in (part 1)",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "4e9fa6d1-de4a-4d77-9825-183397b8c6d4",
            "name": "Biomarker and Randomized part specific exclusion",
            "text": "Specific exclusion criteria for the biomarker cohort (part 2) and the double-blind, randomized, placebo-controlled part (part 3)",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "0471e5e7-45e8-4569-a43b-f1c8e44b68d6",
            "name": "General exclusion criteria",
            "text": "Exclusion criteria for all subjects",
            "instanceType": "EligibilityCriterionItem"
          }
        ],
        "studyInterventions": [
          {
            "id": "9c13d437-1bef-45bd-ae4b-c8335866bc45",
            "name": "PDR001",
            "type": {
              "id": "43736051-282c-40ed-9c1c-405c3a7d2ed4",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "role": {
              "id": "7645f4f0-0ed0-41c8-8bb6-b51e45d2a7a3",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Anti-PD-1 antibody",
            "productIds": [
              "5e0a3ce2-663c-4407-8927-8000e33227b6"
            ],
            "administrationIds": [
              "8786617a-a60d-4275-94c4-8ae5c17c3ef7",
              "0bbfa90a-1e37-46df-a82b-802792408006"
            ]
          },
          {
            "id": "2d718e10-d8b2-4b98-b20c-d2f33065ea74",
            "name": "Dabrafenib",
            "type": {
              "id": "9a638b4f-65d9-4043-b396-2e0ffb76d2c6",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "role": {
              "id": "881157b9-7ee0-434f-8f05-5eaca7840bfa",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "BRAF inhibitor",
            "productIds": [
              "71f6427a-d909-4b10-9619-d6aa47720d8a"
            ],
            "administrationIds": [
              "6a840547-9274-4019-9bd8-6bda5ade8b65",
              "5a73d391-ed6a-45be-84e6-5a3dd8ce061a"
            ]
          },
          {
            "id": "b7fa0289-3293-4230-be6a-a424ea43e7b0",
            "name": "Trametinib",
            "type": {
              "id": "4f97e8c1-6086-471e-9ba7-c6202e156e4b",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "role": {
              "id": "b7dfe8ce-6fbe-4fc6-86b6-b6b868728dfb",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "MEK inhibitor",
            "productIds": [
              "9cce8ae5-64db-448c-b930-e6dc74f6fe6b"
            ],
            "administrationIds": [
              "b8cfcb60-3a73-4aa8-bf9c-545daefad6e0"
            ]
          },
          {
            "id": "03bc2029-4fae-4cdb-9af6-5b481ad24d3a",
            "name": "Placebo",
            "type": {
              "id": "bf7549cb-d018-4f6b-af23-0c27bd04231e",
              "code": "C41132",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Placebo",
              "instanceType": "Code"
            },
            "role": {
              "id": "ccb7e485-f3af-49a6-97ff-bfee88e60117",
              "code": "C41132",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Placebo",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Matching placebo for PDR001",
            "administrationIds": [
              "5d387cc6-449d-4e66-9d09-d2baed202275"
            ]
          },
          {
            "id": "8273f049-2782-46b7-b6e8-c3968f923926",
            "name": "Corticosteroids",
            "type": {
              "id": "191c9268-3bc8-4951-b0d6-d88a7cb8bd3c",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "c58a725d-fa21-442c-8a90-542231f75cdb",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Used for management of immune-related adverse events (irAEs) and pyrexia"
          },
          {
            "id": "97845376-88e8-407e-bcd4-1315b4fceeac",
            "name": "RANK-ligand inhibitors",
            "type": {
              "id": "099f721b-faac-4a7e-9c9a-ba0f69e81bed",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "842547ee-1c7a-442b-8511-c9e8a1b356ad",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted bone targeted therapies (e.g., denosumab)"
          },
          {
            "id": "d9195cae-32a7-42ee-be1f-db3efc38fb7f",
            "name": "Bisphosphonates",
            "type": {
              "id": "34a81297-49b3-45b1-b828-5e5e8df8354f",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "20ccf21f-a7af-4902-a1b5-429980373893",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted concomitant agents"
          },
          {
            "id": "4b45eeca-193e-40d0-8ebc-5bf16acaa04a",
            "name": "CYP2C or CYP3A4 substrates",
            "type": {
              "id": "1a44178c-7e7b-4498-8fd7-36dd909e1e4f",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "322d33e9-55b4-406b-b4f3-b5a9f3fc9222",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Require caution when co-administered with dabrafenib due to drug-drug interactions"
          }
        ],
        "administrableProducts": [
          {
            "id": "5e0a3ce2-663c-4407-8927-8000e33227b6",
            "name": "PDR001",
            "administrableDoseForm": {
              "id": "fec2cc3f-fc78-473b-9477-f67f49195510",
              "code": "C42986",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Solution",
              "instanceType": "Code",
              "standardCode": {
                "id": "93b0da2c-11c7-4e79-80b7-8aafdcf75a4a",
                "code": "C42986",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Solution",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "10a76034-2bd8-42b9-8641-32175ff0c3cb",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "Not specified",
            "substanceIds": [
              "37d3e3a1-23eb-421d-98c9-b043d57e0f6f"
            ],
            "manufacturer": "Novartis"
          },
          {
            "id": "71f6427a-d909-4b10-9619-d6aa47720d8a",
            "name": "Dabrafenib",
            "administrableDoseForm": {
              "id": "d328fcf5-e788-452c-bda1-6e9c62c7f3b2",
              "code": "C17998",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Unknown",
              "instanceType": "Code",
              "standardCode": {
                "id": "da9bc0c1-5f20-47a9-a9c1-2bb7793d876d",
                "code": "C17998",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Unknown",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "99f83c0a-003c-4d5c-b4dc-bb9a2006310d",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "Not specified",
            "substanceIds": [
              "7c03fd70-0088-4d67-ae8f-9e06b128b5b4"
            ],
            "manufacturer": "Novartis"
          },
          {
            "id": "9cce8ae5-64db-448c-b930-e6dc74f6fe6b",
            "name": "Trametinib",
            "administrableDoseForm": {
              "id": "be107da1-040b-4332-b220-49000ec6436a",
              "code": "C17998",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Unknown",
              "instanceType": "Code",
              "standardCode": {
                "id": "d3667a9b-7b99-4b6c-9c7c-36c1605d63cf",
                "code": "C17998",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Unknown",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "6132d7f8-ce81-4e61-886e-35774abbe893",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "Not specified",
            "substanceIds": [
              "fabe9dcd-6db0-4091-8f67-56e12388363c"
            ],
            "manufacturer": "Novartis"
          }
        ],
        "narrativeContents": [
          {
            "id": "d7c8b419-107c-4150-98f8-6a1490d7961b",
            "name": "Background",
            "text": "Background",
            "order": 0,
            "instanceType": "NarrativeContent",
            "sectionNumber": "1",
            "sectionTitle": "Background",
            "sectionType": {
              "id": "12ecf622-a29a-47f7-8b56-5a55a8b3d097",
              "code": "Introduction",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Introduction",
              "instanceType": "Code"
            },
            "childIds": [
              "9ee40229-2363-4f91-ae81-5fa70f774069",
              "917d2505-140f-4c5b-b60c-342b0f8e5325"
            ]
          },
          {
            "id": "22184ca8-86f6-4a0b-a33b-9075d3228e91",
            "name": "Rationale",
            "text": "Rationale",
            "order": 1,
            "instanceType": "NarrativeContent",
            "sectionNumber": "2",
            "sectionTitle": "Rationale",
            "sectionType": {
              "id": "c31a98c5-e978-4da9-a3fb-5b2b850a0ffb",
              "code": "Other",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Other",
              "instanceType": "Code"
            },
            "childIds": [
              "d80a9905-b512-44db-bc63-0200688e26e6",
              "5099537d-cc40-4890-b02f-47dbd3a59310",
              "9acfed48-c95a-42b3-b55f-3e0cf60531bb",
              "71984b5c-520b-4aa4-8c19-3b9ce624516d",
              "55926278-88c7-47eb-bd26-a9893198417d",
              "58cc380d-5391-4177-baef-fd3f1d419c75",
              "6ed139e5-68a3-4a2b-b122-49473d61b13e"
            ]
          },
          {
            "id": "7c544ee3-b02a-4ab8-a7e0-3ddfa83d501b",
            "name": "Objectives and endpoints",
            "text": "Objectives and endpoints",
            "order": 2,
            "instanceType": "NarrativeContent",
            "sectionNumber": "3",
            "sectionTitle": "Objectives and endpoints",
            "sectionType": {
              "id": "16ba771d-1109-4817-adaa-c1b879eb0cb2",
              "code": "Objectives",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Objectives",
              "instanceType": "Code"
            }
          },
          {
            "id": "c91b0fb8-d216-4fed-9ee5-f8026100bffd",
            "name": "Study design",
            "text": "Study design",
            "order": 3,
            "instanceType": "NarrativeContent",
            "sectionNumber": "4",
            "sectionTitle": "Study design",
            "sectionType": {
              "id": "cea2fa28-5315-4ace-b612-e6ea682edecb",
              "code": "Study Design",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Study Design",
              "instanceType": "Code"
            },
            "childIds": [
              "40c371e9-f235-40dd-91d4-4f24e07b6fea",
              "72b707ca-4e1d-4a76-9464-4d951ef66896"
            ]
          }
        ],
        "narrativeContentItems": [
          {
            "id": "9ee40229-2363-4f91-ae81-5fa70f774069",
            "name": "Overview of disease pathogenesis, epidemiology and current treatment",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "1.1",
            "sectionTitle": "Overview of disease pathogenesis, epidemiology and current treatment"
          },
          {
            "id": "917d2505-140f-4c5b-b60c-342b0f8e5325",
            "name": "Introduction to investigational treatment(s) and other study treatment(s)",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "1.2",
            "sectionTitle": "Introduction to investigational treatment(s) and other study treatment(s)"
          },
          {
            "id": "d80a9905-b512-44db-bc63-0200688e26e6",
            "name": "Study rationale and purpose",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.1",
            "sectionTitle": "Study rationale and purpose"
          },
          {
            "id": "5099537d-cc40-4890-b02f-47dbd3a59310",
            "name": "Rationale for the study design",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.2",
            "sectionTitle": "Rationale for the study design"
          },
          {
            "id": "9acfed48-c95a-42b3-b55f-3e0cf60531bb",
            "name": "Rationale for dose and regimen selection",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.3",
            "sectionTitle": "Rationale for dose and regimen selection"
          },
          {
            "id": "71984b5c-520b-4aa4-8c19-3b9ce624516d",
            "name": "Rationale for choice of combination drugs",
            "text": "",
            "order": 3,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.4",
            "sectionTitle": "Rationale for choice of combination drugs"
          },
          {
            "id": "55926278-88c7-47eb-bd26-a9893198417d",
            "name": "Rationale for choice of comparator drugs",
            "text": "",
            "order": 4,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.5",
            "sectionTitle": "Rationale for choice of comparator drugs"
          },
          {
            "id": "58cc380d-5391-4177-baef-fd3f1d419c75",
            "name": "Risks and benefits",
            "text": "",
            "order": 5,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.6",
            "sectionTitle": "Risks and benefits"
          },
          {
            "id": "6ed139e5-68a3-4a2b-b122-49473d61b13e",
            "name": "Rationale for public health emergency mitigation procedures",
            "text": "",
            "order": 6,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.7",
            "sectionTitle": "Rationale for public health emergency mitigation procedures"
          },
          {
            "id": "40c371e9-f235-40dd-91d4-4f24e07b6fea",
            "name": "Description of study design",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.1",
            "sectionTitle": "Description of study design"
          },
          {
            "id": "72b707ca-4e1d-4a76-9464-4d951ef66896",
            "name": "Timing of interim analyses and design adaptations",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.2",
            "sectionTitle": "Timing of interim analyses and design adaptations"
          }
        ],
        "abbreviations": [
          {
            "id": "b539e1d4-b636-4072-9550-1803af0f1a36",
            "abbreviatedText": "ADA",
            "expandedText": "Anti-Drug Antibodies",
            "instanceType": "Abbreviation"
          },
          {
            "id": "e2bbbcf6-2daa-4bad-93c8-8ea68a2553f4",
            "abbreviatedText": "ADL",
            "expandedText": "Activities of Daily Living",
            "instanceType": "Abbreviation"
          },
          {
            "id": "1385ab3e-867d-4782-9223-db5708b88995",
            "abbreviatedText": "AE",
            "expandedText": "Adverse Event",
            "instanceType": "Abbreviation"
          },
          {
            "id": "f3f3cd07-f962-49b0-bd88-3781db060be5",
            "abbreviatedText": "AESI",
            "expandedText": "Adverse Events of Special Interest",
            "instanceType": "Abbreviation"
          },
          {
            "id": "60259682-5d91-44fd-b2fb-72424451a7d0",
            "abbreviatedText": "AJCC",
            "expandedText": "American Joint Committee on Cancer",
            "instanceType": "Abbreviation"
          },
          {
            "id": "96d89a48-a116-4849-addc-0d29f1a60717",
            "abbreviatedText": "ALT",
            "expandedText": "Alanine Aminotransferase",
            "instanceType": "Abbreviation"
          },
          {
            "id": "a1fbef2d-6d57-4a8f-aa37-ebbca735a453",
            "abbreviatedText": "AST",
            "expandedText": "Aspartate Aminotransferase",
            "instanceType": "Abbreviation"
          },
          {
            "id": "89f246ef-9763-460e-a9a7-415b23df66c5",
            "abbreviatedText": "ATC",
            "expandedText": "Anatomical Therapeutic Chemical",
            "instanceType": "Abbreviation"
          },
          {
            "id": "4d9fbe47-95af-4473-8d20-59469c73f830",
            "abbreviatedText": "AUC",
            "expandedText": "Area Under the Concentration-time Curve",
            "instanceType": "Abbreviation"
          },
          {
            "id": "a392dd9b-6423-4485-8065-81609ac762a5",
            "abbreviatedText": "AV",
            "expandedText": "Atrioventricular",
            "instanceType": "Abbreviation"
          },
          {
            "id": "ce9a87f7-9aed-470f-8f63-7fa54224de8a",
            "abbreviatedText": "BID",
            "expandedText": "bis in diem/twice a day",
            "instanceType": "Abbreviation"
          },
          {
            "id": "8dd520ab-8a0d-4d57-a0a6-cea340b7da92",
            "abbreviatedText": "BLQ",
            "expandedText": "Below Limit of Quantification",
            "instanceType": "Abbreviation"
          },
          {
            "id": "ebdd2692-e077-4f7d-b6bc-5d1906720912",
            "abbreviatedText": "BLRM",
            "expandedText": "Bayesian Logistic Regression Model",
            "instanceType": "Abbreviation"
          },
          {
            "id": "dd06a52e-625b-4dcb-92a4-27dc9f3bce55",
            "abbreviatedText": "BP",
            "expandedText": "Blood Pressure",
            "instanceType": "Abbreviation"
          },
          {
            "id": "6197bbfe-0cea-4cd8-adea-b853987ee294",
            "abbreviatedText": "BUN",
            "expandedText": "Blood Urea Nitrogen",
            "instanceType": "Abbreviation"
          },
          {
            "id": "aa08063e-0e0d-4b93-9661-1762c82878ee",
            "abbreviatedText": "CD4",
            "expandedText": "Cluster of Differentiation 4",
            "instanceType": "Abbreviation"
          },
          {
            "id": "d96de2fe-7bdd-4f6b-982d-4be95fb796ee",
            "abbreviatedText": "CD8",
            "expandedText": "Cluster of Differentiation 8",
            "instanceType": "Abbreviation"
          },
          {
            "id": "bc63a646-35f0-48f4-9c69-4084d21a9b0d",
            "abbreviatedText": "CI",
            "expandedText": "Confidence interval",
            "instanceType": "Abbreviation"
          },
          {
            "id": "51ed7a2f-c91c-4af9-a4f6-8773e219b7c1",
            "abbreviatedText": "Cmax",
            "expandedText": "Maximum Concentration",
            "instanceType": "Abbreviation"
          },
          {
            "id": "e3cc2e63-9366-4a23-9308-6cf4e377ca90",
            "abbreviatedText": "CMO&PS",
            "expandedText": "Chief Medical Office and Patient Safety",
            "instanceType": "Abbreviation"
          },
          {
            "id": "ebd4c21c-d395-46ef-9c52-3c9ef6cfc562",
            "abbreviatedText": "CNS",
            "expandedText": "Central Nervous System",
            "instanceType": "Abbreviation"
          },
          {
            "id": "d1318e89-9cee-4729-bd6c-3ec1a9ce24e5",
            "abbreviatedText": "COVID-19",
            "expandedText": "Coronavirus disease-19",
            "instanceType": "Abbreviation"
          },
          {
            "id": "a50221ff-a5ee-4899-86c7-1e3b599c75a9",
            "abbreviatedText": "CT",
            "expandedText": "Computed Tomography",
            "instanceType": "Abbreviation"
          },
          {
            "id": "e9c453bb-bb15-4294-a317-9041707a3ac5",
            "abbreviatedText": "CRF",
            "expandedText": "Case Report/Record Form",
            "instanceType": "Abbreviation"
          },
          {
            "id": "0129101d-c32a-415d-b443-efa15aa3e4ea",
            "abbreviatedText": "CRO",
            "expandedText": "Contract Research Organization",
            "instanceType": "Abbreviation"
          },
          {
            "id": "3109f36a-894a-4192-b002-24eade64c9c7",
            "abbreviatedText": "CRP",
            "expandedText": "C-Reactive Protein",
            "instanceType": "Abbreviation"
          },
          {
            "id": "a3eb3b2d-5c4a-4bcf-bcd9-91706ae1713f",
            "abbreviatedText": "CSP",
            "expandedText": "Clinical Study Protocol",
            "instanceType": "Abbreviation"
          },
          {
            "id": "b8c7b3e1-4e17-4edc-b571-9bb3d4d1affc",
            "abbreviatedText": "CSR",
            "expandedText": "Clinical Study Report",
            "instanceType": "Abbreviation"
          },
          {
            "id": "cd640567-0e7a-42fe-a3da-81d6ba719b89",
            "abbreviatedText": "CTCAE",
            "expandedText": "Common Terminology Criteria for Adverse Events",
            "instanceType": "Abbreviation"
          },
          {
            "id": "fefe1e31-9504-4dbe-b03e-eb0cd5157b9e",
            "abbreviatedText": "CTLA-4",
            "expandedText": "Cytotoxic T Lymphocyte Antigen 4",
            "instanceType": "Abbreviation"
          },
          {
            "id": "be6393fd-7cd7-4eba-95be-9ef023861d3e",
            "abbreviatedText": "CV",
            "expandedText": "Coefficient of Variation",
            "instanceType": "Abbreviation"
          },
          {
            "id": "550babc5-3e3b-4f39-8f69-4572ebaaac96",
            "abbreviatedText": "CYP",
            "expandedText": "Cytochromes P450",
            "instanceType": "Abbreviation"
          },
          {
            "id": "afc3c3ed-d3d2-4ff4-b49a-ccb5424d6194",
            "abbreviatedText": "D + T",
            "expandedText": "Dabrafenib and trametinib",
            "instanceType": "Abbreviation"
          },
          {
            "id": "9072946c-e99a-4768-a5d9-37c2f8ab6523",
            "abbreviatedText": "D5W",
            "expandedText": "Dextrose 5% in Water",
            "instanceType": "Abbreviation"
          },
          {
            "id": "648863b3-67e2-48a4-9b02-11988a9c6c16",
            "abbreviatedText": "DAR",
            "expandedText": "Dosage Administration Record",
            "instanceType": "Abbreviation"
          },
          {
            "id": "b484bf99-34a6-43a7-88f6-e2d847b4ff42",
            "abbreviatedText": "DBP",
            "expandedText": "Diastolic Blood Pressure",
            "instanceType": "Abbreviation"
          },
          {
            "id": "850c1756-2d2b-4957-a0de-4912d9d82549",
            "abbreviatedText": "DCO",
            "expandedText": "Data cut-off",
            "instanceType": "Abbreviation"
          },
          {
            "id": "26be2c25-27bb-49f7-a6bd-734246d03867",
            "abbreviatedText": "DCR",
            "expandedText": "Disease Control Rate",
            "instanceType": "Abbreviation"
          },
          {
            "id": "1b7f68b9-02c0-4fce-ad8f-8c49a25cd916",
            "abbreviatedText": "DDI",
            "expandedText": "Drug-Drug Interaction",
            "instanceType": "Abbreviation"
          },
          {
            "id": "96c901f8-9a35-4aca-a002-dc5dab7a0ee7",
            "abbreviatedText": "DDS",
            "expandedText": "Dose-Determining Set",
            "instanceType": "Abbreviation"
          },
          {
            "id": "8aa742f1-f534-4f6a-8f06-2302b56f2f9f",
            "abbreviatedText": "DILI",
            "expandedText": "Drug Induced Liver Injury",
            "instanceType": "Abbreviation"
          },
          {
            "id": "eb39a454-6815-42e8-b6fc-4bd8504f534c",
            "abbreviatedText": "DL",
            "expandedText": "Dose Level",
            "instanceType": "Abbreviation"
          },
          {
            "id": "cf523e09-7065-4037-82e0-83d87c75f0be",
            "abbreviatedText": "DLRT",
            "expandedText": "Dose Level Review Team",
            "instanceType": "Abbreviation"
          },
          {
            "id": "be449c1c-b51f-49e3-a742-a1ec8dcaaba0",
            "abbreviatedText": "PTA",
            "expandedText": "Post-Trial Access",
            "instanceType": "Abbreviation"
          },
          {
            "id": "750dc20d-89c4-4551-a679-09a52c0de237",
            "abbreviatedText": "PSDS",
            "expandedText": "post study drug supply",
            "instanceType": "Abbreviation"
          },
          {
            "id": "6377371f-6216-4799-b16d-089698a40cfa",
            "abbreviatedText": "HLH",
            "expandedText": "hemophagocytic lymphohistiocytosis",
            "instanceType": "Abbreviation"
          },
          {
            "id": "b3594d74-2f59-42f0-906c-898575bc1bb6",
            "abbreviatedText": "MHRA",
            "expandedText": "UK Health Authority",
            "instanceType": "Abbreviation"
          },
          {
            "id": "af3df1f7-0229-40b3-b3fa-4783fe925a41",
            "abbreviatedText": "PK",
            "expandedText": "Pharmacokinetic",
            "instanceType": "Abbreviation"
          },
          {
            "id": "96035f4f-e68f-4d93-a125-28a111e6f6ee",
            "abbreviatedText": "IG",
            "expandedText": "Immunogenicity",
            "instanceType": "Abbreviation"
          },
          {
            "id": "b13ecb14-191c-47e7-a3e9-9f1bf05dbbe2",
            "abbreviatedText": "RECIST 1.1",
            "expandedText": "Response Evaluation Criteria in Solid Tumors",
            "instanceType": "Abbreviation"
          },
          {
            "id": "49342a38-e0a4-4ae8-9446-e6b477e04f95",
            "abbreviatedText": "PRO",
            "expandedText": "Patient reported outcomes",
            "instanceType": "Abbreviation"
          },
          {
            "id": "f80a0861-7079-4364-85ba-aeb8914496a9",
            "abbreviatedText": "PFS",
            "expandedText": "progression-free survival",
            "instanceType": "Abbreviation"
          },
          {
            "id": "033eeb89-0301-4559-b91d-049e74f94d7a",
            "abbreviatedText": "OS",
            "expandedText": "overall survival",
            "instanceType": "Abbreviation"
          },
          {
            "id": "1e19906a-5cd4-4fb7-8577-d48580dcbe7d",
            "abbreviatedText": "SAE",
            "expandedText": "Serious Adverse Events",
            "instanceType": "Abbreviation"
          },
          {
            "id": "b682c4b8-0f3f-4b8d-97c4-5d2e607fa5a5",
            "abbreviatedText": "IWRS",
            "expandedText": "Interactive Web Response System",
            "instanceType": "Abbreviation"
          },
          {
            "id": "4851c971-b129-41bf-b43f-39caf5364d6b",
            "abbreviatedText": "DMC",
            "expandedText": "Data Monitoring Committee",
            "instanceType": "Abbreviation"
          },
          {
            "id": "4b5a58c1-f7ba-4fec-808d-a46df44bf204",
            "abbreviatedText": "IRB",
            "expandedText": "Institutional Review Board",
            "instanceType": "Abbreviation"
          },
          {
            "id": "4efbc36e-83ce-4825-8175-6031cf83ae96",
            "abbreviatedText": "IEC",
            "expandedText": "Independent Ethics Committee",
            "instanceType": "Abbreviation"
          }
        ],
        "amendments": [
          {
            "id": "afda4971-9fbb-4b03-bebc-98174c15f15a",
            "number": "7",
            "name": "Amendment 7",
            "scope": {
              "id": "e8caaa83-635f-45a1-ad48-e255145be932",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "7fa30912-3552-4b17-a073-c1469ce3284e",
              "code": {
                "id": "24b49b59-8fd8-4a4a-9038-708c56ad08cc",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "26370f3a-8d39-4fcd-be00-997073f7b9b0",
                "type": {
                  "id": "9ba68109-bb6d-4413-82ad-46b6dc4cdbf3",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The main purpose of this amendment is to: 1) revise the definition of end of study to include Post-Trial Access (PTA) program i.e rollover protocol or a post study drug supply (PSDS) option for patients still on study treatment and in the opinion of the investigator still deriving clinical benefit at the time of end of the study, 2) update safety information on hemophagocytic lymphohistiocytosis (HLH), and update of 'dose modification and recommended clinical management guidelines' in the safety section including treatment resumption for recurrent grade 4 asymptomatic amylase or lipase elevation per UK Health Authority (MHRA) request.",
            "effectiveDate": "2023-01-27",
            "reasonIds": [
              "f09021e1-a09f-4794-90be-e4dc0a034aed",
              "a5002bd9-2998-4181-9bda-53ba17206923",
              "adb95fa2-6d2f-4627-b823-a540e3bffc44"
            ],
            "previousVersion": "6",
            "newVersion": "7"
          },
          {
            "id": "5cf78b26-77db-418b-940f-621e47b9e635",
            "number": "6",
            "name": "Amendment 6",
            "scope": {
              "id": "e7cab561-3706-4142-b61d-58bb10e73369",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "9153ab25-7743-4234-b90e-8ed2cda1618e",
              "code": {
                "id": "08be169e-2bf9-47fe-86a0-3d1a8a4b624d",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "b7833d1c-2e57-4764-a6e2-5e6445c27969",
                "type": {
                  "id": "796e6bb4-ec59-4d8b-9b27-d9baa60c7888",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The main reason for preparation of this amendment was to update on primary PFS analysis outcome and provide rationale for continued safety and overall survival follow-up of ongoing patients. It also includes guidance on COVID-19 related challenges, updates contraception requirements based on new Investigator's Brochure data, and mandates unblinding of study treatment for ongoing patients.",
            "effectiveDate": "2020-10-13",
            "reasonIds": [
              "0772b3e7-463c-4c61-8049-5f085c13b242",
              "2e1d2682-6acc-444b-b579-1745b1c166e3",
              "ade9408f-f3ea-4015-84cc-40908e0bb248"
            ],
            "previousVersion": "5",
            "newVersion": "6"
          },
          {
            "id": "a7a163d5-8cbf-4289-ac17-39de4b7d8f20",
            "number": "5",
            "name": "Amendment 5",
            "scope": {
              "id": "a150e44e-0df6-474d-a10d-14415175efc3",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "6ff9900e-40da-4f1a-a6eb-4d9a20637197",
              "code": {
                "id": "bac90376-468f-44b6-a9ad-e108beeec95a",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "686da295-7da9-483e-a9c7-a1769ec7ed05",
                "type": {
                  "id": "445a7dd3-d4bb-41d8-be5e-ceed330985c7",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The primary objective of this protocol amendment is to adjust the timing of the final PFS analysis and to include an interim analysis for PFS based on revised assumptions on the delayed treatment effect, following observations from the KEYNOTE-022 trial in a similar patient population.",
            "effectiveDate": "2019-03-08",
            "reasonIds": [
              "95a0ea43-1c0b-43b5-bf0a-4ff5964c5a8f",
              "1126f714-953f-4cbe-9241-a4cc76ac55f8"
            ],
            "previousVersion": "4",
            "newVersion": "5"
          },
          {
            "id": "3f839013-21ec-42cb-99c4-4ef16cf859a9",
            "number": "4",
            "name": "Amendment 4",
            "scope": {
              "id": "72aea842-bc9c-4410-84fe-8a49a2b5ff38",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "1307ae24-7b95-4e26-985d-5b44e9a11753",
              "code": {
                "id": "015e8f82-3340-4abb-a067-0b1fdbe1cad5",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "6389b533-063d-465f-814f-a930a28df055",
                "type": {
                  "id": "12622d37-e874-4012-8cd2-8cc3492ab2f1",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The primary objective of this protocol amendment is to align the contraception requirements during and after study treatment based on the dabrafenib Investigators Brochure (IB) Edition 10 and trametinib IB Edition 9. Further, the safety follow-up periods have been aligned with the contraception requirements.",
            "effectiveDate": "2018-08-14",
            "reasonIds": [
              "d9fdd53e-ff2c-4b20-a7b2-19d97f2f510c",
              "6d6f5d00-c01d-4576-a106-700fd8145005",
              "5824c036-3425-4cbc-8a7f-b1c1f2bab7be"
            ],
            "previousVersion": "3",
            "newVersion": "4"
          },
          {
            "id": "da592c84-9b2c-4d42-b4eb-d407eccd34b8",
            "number": "3",
            "name": "Amendment 3",
            "scope": {
              "id": "58c4cc18-fabf-4fea-b31f-5512165191ea",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "f5a5c063-5395-4a8d-aef6-668ec3d927e1",
              "code": {
                "id": "83df0648-8e95-4fb0-87f7-668414b3baee",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "90a841cf-cc18-4b85-9e9a-5b6317f7dd34",
                "type": {
                  "id": "b7b89554-b5e6-46bd-9967-86ea6c2ebbbf",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The primary objective of this protocol amendment is to change pyrexia management guidelines based on the safety profile observed in the safety run-in (part 1) and feedback received from investigators upon review of safety data.",
            "effectiveDate": "2017-07-14",
            "reasonIds": [
              "5dcaadf5-4fe3-4c40-810a-24b57700ec5c",
              "f1fa944c-c262-4177-8caa-aaf2f56b727d"
            ],
            "previousVersion": "2",
            "newVersion": "3"
          },
          {
            "id": "27727ee8-3ea9-488d-8423-955355285ef9",
            "number": "2",
            "name": "Amendment 2",
            "scope": {
              "id": "eb04faa7-4f17-4c50-a3b4-bc5b87018c77",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "9ab2afbc-83f9-46c1-b199-d49f6380103d",
              "code": {
                "id": "e3e2f361-54f6-459b-8d74-5d707c2b9b1d",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "2a66f5b0-77ca-471d-bf20-eaf59452d0da",
                "type": {
                  "id": "3839cd75-5a16-43da-9e08-1d175588d77b",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "Amendment 2 is required to implement specific feedback received from the U.S. Food and Drug Administration (FDA) and the German Paul-Ehrlich Institute (PEI) and the French health authority ANSM (agence nationale de scurit du medicament) upon review of the protocol.",
            "effectiveDate": "2017-03-07",
            "reasonIds": [
              "876ea656-b15f-47dd-ac57-9fdb26524ac9"
            ],
            "previousVersion": "1",
            "newVersion": "2"
          },
          {
            "id": "287fa26c-e027-4eef-a003-7b2699b99170",
            "number": "1",
            "name": "Amendment 1",
            "scope": {
              "id": "0b796c84-38d4-41c8-82bb-e84c78de7954",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "fc4149c8-f284-49ee-88bd-0f137f8c78b8",
              "code": {
                "id": "4e21dff8-a35c-4391-b8cb-2e6795a73b71",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "15d716b0-4b9a-4579-910e-b428f43d1558",
                "type": {
                  "id": "a95d257c-f375-45b6-bad8-4122049380fa",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The primary purpose of this protocol amendment is to clarify that double barrier contraception methods are not classified as highly effective methods, per Clinical Trial Facilitation Group (CTFG) guidelines.",
            "effectiveDate": "2017-01-27",
            "reasonIds": [
              "07bd6127-3898-43da-8245-ef01a9c18fd3",
              "668d29eb-4709-40ae-b594-ddefc41c43d7"
            ],
            "previousVersion": "Original Protocol",
            "newVersion": "1"
          }
        ],
        "medicalDevices": [
          {
            "id": "8ac9489d-e8d8-4de2-9ade-189b912a38b6",
            "name": "Electrocardiograph",
            "instanceType": "MedicalDevice",
            "label": "ECG Device",
            "description": "Device used to record the electrical activity of the heart",
            "deviceType": {
              "id": "532e0d0a-4173-4859-b0ff-ab86bf74bfc0",
              "code": "Diagnostic Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Diagnostic Device",
              "instanceType": "Code"
            }
          },
          {
            "id": "b330b643-73e4-4fa1-a328-dfcb574ae20b",
            "name": "Optical Coherence Tomography",
            "instanceType": "MedicalDevice",
            "label": "OCT",
            "description": "Imaging device for retinal abnormalities",
            "deviceType": {
              "id": "7487cf67-0ffb-496f-9cb6-e5727528eb4b",
              "code": "Diagnostic Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Diagnostic Device",
              "instanceType": "Code"
            }
          },
          {
            "id": "7f0ce74f-14ff-4e81-80d3-ab7d949fc1c9",
            "name": "Infusion Set",
            "instanceType": "MedicalDevice",
            "label": "IV Line",
            "description": "Equipment for intravenous administration of PDR001",
            "deviceType": {
              "id": "ed3e1810-d86e-4346-8d3d-b6e2e67c0839",
              "code": "Drug Delivery Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Drug Delivery Device",
              "instanceType": "Code"
            }
          },
          {
            "id": "5b5cb51c-e8b4-407c-955e-dc62a99f71c5",
            "name": "THxID-BRAF Assay",
            "instanceType": "MedicalDevice",
            "label": "BRAF V600 Assay",
            "description": "FDA approved molecular test for BRAF mutation status",
            "deviceType": {
              "id": "2d6f4f27-8f15-4dae-bcbc-7bbbef8b298b",
              "code": "Diagnostic Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Diagnostic Device",
              "instanceType": "Code"
            },
            "manufacturer": "Biomerieux",
            "modelNumber": "THxID-BRAF"
          },
          {
            "id": "04f4845b-a668-434d-bf28-600ec80c81b1",
            "name": "Intrauterine Device",
            "instanceType": "MedicalDevice",
            "label": "IUD",
            "description": "Contraceptive device",
            "deviceType": {
              "id": "8e13771c-9f57-40df-a0df-ca4b61ff2f6f",
              "code": "Implantable Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Implantable Device",
              "instanceType": "Code"
            }
          }
        ],
        "conditions": [
          {
            "id": "43b010eb-b3e2-4678-b785-0da623181999",
            "name": "Dose Limiting Toxicity (DLT)",
            "instanceType": "Condition",
            "description": "Criteria for defining toxicities that limit dose escalation in Part 1",
            "text": "Criteria for defining dose-limiting toxicities as per Table 6-6"
          },
          {
            "id": "bf32d32c-509b-4700-9139-4f14435c0794",
            "name": "Pyrexia Management",
            "instanceType": "Condition",
            "description": "Trigger for dose interruption due to fever",
            "text": "Fever higher than 40C (104F) or complicated by rigors, hypotension, dehydration, or renal failure"
          },
          {
            "id": "e2af4796-3e1f-4332-8595-6d56c866639e",
            "name": "Liver Enzyme Toxicity",
            "instanceType": "Condition",
            "description": "Permanent discontinuation criteria for PDR001",
            "text": "Abnormal liver enzyme functions considered related to study treatment by the investigator"
          }
        ],
        "studySites": [
          {
            "id": "6424f2fc-397d-4564-9cfa-dad92f17a6a1",
            "name": "California Cancer Associates for Research and Excellence",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "1",
            "organizationId": "3b99560b-0f37-4db8-9f61-7709294caed9",
            "country": "United States"
          },
          {
            "id": "e9373ca2-66bb-48bf-8651-81a2d767a1ac",
            "name": "UC Irvine Medical Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "2",
            "organizationId": "b97f6825-cc67-4e34-8c7f-330875dfed6c",
            "country": "United States"
          },
          {
            "id": "152fcbb0-09d3-460d-b3e5-7ae8a69cec95",
            "name": "California Pacific Medical Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "3",
            "organizationId": "23630f9a-3cce-4e60-990a-fbd041cc29e5",
            "country": "United States"
          },
          {
            "id": "519533f9-8cff-4cba-bcb5-b4ce9cfcb4d6",
            "name": "Stanford Cancer Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "4",
            "organizationId": "a6de8037-adc6-4504-bff3-a7151e284b6d",
            "country": "United States"
          },
          {
            "id": "e3d8ca60-ba46-4e58-a156-cf32753c3e25",
            "name": "University of Kansas Cancer Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "5",
            "organizationId": "a02ac875-2a86-4e34-83c7-7db3bfadc560",
            "country": "United States"
          },
          {
            "id": "abcc4426-4960-41b3-a056-6ec3b352e1ba",
            "name": "Johns Hopkins U",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "6",
            "organizationId": "25f2edf0-18dd-41d6-8f74-342eddbbdd29",
            "country": "United States"
          },
          {
            "id": "dac2310a-6d2b-4102-b9c3-33d8b9c4f486",
            "name": "Nebraska Cancer Specialists",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "7",
            "organizationId": "768e5440-d33c-44a4-a841-d3d591ade0cc",
            "country": "United States"
          },
          {
            "id": "2f23e232-ed34-428f-b749-5d9f1c98061b",
            "name": "NYU Laura and Isaac Perlmutter Cancer Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "8",
            "organizationId": "25320e92-9c56-42b3-82fa-a0bdc62cd57e",
            "country": "United States"
          },
          {
            "id": "f9f3dc08-f997-4626-b0a6-1ebdac77fca9",
            "name": "University of Pittsburgh Med Center",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "9",
            "organizationId": "80e84606-b286-4880-9e11-7fcc34246a1e",
            "country": "United States"
          },
          {
            "id": "3b7ceef3-eca8-4445-82a1-5df2de6c501a",
            "name": "University of Tennessee Medical Ctr",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "10",
            "organizationId": "7b100b72-0768-4939-86a8-7ec82d70b849",
            "country": "United States"
          },
          {
            "id": "0b06314a-908c-453c-b8b4-8b79b86f2b1d",
            "name": "Univ of TX MD Anderson Cancer Cntr",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "11",
            "organizationId": "cd9429c1-18cf-4ffd-8f23-78c6c82fb37e",
            "country": "United States"
          },
          {
            "id": "4f948645-3a86-4c04-bdef-e38508ec501c",
            "name": "Utah Cancer Specialists",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "12",
            "organizationId": "16fb6987-0676-4bfe-8e1d-17e3a23ab54f",
            "country": "United States"
          },
          {
            "id": "07a6285a-dab0-491c-a1d0-ab09e45792d8",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "13",
            "organizationId": "17eaf46e-b798-4124-b5d5-cf2b82c25eb7",
            "country": "Argentina"
          },
          {
            "id": "07d773d9-06d1-4423-b577-c1e7e5926956",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "14",
            "organizationId": "4e0f5b06-e1aa-4b22-9e80-ad9b5a944957",
            "country": "Argentina"
          },
          {
            "id": "77eb73b0-d1fe-4089-983a-e035b5c8db49",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "15",
            "organizationId": "2cc8a2a3-6b5a-44ab-b404-c549b0ea50d2",
            "country": "Argentina"
          },
          {
            "id": "d60a9a5b-6c8c-4a9b-a692-583419e36bfb",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "16",
            "organizationId": "e92278d5-6a27-414b-a240-e535978f2b72",
            "country": "Argentina"
          },
          {
            "id": "c07eee2b-55d3-4e86-a157-a71b39fa909c",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "17",
            "organizationId": "9b62cf8c-4b54-4eed-845e-21bcc4567a89",
            "country": "Australia"
          },
          {
            "id": "1d7c252b-f138-4fe3-a065-63b424c5a820",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "18",
            "organizationId": "0825f219-2b97-4cf7-8166-a2afccd86d86",
            "country": "Australia"
          },
          {
            "id": "46cc5d8c-6c1f-47d8-9345-5b8c1c686031",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "19",
            "organizationId": "4aacc3fe-d1c9-4fa9-82ab-b498c115aabb",
            "country": "Australia"
          },
          {
            "id": "7ed312ce-502d-472e-9ed2-192376fc6567",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "20",
            "organizationId": "2c82fec9-11df-40c4-9e77-52dbe3834643",
            "country": "Australia"
          },
          {
            "id": "9b133f0f-5231-4328-a487-a8ae70820228",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "21",
            "organizationId": "97a354c6-c4a3-4214-b768-a4dd5459fbc3",
            "country": "Australia"
          },
          {
            "id": "ee2f994c-5ede-41e9-a6a6-cc7112e60bd3",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "22",
            "organizationId": "3d2166b5-10db-4509-b9ff-68f5fe443017",
            "country": "Austria"
          },
          {
            "id": "8539fc87-0623-4fd1-beff-6b677e578e5c",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "23",
            "organizationId": "7405d6ac-1506-4590-9fe3-39cd4b71b81b",
            "country": "Austria"
          },
          {
            "id": "d537f754-e90b-469c-bf6b-7341cb575d12",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "24",
            "organizationId": "608f5b75-e3dc-47e0-81c1-314bdc2bb14a",
            "country": "Austria"
          },
          {
            "id": "fbaec538-6fa3-436f-bf8d-f2478f6a7f35",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "25",
            "organizationId": "711ace5d-86ac-48fb-865b-6f30af276fd9",
            "country": "Austria"
          },
          {
            "id": "87f6b06c-f194-49b2-8736-2f4d0d1aaa7d",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "26",
            "organizationId": "c29a9940-a04b-44e9-a79d-e6277efae46c",
            "country": "Austria"
          },
          {
            "id": "106bae4b-4c2b-4b59-adce-596ed3370ec9",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "27",
            "organizationId": "2ea0e486-f4d3-4dd0-aaaa-e60223a45b9c",
            "country": "Belgium"
          },
          {
            "id": "0b7866c0-8a23-4c77-9aa5-be9dc3f28292",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "28",
            "organizationId": "d6ac8e4c-2a33-40b1-85ee-b8c961cad14b",
            "country": "Belgium"
          },
          {
            "id": "e280d660-542a-4a2e-9dd2-c4275c2f9acb",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "29",
            "organizationId": "58c49b50-095c-4612-ada9-629ed4e559d5",
            "country": "Brazil"
          },
          {
            "id": "1991967f-166d-40a5-9776-2174fcd72914",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "30",
            "organizationId": "b4e61522-3345-4d96-9af7-197c306c24f5",
            "country": "Brazil"
          },
          {
            "id": "6bfb5b9c-4ad5-4350-b839-5f1cd5e19d61",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "31",
            "organizationId": "4b5d8244-c828-4a8f-aedf-9f4af8a15b2c",
            "country": "Brazil"
          },
          {
            "id": "0f177ab0-4e77-4ac3-a71a-94c5e9a78baa",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "32",
            "organizationId": "d7d560cc-bdcb-4279-b1c9-e114b07d9abb",
            "country": "Brazil"
          },
          {
            "id": "a4a4d4e1-0dd1-4d31-bc8a-1d6f16882df1",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "33",
            "organizationId": "aed94b6a-9710-4a96-abdd-3513a3c344a7",
            "country": "Bulgaria"
          },
          {
            "id": "4755ce68-f16e-4df9-9f47-2a7936bcdf8d",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "34",
            "organizationId": "6d826232-292c-401e-a0ec-dd023557cc12",
            "country": "Bulgaria"
          },
          {
            "id": "83b232df-9ebe-4824-bdfa-c2449a6f9de4",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "35",
            "organizationId": "3ae750dc-9f00-43c4-a98b-cee09ee6e493",
            "country": "Canada"
          },
          {
            "id": "63a0ba7a-381a-4339-be39-7df24fe2a94a",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "36",
            "organizationId": "a9217b07-150f-4086-9ecc-4e736ec04a10",
            "country": "Canada"
          },
          {
            "id": "ef92df83-a9a8-492c-b249-d4329fe4440f",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "37",
            "organizationId": "7041cbca-5506-4a50-8206-ea8caeb90251",
            "country": "Canada"
          },
          {
            "id": "04c5eb32-44ef-439d-9c24-391909b1b35a",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "38",
            "organizationId": "28522dda-e1cc-4a08-b064-4bd522d98a2a",
            "country": "Canada"
          },
          {
            "id": "5eaae387-d381-41e8-8501-6eac63fdf7cb",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "39",
            "organizationId": "3f252baf-0c78-4144-9948-45aa4633118d",
            "country": "Canada"
          },
          {
            "id": "f1e7da7f-01c9-4187-a38e-94b5104a2c9e",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "40",
            "organizationId": "c4b9ae91-2fcb-4819-b7e8-78702376c44e",
            "country": "Chile"
          },
          {
            "id": "a8b6f4ff-d228-4de5-96ac-8a730228235e",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "41",
            "organizationId": "4dfbccc1-9f35-4fa0-8514-6661449c5dc2",
            "country": "Chile"
          },
          {
            "id": "ec280e6d-a385-47e2-8124-f23c61d689ea",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "42",
            "organizationId": "aacf85eb-9705-4cee-85c8-ee60389c95d8",
            "country": "Chile"
          },
          {
            "id": "2208cff6-4f72-4a36-a827-9c777e849bac",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "43",
            "organizationId": "cae405bc-9efb-442d-af35-62e7e876d3e2",
            "country": "Czechia"
          },
          {
            "id": "b0c8e57d-bd53-4d13-aa5a-9f39ea6afc61",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "44",
            "organizationId": "8b9c775f-e2ec-4140-b81f-a638f400c0b3",
            "country": "Czechia"
          },
          {
            "id": "fe7c839d-ddae-4a09-87a6-18a3b2490e2d",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "45",
            "organizationId": "d53c627d-ffa6-4f36-b03f-4d0544b34fef",
            "country": "Czechia"
          },
          {
            "id": "3a79bf6e-fc36-40c8-a8dc-d7fb1138b708",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "46",
            "organizationId": "d8849d44-7626-4cec-8533-7e21e3081f61",
            "country": "Czechia"
          },
          {
            "id": "1ed13c87-2b3e-4277-b36e-93e5fe03cae4",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "47",
            "organizationId": "511b9228-950c-4244-9da0-77a1b52c53a1",
            "country": "Czechia"
          },
          {
            "id": "2861c5bc-0fcb-4e99-a79c-aa2cffebe940",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "48",
            "organizationId": "7ad1c0c4-8fa5-4f57-b22c-ea228e21a0e8",
            "country": "Czechia"
          },
          {
            "id": "a3c8f7e3-c154-47c0-b392-11f7ae4611ea",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "49",
            "organizationId": "8b28c468-9a2d-42de-943d-45b09ff1ba1a",
            "country": "Czechia"
          },
          {
            "id": "345a5b36-6724-4b2a-afaf-df1672fb94a1",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "50",
            "organizationId": "8ade3306-2e03-431a-9a2a-457cbda60345",
            "country": "Denmark"
          },
          {
            "id": "c445f610-3493-4eae-9a48-e28dcb049688",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "51",
            "organizationId": "1c394bad-2a94-4b4e-954d-87e980da34a4",
            "country": "France"
          },
          {
            "id": "539ec095-3732-4045-936c-5edec8b8f0fc",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "52",
            "organizationId": "30398518-1110-4373-a458-856b11d24580",
            "country": "France"
          },
          {
            "id": "f7e08190-d9af-4ac2-a291-d76bb309895d",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "53",
            "organizationId": "8dcbabba-2f5c-4e74-b848-c666ae141bd4",
            "country": "France"
          },
          {
            "id": "278fc307-47b5-4d60-87f6-720fe4ed35b3",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "54",
            "organizationId": "494926a4-8580-4e2a-bca0-75061cace039",
            "country": "France"
          },
          {
            "id": "8bb6a641-2602-4855-9b37-0d846f5fb845",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "55",
            "organizationId": "a54b0f0f-6b21-4ea0-aabb-b7fb8f0a29cb",
            "country": "France"
          },
          {
            "id": "c5701cb1-7270-4cfb-ae76-7618ed19857f",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "56",
            "organizationId": "acd0db0b-aef5-46f5-9168-5837aef7c029",
            "country": "France"
          },
          {
            "id": "7ec4f63a-27b1-42ec-ae93-968d40d0a6d2",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "57",
            "organizationId": "0619a745-9fba-4859-9551-682860212ae4",
            "country": "France"
          },
          {
            "id": "ac499ebd-33a5-4cb3-a2bb-8f7d3b8cc910",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "58",
            "organizationId": "62f1d851-213a-40d1-b807-3003aa7f20a4",
            "country": "France"
          },
          {
            "id": "20725702-9517-4a7d-85ba-2de1e1a46ffa",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "59",
            "organizationId": "2241d68a-9e74-4a86-8ee8-6fa8ffcc6045",
            "country": "France"
          },
          {
            "id": "84b26c7e-4f00-4d82-9f91-c8a73a434099",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "60",
            "organizationId": "0af276e3-8a4a-45a6-b3d5-113d6ed87b86",
            "country": "France"
          },
          {
            "id": "2f0fad36-3bac-4a9b-9b30-860506d22900",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "61",
            "organizationId": "6e30d96c-ef1e-4b04-8c85-5c7b8628e380",
            "country": "France"
          },
          {
            "id": "1531e0bc-f2ca-4d49-9e21-651881ab55bf",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "62",
            "organizationId": "0b3071f1-147d-4ba4-a399-743eebaa7538",
            "country": "France"
          },
          {
            "id": "c70d9bcf-48d2-4c9f-b7d0-ce592760d337",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "63",
            "organizationId": "c59d5305-7b82-42ae-b15c-903f97a42565",
            "country": "France"
          },
          {
            "id": "28214168-995d-4d89-9db9-02b58438ad5b",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "64",
            "organizationId": "16ae2069-4b79-4286-ac6d-c2971ca32f11",
            "country": "France"
          },
          {
            "id": "70e47b21-232d-44c4-a593-06f03e95d26e",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "65",
            "organizationId": "781de71e-524e-46a6-98af-d6efb16fd325",
            "country": "France"
          },
          {
            "id": "5c20f163-9866-4591-80c3-475711269e99",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "66",
            "organizationId": "6840bb9a-ceb6-46e0-887f-265148b12840",
            "country": "France"
          },
          {
            "id": "7ef7bb5d-d4e6-4e62-a1d3-c4cb583202fc",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "67",
            "organizationId": "81266d04-ed59-4290-8cf5-66cad844b275",
            "country": "France"
          },
          {
            "id": "9620c0bd-02c5-4307-a029-ada1a92b71b9",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "68",
            "organizationId": "57cc6d7f-685f-4d9e-98c3-78dd36c7770c",
            "country": "France"
          },
          {
            "id": "61530e82-fd76-4886-8729-e85b49231f58",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "69",
            "organizationId": "8f169dd9-262d-42b4-ba8a-673648fa1a74",
            "country": "France"
          },
          {
            "id": "0460872c-437b-4dc0-bf66-b1cf2643cd94",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "70",
            "organizationId": "4b46d47e-47e5-41eb-b8d9-0c561a022bd5",
            "country": "France"
          },
          {
            "id": "853d104e-4dbe-4a28-9a4c-3245a855fa75",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "71",
            "organizationId": "006432ee-c95c-473b-bc97-bb0022ed9502",
            "country": "France"
          },
          {
            "id": "dcd37087-2b75-4f96-b4e5-264d0d042080",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "72",
            "organizationId": "13a6545c-2139-4a9b-be60-a9c0a83a1a58",
            "country": "France"
          },
          {
            "id": "f7d780c0-645b-4f2b-9834-28f3b3c5b320",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "73",
            "organizationId": "e5ead6ea-8766-4d55-8300-17b0b3b1d54a",
            "country": "France"
          },
          {
            "id": "4ca23123-8f27-4996-a3f2-838d1ed61e6d",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "74",
            "organizationId": "ad88e84e-0ab0-449d-afde-89f263d5f400",
            "country": "France"
          },
          {
            "id": "c4e9d0e1-ed7e-4a44-b865-0ca95bb765f3",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "75",
            "organizationId": "612f1bc7-7ccd-4d66-ba95-aba0bab78e6f",
            "country": "France"
          },
          {
            "id": "dc6672b5-22c8-453e-8e19-b48297185663",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "76",
            "organizationId": "30cf0dd8-2ddc-4b6f-b455-2076b39b4539",
            "country": "France"
          },
          {
            "id": "cc9dba6e-8981-4f55-a557-07e474cf9175",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "77",
            "organizationId": "f18a5c98-780b-482f-93af-424672b92077",
            "country": "Germany"
          },
          {
            "id": "74f74c23-f9a7-4540-8757-63dfabd4131f",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "78",
            "organizationId": "995e34e7-8eee-4f4e-b487-0e81cc440d23",
            "country": "Germany"
          },
          {
            "id": "c9ca1947-4406-45de-ba57-bbc8db3360b0",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "79",
            "organizationId": "777b8d37-b783-4f6d-96fb-490a348154e5",
            "country": "Germany"
          },
          {
            "id": "fa9a7b9e-5d06-46c0-b164-a9e54d9ddb49",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "80",
            "organizationId": "fab21bb5-a4b1-48f3-b01d-8348912e4698",
            "country": "Germany"
          },
          {
            "id": "51fdaa50-c918-4c6f-9d52-02ccb631e375",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "81",
            "organizationId": "01bc7776-8ca8-49a7-84d8-c6757ba7f3bc",
            "country": "Germany"
          },
          {
            "id": "64b1610f-9004-492c-afea-6a124c338cc9",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "82",
            "organizationId": "e125d524-8dfd-4304-9e12-752e2100f000",
            "country": "Germany"
          },
          {
            "id": "08ec1f49-3976-49db-81ec-cee6c2d49637",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "83",
            "organizationId": "683f9649-9808-4d18-b094-a4fa04c730ba",
            "country": "Germany"
          },
          {
            "id": "e5fb3259-7cba-4449-9622-471f28284473",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "84",
            "organizationId": "7b326a3a-6307-4f15-b926-5cf0cd562a21",
            "country": "Germany"
          },
          {
            "id": "3c416f72-11a9-41e8-ab51-70230270cf8a",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "85",
            "organizationId": "9493637f-3224-4706-9619-abb305f09afa",
            "country": "Germany"
          },
          {
            "id": "0bf8d6d2-7ee2-490f-b856-b42374e343f6",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "86",
            "organizationId": "10bafece-530a-46bf-a02d-d704f9196fd8",
            "country": "Germany"
          },
          {
            "id": "22fcc90a-f1cb-41b5-b518-17f3ea2a5760",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "87",
            "organizationId": "342bab38-f78b-4d8b-8468-4a75337d9380",
            "country": "Germany"
          },
          {
            "id": "cb18f569-5b3b-4a88-b232-1ac47b7774ef",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "88",
            "organizationId": "d5043a90-f1d8-4292-abf1-9742218309ef",
            "country": "Germany"
          },
          {
            "id": "caf82eba-b546-4e47-ad33-20b4d89f44bf",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "89",
            "organizationId": "3788bed7-78d3-4eff-bd52-2e904950f21d",
            "country": "Germany"
          },
          {
            "id": "7e5085c9-6515-4fe1-a743-c1a41700abf9",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "90",
            "organizationId": "cd882bed-1dd2-4a8c-b6cd-d354a5dd3879",
            "country": "Germany"
          },
          {
            "id": "9282815a-255b-4913-a598-ebced91d8d21",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "91",
            "organizationId": "12641909-457b-4374-8cc9-ff9ff05899d1",
            "country": "Germany"
          },
          {
            "id": "28c8692b-3ce9-4c02-8b67-9889e39df220",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "92",
            "organizationId": "4a57dcf3-0abc-49bf-9e8e-8c67b5df21e5",
            "country": "Germany"
          },
          {
            "id": "3da568f3-6f2f-47d0-9f7a-b6e09265d876",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "93",
            "organizationId": "5013248a-e64d-4412-a1a6-010345bdf823",
            "country": "Germany"
          },
          {
            "id": "2e6bfccf-d2b6-4895-bbfe-6074bef051e5",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "94",
            "organizationId": "93ca8888-074d-4f04-945a-db399c57f42e",
            "country": "Germany"
          },
          {
            "id": "d52c2cee-6822-4acc-96c1-ae23e387e67f",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "95",
            "organizationId": "51eed748-97e3-4a9d-97b3-479b860d4a1e",
            "country": "Germany"
          },
          {
            "id": "1eb6035c-c3b1-4480-9447-eaa5b29d6b9b",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "96",
            "organizationId": "3780ac8d-c578-4ecd-90a4-9dd2c73f7875",
            "country": "Germany"
          },
          {
            "id": "902cabda-676a-4746-a416-d9cf190a875a",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "97",
            "organizationId": "25a0dad3-9d9e-482c-8ba6-d1e75a169256",
            "country": "Germany"
          },
          {
            "id": "22d01eaf-2141-4e6c-9695-b3c5986239d4",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "98",
            "organizationId": "06d24fb6-d4a2-49b0-962b-109821c3f426",
            "country": "Germany"
          },
          {
            "id": "ed5dceea-3cd6-49a1-a94b-b39682653163",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "99",
            "organizationId": "9c39ac4d-cbc3-47be-9c45-a28fcf4b4883",
            "country": "Germany"
          },
          {
            "id": "b641dfb8-2160-4b06-9486-adfc32082f8b",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "100",
            "organizationId": "1e3603a8-f310-4231-8945-15a4f3a0ab3b",
            "country": "Germany"
          },
          {
            "id": "f909562e-bfcd-4871-bcf4-773f91ee949e",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "101",
            "organizationId": "7f4cccff-2cca-4162-9160-2698855a6da5",
            "country": "Germany"
          },
          {
            "id": "ff03f071-bca6-4105-8d72-7d47f38b9d3d",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "102",
            "organizationId": "50006269-f41d-4d17-b13c-33374d11d9fb",
            "country": "Germany"
          },
          {
            "id": "dabd6231-10d3-49d0-a53e-faf03130bcaf",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "103",
            "organizationId": "ef08d6ba-6e65-429a-a400-3bec9af5dbad",
            "country": "Greece"
          },
          {
            "id": "27620e02-5f23-4f96-a2de-b471ec0b23a5",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "104",
            "organizationId": "8066832c-b6fd-47cb-8597-93bbf120d76e",
            "country": "Greece"
          },
          {
            "id": "ac942c87-da7e-4881-98bc-15fbaf98a646",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "105",
            "organizationId": "8996e625-30b2-42d7-8d60-0f3906d8b752",
            "country": "Hungary"
          },
          {
            "id": "ed5ac1e1-7f57-4227-ae91-b0fc884127dc",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "106",
            "organizationId": "9bfe2f69-3fd5-4c3c-b190-5ae5287af696",
            "country": "Hungary"
          },
          {
            "id": "e40116d3-601b-4021-85f3-89da76560972",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "107",
            "organizationId": "887fa372-49e9-4e26-a4b5-517c9a505b7d",
            "country": "Hungary"
          },
          {
            "id": "da811485-ad9f-414b-8457-29c3e80dfe0d",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "108",
            "organizationId": "e95ca027-db59-49c1-b356-9be95fb8bdfe",
            "country": "Israel"
          },
          {
            "id": "aa76560a-99a5-4b0c-9320-b496035d67c0",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "109",
            "organizationId": "a8a1cee6-1b22-46fc-b651-e41b23222357",
            "country": "Israel"
          },
          {
            "id": "9440de47-a43c-41d1-ab99-3d0d79b0f52b",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "110",
            "organizationId": "37473a34-f737-4bab-86b8-8230787f87fc",
            "country": "Israel"
          },
          {
            "id": "abb5d5e7-bc8c-4ebf-b4bc-0702d717e24b",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "111",
            "organizationId": "070ff2ca-ff37-460f-8610-35b46398b29a",
            "country": "Italy"
          },
          {
            "id": "67ece5bf-2bb5-4cf9-bcc1-eef38e9f42db",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "112",
            "organizationId": "fa12b09e-44c1-4cb6-9d59-f5c6e34c3d82",
            "country": "Italy"
          },
          {
            "id": "b50b49c5-4389-40a0-9615-e39c5358dbee",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "113",
            "organizationId": "2db44d6b-3d25-4d9a-a70b-39ec3645dbf3",
            "country": "Italy"
          },
          {
            "id": "26c10b22-0218-433f-adb8-b0883c57734f",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "114",
            "organizationId": "7cc8a518-7465-47f8-ad3d-4f942797e3e5",
            "country": "Italy"
          },
          {
            "id": "7b9ec04f-6376-43e5-b97b-c35aafa33d45",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "115",
            "organizationId": "44fb1573-93e0-4d9c-b319-a55f876e088b",
            "country": "Italy"
          },
          {
            "id": "2dabdb85-a397-4cbc-b4bd-e0ea356a3f57",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "116",
            "organizationId": "4e804634-62a5-4fb4-856b-015033ff0ce8",
            "country": "Italy"
          },
          {
            "id": "b420f955-119b-47ac-befb-f47190c72403",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "117",
            "organizationId": "ddfb3d4f-e8a6-49fa-968e-872534ea27d8",
            "country": "Italy"
          },
          {
            "id": "21f64d72-ae20-4358-a691-384a9e0e6bc1",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "118",
            "organizationId": "2f6e3b64-37f0-4385-95a6-fc3cfe0bb850",
            "country": "Italy"
          },
          {
            "id": "cdaad21f-9cba-4f53-bf4d-6a6e375bdc8d",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "119",
            "organizationId": "1e73ffc5-6cee-46fb-81fe-48f8089cedf0",
            "country": "Italy"
          },
          {
            "id": "2bfdef63-eee0-40d1-a09b-5243f4452a79",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "120",
            "organizationId": "15e9a182-9660-4996-a0a6-6ff424f17fcf",
            "country": "Italy"
          },
          {
            "id": "721c4648-4dec-4af0-8c34-ae2a9977c94e",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "121",
            "organizationId": "43f192de-ae33-4373-9e90-5543fa3d2a01",
            "country": "Italy"
          },
          {
            "id": "dd4ce4ab-a92c-4163-984b-46aec27fd572",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "122",
            "organizationId": "0ac8378c-5f61-42e5-a365-31257776b234",
            "country": "Italy"
          },
          {
            "id": "18d2d6ab-5172-4bd2-b250-accf28212ea9",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "123",
            "organizationId": "1e115e5c-d590-406b-9882-2822a74bcfb1",
            "country": "Italy"
          },
          {
            "id": "e01ae490-6fa6-4b13-8ffa-55105ce290e5",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "124",
            "organizationId": "72ddf273-2423-4f1f-ae06-aa312398e2e0",
            "country": "Italy"
          },
          {
            "id": "02e791ea-cff4-43d0-bd36-bdfc55cb438d",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "125",
            "organizationId": "7f5929c0-b971-4c0f-830d-1efde953da83",
            "country": "Italy"
          },
          {
            "id": "57743393-4adb-4788-8df9-d9b0fa62ed6d",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "126",
            "organizationId": "e70243a2-f25f-416d-9806-09f2007fcbe4",
            "country": "Italy"
          },
          {
            "id": "ed2d0cce-9b8d-4f70-9efc-ea2a6002a7ef",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "127",
            "organizationId": "40326a18-8d6d-4cb3-a190-1c8e458d4cbe",
            "country": "Italy"
          },
          {
            "id": "09320edc-41cf-4dfa-802d-c202d6f69b9c",
            "name": "Kyushu University Hospital",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "128",
            "organizationId": "9297d242-bf67-4fe2-8d1f-db589eada746",
            "country": "Japan"
          },
          {
            "id": "f2166589-ca86-4d85-aeae-726ae6d7b1d8",
            "name": "Kyoto University Hospital",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "129",
            "organizationId": "9ba039c8-0f87-4f32-8305-9b02d4f338d9",
            "country": "Japan"
          },
          {
            "id": "c48a2471-8088-4788-abfb-e1a846b8fd7b",
            "name": "Osaka International Cancer Institute",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "130",
            "organizationId": "2b8de7cf-e3eb-4261-b6ae-f24f0036ab43",
            "country": "Japan"
          },
          {
            "id": "29a78d9d-6953-46bf-9795-50caa716ea47",
            "name": "Tokyo Metropolitan Komagome Hospital",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "131",
            "organizationId": "3fd75078-05e8-40e9-aba6-2eebc1119923",
            "country": "Japan"
          },
          {
            "id": "9a60e897-eba1-484c-94f4-815e5f73b98b",
            "name": "National Cancer Hospital",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "132",
            "organizationId": "f891caad-ab61-42fa-a970-692d5af3c18d",
            "country": "Japan"
          },
          {
            "id": "ad160a5a-7c88-4654-9828-d4c21b10d619",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "133",
            "organizationId": "20e0dfc4-c135-4890-b250-d39a76756b28",
            "country": "Mexico"
          },
          {
            "id": "09d1e0f4-4520-4f84-bfb2-d70b61db7de0",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "134",
            "organizationId": "99eabf58-5e5d-42d5-bd1d-351babb4716a",
            "country": "Mexico"
          },
          {
            "id": "d4ec5bd2-55dc-4afe-bf66-85872da47322",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "135",
            "organizationId": "96a5d88a-cd7e-4410-ac93-8ca3fd62dd03",
            "country": "Mexico"
          },
          {
            "id": "074d9560-0d77-4a75-8c66-ca6c009d133d",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "136",
            "organizationId": "fa0dd2d4-8885-488a-afaf-42f666dc4c9d",
            "country": "Netherlands"
          },
          {
            "id": "5a385584-9352-4b46-b93e-90af2721e128",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "137",
            "organizationId": "27786173-dd5b-46b3-adc4-e6a8aa533c15",
            "country": "Netherlands"
          },
          {
            "id": "32ae184f-4801-4cb9-8b5b-2a61b63c11ec",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "138",
            "organizationId": "50c7af8b-83f7-46ca-a066-41053b681988",
            "country": "Norway"
          },
          {
            "id": "f8a49039-f979-490a-9978-9c0b6b7a7507",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "139",
            "organizationId": "47f96244-0a91-4de7-955c-f7d1287f26cf",
            "country": "Poland"
          },
          {
            "id": "de08acf1-e593-4d1c-9732-1e8f1250f689",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "140",
            "organizationId": "7d0bc13d-1858-42f7-9b1e-ea4272987a55",
            "country": "Poland"
          },
          {
            "id": "4e80e032-9439-410d-9815-5e3e1e60f1c8",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "141",
            "organizationId": "71df38fc-14c0-4609-ae00-0e1c1cc078e8",
            "country": "Portugal"
          },
          {
            "id": "9b0d226a-a4df-4841-bce9-43ab41b2cf26",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "142",
            "organizationId": "f9feeb80-bca1-4d50-a184-5cef674eb834",
            "country": "Portugal"
          },
          {
            "id": "726162b3-b5e4-44be-a8d9-19f155f2746c",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "143",
            "organizationId": "9e6db355-cd40-492f-a952-2082f46b2c69",
            "country": "Russia"
          },
          {
            "id": "a5304d6d-6640-4459-a5b3-c416078d00f3",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "144",
            "organizationId": "e61478af-f48d-4d24-812c-a79dafb6cd4e",
            "country": "Russia"
          },
          {
            "id": "f1746325-4838-4805-bfd6-6d70a666a343",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "145",
            "organizationId": "290bbdea-af87-43b2-bcda-94d215fa1573",
            "country": "Russia"
          },
          {
            "id": "99e5d595-4a9e-4d3e-9e74-e77c4df753ba",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "146",
            "organizationId": "69451169-3775-497b-882b-da5f8d33de25",
            "country": "Russia"
          },
          {
            "id": "71c9e4f0-245c-4836-bf61-fa7b0ffd0f06",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "147",
            "organizationId": "fbb82125-705b-4d53-9034-8cf94068b964",
            "country": "Russia"
          },
          {
            "id": "8e1d0a3c-7254-4747-969b-cdb1374a93a0",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "148",
            "organizationId": "a5a0575f-4e76-41d4-98a9-c39a1e59e02e",
            "country": "Russia"
          },
          {
            "id": "add93c00-eb43-48e4-9893-7e2c8dde9d9b",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "149",
            "organizationId": "ded28505-690c-499a-adb1-541952e73a17",
            "country": "Russia"
          },
          {
            "id": "39bcb0c9-ce9f-4a3e-bcdd-e21b285f4c18",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "150",
            "organizationId": "1b664dbb-4f2f-44d0-9f01-a1777d99cc9e",
            "country": "Russia"
          },
          {
            "id": "06dd6fac-4cfc-4af3-9f97-f60d3fa3019e",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "151",
            "organizationId": "9effbcdc-b53c-40cf-aeb4-07366370fa30",
            "country": "Spain"
          },
          {
            "id": "a446af7d-a64b-4d42-8dab-11622ebfb753",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "152",
            "organizationId": "55de569b-9faa-480f-a082-0d3f1410bb53",
            "country": "Spain"
          },
          {
            "id": "3265813c-c9d0-4187-bda1-e79bf35d74bf",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "153",
            "organizationId": "2f0de98d-b831-443f-8f6b-c2a08cabeadb",
            "country": "Spain"
          },
          {
            "id": "7b772e6a-1491-47c0-8d54-c2fb0e043034",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "154",
            "organizationId": "0da5b18c-b7d6-4b73-a4c5-26737ce3eb5a",
            "country": "Spain"
          },
          {
            "id": "f89a9d74-68c3-467a-8856-f08143031ce4",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "155",
            "organizationId": "913e7ed2-81c3-432e-a223-eb6fe1e1ac44",
            "country": "Spain"
          },
          {
            "id": "2532509a-5a7f-4416-9be4-aee4205f67e3",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "156",
            "organizationId": "07f4a072-7199-430b-883a-c53fcf4312b8",
            "country": "Spain"
          },
          {
            "id": "c1496613-ef9b-4697-bdee-a73416db3f8c",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "157",
            "organizationId": "a740eacc-bf19-44c4-a3bf-d7cfb2016c2a",
            "country": "Spain"
          },
          {
            "id": "5cc7f407-ade8-46fc-8432-f799803b3bc2",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "158",
            "organizationId": "7ef9612d-4a36-464c-91be-cec22f2e1caa",
            "country": "Spain"
          },
          {
            "id": "2211859e-cb47-4354-96e4-41d45cb2983b",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "159",
            "organizationId": "e6ba6f67-7ff4-410a-b59e-82293a76fab6",
            "country": "Spain"
          },
          {
            "id": "b23accc1-2da2-4cd1-a479-bbb497d8718c",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "160",
            "organizationId": "535ec041-a8c7-4abd-8eae-e9d04ec8e152",
            "country": "Spain"
          },
          {
            "id": "5511a785-3d43-48da-9293-bcd34623d09c",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "161",
            "organizationId": "35033825-e007-46f0-9083-d6b95193be2f",
            "country": "Spain"
          },
          {
            "id": "e7d20716-939a-4919-9661-cbb0113470da",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "162",
            "organizationId": "b6d2b7e4-25d2-4927-877e-ed4e2aaf2701",
            "country": "Spain"
          },
          {
            "id": "eb2fe0d2-9968-4db8-baff-bc337f632a24",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "163",
            "organizationId": "1fb6542f-9729-434a-a2c2-c00781da12ce",
            "country": "Spain"
          },
          {
            "id": "dc509c00-91a9-434c-984b-b6c0990617f3",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "164",
            "organizationId": "1a216f3d-822b-47bb-a35b-bd831632d3eb",
            "country": "Sweden"
          },
          {
            "id": "fcada914-327a-4b53-991b-270accf99097",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "165",
            "organizationId": "5119a2ed-c9c8-4702-b3e0-b83fb6299138",
            "country": "Sweden"
          },
          {
            "id": "32e2b950-8162-434e-a616-2337e9ca479f",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "166",
            "organizationId": "ba61ee2f-f5af-48bf-95d8-293342c4bc47",
            "country": "Sweden"
          },
          {
            "id": "b226a908-2fdc-49ae-80c2-02ae5c09be7e",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "167",
            "organizationId": "d2eb85fa-6089-45ea-a1ff-0b57f0725967",
            "country": "Switzerland"
          },
          {
            "id": "f959e78f-69e8-45a2-978b-13bc0fd6f942",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "168",
            "organizationId": "a58ea1e4-ba41-4a78-984f-6915a60ec323",
            "country": "Switzerland"
          },
          {
            "id": "29f4dff7-77c3-46df-8735-20d8d39a92e0",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "169",
            "organizationId": "c9f96d53-95a3-45a9-a2ab-fe94998e1116",
            "country": "Thailand"
          },
          {
            "id": "951c3caf-70ec-40c3-b9d6-4b9cd5af5023",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "170",
            "organizationId": "e76517c5-84d2-42a7-a5c7-d0d51ef7becd",
            "country": "Thailand"
          },
          {
            "id": "a2430ced-72a4-4a9b-a9f5-b3873b34ef09",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "171",
            "organizationId": "e53602d2-6666-428d-a217-2c1d2f907890",
            "country": "United Kingdom"
          },
          {
            "id": "198939b2-5239-4acd-ae83-97712e4f5f8c",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "172",
            "organizationId": "7a26b153-ccf3-4480-973a-74e0baa62bb3",
            "country": "United Kingdom"
          },
          {
            "id": "b853d29a-6135-42d0-9040-50ab8399a8c4",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "173",
            "organizationId": "89870f34-414d-4796-a874-1bdac1e9541a",
            "country": "United Kingdom"
          },
          {
            "id": "75f626bf-8c59-4678-88a9-9c9e2ea3b163",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "174",
            "organizationId": "7e17dc5e-0933-4a4e-84d7-94ffea337edd",
            "country": "United Kingdom"
          },
          {
            "id": "7f41f6c2-23eb-4118-8557-c0d056a3f975",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "175",
            "organizationId": "3cd1d25e-3260-48ec-81fc-f7c129ad8f5d",
            "country": "United Kingdom"
          },
          {
            "id": "899ec35b-b6d4-4162-bdf5-5aa819d2d140",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "176",
            "organizationId": "a32bb51f-18d8-4f90-94d1-dff9a64b1353",
            "country": "United Kingdom"
          },
          {
            "id": "3640e576-171d-40a2-a8f3-ffddde8156cc",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "177",
            "organizationId": "39c4257e-cf45-4f39-9c28-9640eef85a76",
            "country": "United Kingdom"
          },
          {
            "id": "4205085e-5e6c-467b-94d4-3aa05b96db9c",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "178",
            "organizationId": "06378412-5feb-483a-a86f-d8d24bca0a5d",
            "country": "United Kingdom"
          },
          {
            "id": "6158cd68-5da5-46fb-abbe-43c631c0a3c5",
            "name": "Novartis Investigative Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "179",
            "organizationId": "489224ab-66a0-4961-9060-59e5183c00b2",
            "country": "United Kingdom"
          }
        ],
        "administrations": [
          {
            "id": "0bbfa90a-1e37-46df-a82b-802792408006",
            "name": "Administration of PDR001 (spartalizumab)",
            "description": "RouteOfAdministration.INTRAVENOUS DosingFrequency.EVERY_FOUR_WEEKS",
            "instanceType": "Administration",
            "route": {
              "id": "531f266c-00bb-4644-babb-4cd80d3493cb",
              "code": "C38276",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "Intravenous",
              "instanceType": "Code"
            }
          },
          {
            "id": "5a73d391-ed6a-45be-84e6-5a3dd8ce061a",
            "name": "Administration of Dabrafenib",
            "description": "RouteOfAdministration.ORAL DosingFrequency.TWICE_DAILY",
            "instanceType": "Administration",
            "route": {
              "id": "f21f0584-6494-40b5-bae3-120c3cbf00e8",
              "code": "C38288",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "Oral",
              "instanceType": "Code"
            }
          },
          {
            "id": "b8cfcb60-3a73-4aa8-bf9c-545daefad6e0",
            "name": "Administration of Trametinib",
            "description": "RouteOfAdministration.ORAL DosingFrequency.ONCE_DAILY",
            "instanceType": "Administration",
            "route": {
              "id": "aa447249-1c12-4fa8-86e4-e8380289b808",
              "code": "C38288",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "Oral",
              "instanceType": "Code"
            }
          },
          {
            "id": "5d387cc6-449d-4e66-9d09-d2baed202275",
            "name": "Administration of Placebo",
            "description": "RouteOfAdministration.INTRAVENOUS DosingFrequency.EVERY_FOUR_WEEKS",
            "instanceType": "Administration",
            "route": {
              "id": "bfd9baa3-af1f-4992-8728-b4e7a334e770",
              "code": "C38276",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "Intravenous",
              "instanceType": "Code"
            }
          }
        ],
        "rationale": "Protocol version"
      }
    ],
    "name": "A Phase III, randomized, double-blind, placebo-controlled study of PDR001 in combination with dabrafenib and trametinib in patients with BRAF V600 mutation-positive unresectable or metastatic melanoma"
  },
  "administrations": [
    {
      "id": "8786617a-a60d-4275-94c4-8ae5c17c3ef7",
      "name": "Standard Triplet Regimen",
      "instanceType": "Administration",
      "dose": "PDR001 400 mg, Dabrafenib 150 mg, Trametinib 2 mg",
      "doseFrequency": "PDR001 Q4W, Dabrafenib BID, Trametinib QD",
      "route": {
        "id": "1ace21fd-9792-4cab-9655-f4b08d0f83b8",
        "code": "Oral",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Oral",
        "instanceType": "Code"
      },
      "duration": "Until disease progression or unacceptable toxicity"
    },
    {
      "id": "6a840547-9274-4019-9bd8-6bda5ade8b65",
      "name": "Safety Run-in Co-administration",
      "instanceType": "Administration",
      "dose": "Dabrafenib 150 mg, Trametinib 2 mg",
      "doseFrequency": "90 minutes after PDR001 completion",
      "route": {
        "id": "524f1ada-e98d-4dd3-8e3c-01cb0a6e0771",
        "code": "Oral",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Oral",
        "instanceType": "Code"
      },
      "duration": "Part 1 specific instruction"
    }
  ],
  "substances": [
    {
      "id": "37d3e3a1-23eb-421d-98c9-b043d57e0f6f",
      "name": "PDR001",
      "instanceType": "Substance",
      "description": "Anti-PD-1 monoclonal antibody"
    },
    {
      "id": "7c03fd70-0088-4d67-ae8f-9e06b128b5b4",
      "name": "Dabrafenib",
      "instanceType": "Substance",
      "description": "BRAF inhibitor"
    },
    {
      "id": "fabe9dcd-6db0-4091-8f67-56e12388363c",
      "name": "Trametinib",
      "instanceType": "Substance",
      "description": "MEK inhibitor"
    }
  ],
  "studyDefinitionDocument": {
    "id": "fb329c9c-aa4b-4896-b422-49ede356c02d",
    "name": "Protocol No. CPDR001F2301",
    "documentType": "Protocol",
    "language": "en",
    "instanceType": "StudyDefinitionDocument",
    "version": "07 (Clean)",
    "versionDate": "27-Jan-2023",
    "contentIds": [
      "d7c8b419-107c-4150-98f8-6a1490d7961b",
      "22184ca8-86f6-4a0b-a33b-9075d3228e91",
      "7c544ee3-b02a-4ab8-a7e0-3ddfa83d501b",
      "c91b0fb8-d216-4fed-9ee5-f8026100bffd"
    ]
  },
  "geographicScope": {
    "id": "cd8043e7-1c79-4d9d-a299-b9392d7bdac7",
    "name": "Study Geographic Scope",
    "scopeType": "Global",
    "instanceType": "GeographicScope",
    "countryIds": [
      "aa06a7ce-c2a7-4373-8a24-1acd76c28220",
      "46c640ee-9012-4355-8dbf-ef16b6b72093",
      "f4199622-5306-40df-9567-e0b01ff169db",
      "f0b816b5-8a2d-48cb-b598-25fdc3ca2fa8",
      "8af860b9-2cb1-4908-ac0a-34456bfca71c"
    ],
    "regions": [
      "North America",
      "Europe"
    ]
  },
  "countries": [
    {
      "id": "aa06a7ce-c2a7-4373-8a24-1acd76c28220",
      "name": "United States",
      "instanceType": "Country",
      "code": "US"
    },
    {
      "id": "46c640ee-9012-4355-8dbf-ef16b6b72093",
      "name": "Germany",
      "instanceType": "Country",
      "code": "DE"
    },
    {
      "id": "f4199622-5306-40df-9567-e0b01ff169db",
      "name": "France",
      "instanceType": "Country",
      "code": "FR"
    },
    {
      "id": "f0b816b5-8a2d-48cb-b598-25fdc3ca2fa8",
      "name": "United Kingdom",
      "instanceType": "Country",
      "code": "GB"
    },
    {
      "id": "8af860b9-2cb1-4908-ac0a-34456bfca71c",
      "name": "Switzerland",
      "instanceType": "Country",
      "code": "CH"
    }
  ],
  "ingredients": [
    {
      "id": "fbafc248-cee4-4189-8beb-ed914cfa1374",
      "name": "PDR001",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "Spartalizumab"
    },
    {
      "id": "aad4ec7c-1b22-40dd-9911-f7896340c196",
      "name": "Dabrafenib",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "GSK2118436"
    },
    {
      "id": "41cfe340-abf2-4191-b609-fce6d9fd82a5",
      "name": "Trametinib",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "GSK1120212"
    },
    {
      "id": "93546303-b243-425e-afd6-b0a3489cec81",
      "name": "Prednisone",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "Corticosteroid"
    },
    {
      "id": "26acfab6-92b9-45e7-9ba4-09d61c5df7d6",
      "name": "Dacarbazine",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "DTIC"
    }
  ],
  "strengths": [
    {
      "id": "65ac9f1b-7c53-449b-8628-a4745f8e8ef3",
      "instanceType": "Strength",
      "value": 10,
      "unit": "mg",
      "numerator": {
        "value": 10,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "day"
      }
    }
  ],
  "transitionRules": [
    {
      "id": "0e1dafef-3598-476b-add2-d03814692296",
      "name": "Screening to Treatment",
      "instanceType": "TransitionRule",
      "transitionType": "Epoch Transition",
      "fromElementId": "e8c879ff-ffc8-4eb7-b6fa-f769eb6be0dd",
      "toElementId": "743272b1-abe7-4751-92a2-a7373681c2f9",
      "text": "Completion of screening assessments and confirmation of BRAF V600 mutation status"
    },
    {
      "id": "3c54ba0b-928a-4f79-90e5-54c142c8ed44",
      "name": "Dose Modification for Pyrexia",
      "instanceType": "TransitionRule",
      "transitionType": "Dose Modification",
      "text": "Interrupt dabrafenib and trametinib at first symptom; restart at same dose if symptom-free for 24 hours"
    },
    {
      "id": "58a6f8ac-0b7d-4408-954a-4d493dbd7c30",
      "name": "Safety Discontinuation",
      "instanceType": "TransitionRule",
      "transitionType": "Discontinuation",
      "text": "Permanent discontinuation of PDR001 for Grade 2 or higher uveitis of > 6 weeks duration"
    },
    {
      "id": "a9d852bb-f7d7-4b24-8458-3b74875a89c3",
      "name": "Post-Trial Access Transition",
      "instanceType": "TransitionRule",
      "transitionType": "Epoch Transition",
      "fromElementId": "743272b1-abe7-4751-92a2-a7373681c2f9",
      "toElementId": "6937eea0-24ed-477a-912e-6010235ae705",
      "text": "Patients deriving clinical benefit at end of study may transfer to rollover protocol or PSDS option"
    }
  ],
  "documentContentReferences": [
    {
      "id": "5a19d77b-9907-48b0-ad99-fe9af9b6d01f",
      "name": "End of Study Definition",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "4.3",
      "sectionTitle": "Definition of end of study",
      "description": "Revised to include Post-Trial Access (PTA) program information."
    },
    {
      "id": "8ea0a795-d5a7-430a-b2f3-7557746d6ae1",
      "name": "AE Management Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "6.3",
      "sectionTitle": "Dose modifications and reductions",
      "description": "Table 6-8 updated to include Hemophagocytic lymphohistiocytosis (HLH) reference."
    },
    {
      "id": "c0351c17-ffab-4ef5-a603-886c6f3d7d30",
      "name": "Pneumonitis Guidelines",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "6.3.3.6",
      "sectionTitle": "Table 6-13",
      "description": "Clarification of mandatory dose modifications and clinical management for pneumonitis."
    },
    {
      "id": "5395a063-41f6-420f-a7d5-704d8e97b17a",
      "name": "Amylase/Lipase Management",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "6.3.3.11",
      "sectionTitle": "Table 6-18",
      "description": "Updated for PDR001 resumption at 2nd occurrence of grade 4 asymptomatic amylase/lipase."
    },
    {
      "id": "22f86030-c798-48a1-99db-617574621b62",
      "name": "Imaging Assessment Plan",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "7.2.1",
      "sectionTitle": "Table 7-4",
      "description": "Updated to include public health emergency disruption proofing language."
    },
    {
      "id": "63a78d72-111b-42e5-a39d-468c193835a7",
      "name": "Statistical Assumptions",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "10.8",
      "sectionTitle": "Sample size calculation",
      "description": "Reference for statistical analysis and assumptions regarding delayed treatment effect."
    },
    {
      "id": "606ec1f1-cc39-44e0-ac24-dfec294cd6ac",
      "name": "RECIST Appendix",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "14.1",
      "sectionTitle": "Appendix 1: RECIST 1.1",
      "description": "Detailed efficacy assessment and definitions using RECIST 1.1 criteria."
    }
  ],
  "commentAnnotations": [
    {
      "id": "e1feb7d1-f179-49af-9e22-1f251ad96e6d",
      "text": "For asymptomatic amylase and/or lipase elevations refer to Table 6-18",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "6.3.3.12, Table 6-19",
      "pageNumber": 27
    },
    {
      "id": "2867f65c-f47c-4769-a02b-8ba040f386f3",
      "text": "Placebo administrations to those patients randomized to the placebo arm will discontinue while dabrafenib and trametinib may continue for the same patients",
      "annotationType": "Clarification",
      "instanceType": "CommentAnnotation",
      "sourceSection": "6.5.3",
      "pageNumber": 19
    },
    {
      "id": "af93d5d9-b540-446d-b187-2af25281aa76",
      "text": "The changes herein affect the Informed Consent. Sites are required to update and submit for approval a revised Informed Consent.",
      "annotationType": "Note",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Amendment Summary",
      "pageNumber": 20
    },
    {
      "id": "0f447365-0dc5-4188-a14b-807f62cd5e98",
      "text": "Language was updated to align with the latest Novartis protocol template (OneCTP version 5.0).",
      "annotationType": "Note",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Amendment 7 Rationale",
      "pageNumber": 18
    }
  ],
  "studyDefinitionDocumentVersions": [
    {
      "id": "97fa6cda-450c-4562-8296-c915b4132f94",
      "versionNumber": "07",
      "status": "Final",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2023-01-27",
      "description": "Revised end of study definition for PTA, updated HLH safety info, and added public health emergency mitigation.",
      "amendmentNumber": "Amendment 7"
    },
    {
      "id": "a68ac0a5-9239-412a-970b-39ad04fb3094",
      "versionNumber": "06",
      "status": "Final",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2020-10-13",
      "description": "Enabled continuation following final PFS analysis to characterize OS benefit; mandatory unblinding.",
      "amendmentNumber": "Amendment 6"
    },
    {
      "id": "b9aa540d-d1ba-45a7-a910-521526af536b",
      "versionNumber": "05",
      "status": "Final",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2019-03-08",
      "description": "Adjusted timing of final PFS analysis and included interim PFS analysis based on delayed treatment effect.",
      "amendmentNumber": "Amendment 5"
    },
    {
      "id": "5359bf4d-0263-4bfe-8af7-5564d0798790",
      "versionNumber": "04",
      "status": "Final",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2018-08-14",
      "description": "Aligned contraception requirements with IB updates and updated GDPR personal data definitions.",
      "amendmentNumber": "Amendment 4"
    }
  ],
  "computationalExecution": {
    "ready": true,
    "supportedSystems": [
      "EDC",
      "ePRO",
      "CTMS",
      "RTSM"
    ],
    "validationStatus": "complete"
  }
}